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A B S T R A C T
The determination o f total iodine and selenium in human breast milk (H BM ) and infant 
formula (IF) by inductively coupled plasma mass spectrometry (ICP-MS) is presented. 
Instrumental memory effects associated with iodine ( l2 7 I+) signals were reduced through the 
development o f pneumatic nebulisation washout solutions (nitric acid sample digests: 5%  
H 2 SO 4  /  0 .5%  Triton X -1 00 ; tetramethyl ammonium hydroxide (TM A H ) sample digests: 1%  
TM A H ). The use o f nitric acid for sample dissolution did not result in the complete 
digestion o f the fat and protein content. This resulted in poor levels o f ICP-MS signal 
stability, precision and accuracy coupled with the blockage o f ICP-MS nebuliser and 
interface components. For example, the calculated iodine concentration in NIST CR M  1549 
non-fat milk powder was 1233 ±  1 2 1  pg/kg (following digestion with HNO 3 -H 2 O 2 ), 
compared to the certified value o f 3380 pg/kg. However, sample dissolution with T M A H  
resulted in improved precision and accuracy levels o f 3250 ±  160 pg/kg. Similar problems
n q ^
were found for total selenium analysis (using Se ). TM A H  dissolution did not result in the 
complete digestion o f actual milk samples, with deposition o f non-dissolved solids occuring 
0 1 1  the ICP-MS injector. This also resulted in reduced precision levels and ultimately 
instrument shutdown. Enzymolysis o f H BM  and IF with enzymes: C andida rugosa, M ucor 
m iehei and P ronase  addressed this problem through improved sample clean-up, particularly 
when coupled with open vessel T M A H  dissolution. This resulted in improved signal and 
instrument stability o f ICP-MS measurements for total iodine and selenium. The prohibitive 
cost o f enzymes led to the enzymolysis and analysis o f a limited number o f actual milk 
samples. Therefore, the single step method with TM A H  dissolution was applied to the 
complete range o f H BM  and IF collected from around the World. Total iodine (95 -  140 
pg/1) and selenium (16 -  50 pg/1) measured in human breast milk collected from the U K  
agreed with previously reported values. Iodine (265 -  953 pg/kg or 43 -  158 pg/1) and 
selenium (32 -  191 pg/kg or 3 -  32 pg/1) levels measured in U K  infant formula samples 
were in agreement with reported literature values for reconstituted infant formula, but 
slightly higher for dry milk powder. In general, South American IF contained the higher 
iodine and New Zealand higher selenium levels. Speciation analysis o f iodine by ion 
chromatography coupled to ICP-MS, confirmed that iodide present in H BM  and IF (whey) 
was equivalent to 71 and 84%  o f the total iodine content. These findings were in general 
agreement with other published values.
© Michael James Watts 2001
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L ist o f  A bbreviation s
A A S atomic absorption spectrometry
BS british standard
CEM channel electron multiplier
cps counts per second
CRM certified reference material
D D W distilled deionised water
FFA free fatty acid
GC gas chromatography
GC-FID gas chromatography -  flame ionisation detector
GPx glutathione peroxidase
H BM human breast milk
HIV human immunodeficiency virus
HPLC high pressure liquid chromatography
IA E A international atomic energy authority
IC ion chromatography
ICP inductively coupled plasma
ICP-AES inductively coupled plasma atomic emission spectrometry
ICP-MS inductively coupled plasma mass spectrometry
ICP-OES inductively coupled plasma optical emission spectrometry
IDD iodine deficiency disorder
IF infant formula
LCP long chain polyunsaturate
LOD limit o f detection
N A A neutron activation analysis
NFR nebuliser flow rate
R D A recommended daily allowance
R f forward power (radiofrequency)
RP reverse phase
rpm revolutions per minute
rsd relative standard deviation
sd standard deviation
SDS sodium dodecyl suphonate
SEC size exclusion chromatography
TG triacylglycerol
T M A H tetramethyl ammonium hydroxide
T X -100 triton X -100
W H O world health organisation
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Chapter 1
Introduction
CHAPTER 1 - INTRODUCTION
1.0 Introduction
A fundamental requirement o f all analytical measurements is the need to ensure quality 
in terms of accuracy and precision. For trace and ultra-trace elemental analysis of 
biological samples a major problem involves the pre-analysis steps, namely sample 
dissolution / digestion. Traditionally for techniques such as inductively coupled plasma 
mass spectrometry (ICP-MS) the sample must be in a liquid form (for solution 
nebulisation) and have a solids content of less than 1% (to prevent blockage o f the 
nebuliser, sample tubing, interface cones / skimmer). Therefore, biological reference 
materials and samples are digested using mineral acids / peroxides in conjunction with 
open or closed digestion facilities (water bath, oven, heating block, microwave).
Unfortunately, for most biological materials these pre-analysis steps can cause problems 
that affect the quality o f measurements. In particular, body fluids (human breast milk) 
and foodstuffs (infant formula) can contain high levels of lipids relative to many ultra- 
trace element concentrations (essential or toxic). After digestion using nitric / 
hydrofluoric or nitric / peroxide mixtures the sample solution still contains traces of 
undigested lipids. It is generally assumed that this component o f the digested sample 
does not influence either the sample introduction efficiency or the signal sensitivity o f 
the ICP-MS. However, significant changes in nebuliser efficiency and signal stability 
were observed, both of which affect accuracy and precision.
Proposed research will evaluate the use of enzymolysis methods as a pre-digestion 
method to further acid / alkali digestion or direct sample introduction. The analytical 
protocols for using enzymolysis will be developed for the determination o f iodine and 
selenium in human breast milk and infant formula. Subsequent ICP-MS measurements 
will be used to validate the proposed improvements in accuracy and precision. In 
addition, quality assurance measurements will be undertaken using a certified reference 
material (CRM). The impact of this work will be to assess the quality o f traditional pre-
1
analysis acid digestion steps for biological samples and the reliability o f existing 
certified values for biological CRMs.
An additional feature of this work will be to evaluate the speciation o f iodine in terms of 
its bioavailability. There is a need to evaluate, identify, characterise and quantify the 
iodine species in human breast milk to further the understanding o f the chemistry o f 
iodine, in particular its bioavailability and toxicity. In this respect, the development of 
an infant formula may be improved with the supplementation o f the correct ‘species’ or 
form o f trace element, so that it becomes a more ‘humanised’ alternative to human 
breast milk.
1.1 Human Breast M ilk and Infant Formula:
Sources o f Infant Nutrition
It is generally assumed that breast milk is a source o f nutrition that fulfills the human 
infant nutritional requirements. However, in some instances breast milk may not be the 
preferred food for the following reasons;
( 1) infants who have a birth defect in their metabolism are unable to tolerate lactose 
or some amino acids in milk protein, i. e. allergic reaction,
(2) infants whose mothers are infected with agents transmissable through the breast 
milk, such as Human Immuno-deficiency Virus (HIV), and
(3) infants whose mothers are using therapeutic or addictive drugs that may be 
transmissable in the breast milk.
Despite the general assumption that breast milk is the optimum source o f nutrition, for 
many years prior to 1975 the majority o f babies born in the United Kingdom (UK) were 
not breast-fed after leaving hospital. Since then there has been a trend towards 
breastfeeding from birth (1975; 51% and 1990; 64%), although the intake o f breast milk 
towards 6 months of age declined in both periods (1975; 9% and 1990; 21%) [Webb,
1995]. The figures provided by The Office for National Statistics in 1995 showed little
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difference in the breastfeeding pattern in the United Kingdom compared to the data 
from 1990 (from birth; 66% and from 6 months; 21%) [Foster, 1997].
National breastfeeding statistics can conceal considerable differences relating to the age, 
educational status o f the mother, her social class and geographical location. Only 60% 
of mothers in manual social class groups breastfeed their infants from birth, compared 
to 80% of those in non-manual groups. Just 13% of babies in social group V (i.e. 
lowest income, level o f education) receive breast milk at 4 months, compared with 56% 
in social group I (i.e. highest income, level o f education). Mothers who remained in 
full-time education until they were 18 years old were 3.5 times more likely to breastfeed 
their babies to 4 months of age than mothers who left school aged 16 or under. The 
choice o f feeding method for the first-born often influences subsequent children. 
Mothers in Southern England are much more likely to breastfeed than mothers 
elsewhere in the UK. The lowest average rates are found in Northern Ireland, where 
just 45% of babies are breastfed at birth. Large discrepancies can also occur within 
cities, for example breastfeeding rates can vary between 9 and 75% in different 
postcode zones in Glasgow.
Each year, 75,000 mothers stop breastfeeding in the first postnatal week, but only 1% 
chose to do so. More than 80% of mothers who gave up breastfeeding before 4 months 
would have preferred to continue for longer. Many factors lead to the early end of 
breastfeeding such as, illness (mother or infant), the inconvenience for mothers wishing 
to return to work, the general disapproval o f breastfeeding in public in the UK, or the 
exclusion of the father. The mother may also produce insufficient milk, the baby may 
be unable to suckle and breastfeeding may take too long or be painful for the mother. 
The availability o f a cheap and simple alternative, such as infant formula, may also be a 
contributing factor [Foster, 1997].
There are a number o f benefits relating to the breastfeeding of an infant, such as;
(1) improved bonding between mother and infant [Zetterstrom, 1999, BFHI, 
2000];
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(2) improved immunity o f the infant - breast milk contains immunoglobulin A 
which protects the mucosal surfaces of the digestive tract and upper respiratory 
tract from pathogens. It also contains immune cells, which aid immunological 
protection of the infant gut. The iron binding protein lactoferrin has a 
bacteriostatic effect, as well as aiding iron absorption;
(3) the restoration o f maternal pre-pregnant weight -  fat stored during pregnancy 
acts as a store to help meet the energy demands placed upon the mother during 
lactation;
(4) breastfeeding reduces the risk o f developing breast cancer in young women 
[WHO, 2000];
(5) the cost of infant formula in the industrialised countries is negligible, but can be 
prohibitive in many Third World countries where the formula would account for 
a substantial proportion of the household budget. This problem may also lead to 
the over-dilution o f the formula as an economy measure, potentially starving the 
infant;
(6) hygiene is not a problem in industrialised countries since water used to prepare 
the formula is very safe and is prepared with boiled water in sterile bottles. The 
risk o f contamination in Third World countries is very serious owing to the 
purity o f water supplies, the lack o f sterilising facilities, relatively high cost of 
fuel used for boiling water and inadequate storage conditions for pre-mixed 
formula. Therefore, bottle-fed babies in Third World countries are at a greater 
risk o f developing gastrointestinal infections [UNICEF, 2000, W HO, 2000];
(7) in cultures where suckling occurs for extended periods rather just in early 
infancy, fertility is reduced. Although it is not a reliable method of 
contraception, prolonged breastfeeding could have a useful contribution to 
overall birth control in Third World countries [Webb, 1995], and
(8) higher breastfeeding initiation and duration rates would significantly improve 
the health of a nation. Savings associated with increased breastfeeding rates 
could release funds for training in other areas o f care [UNICEF, 2000]. Breast 
feeding infants and their mothers are at a lower risk o f certain illnesses. 
Therefore, in addition to the health benefits of breastfeeding there are potential
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cost savings for the health system. It is estimated that the NHS spends £35 
million per year in England and Wales in treating gastroenteritis in bottle-fed 
infants and for each 1% increase in breastfeeding at 13 weeks, a saving o f 
£500,000 in the treatment o f gastroenteritis would be achieved [Department of 
Health, 1995].
The main aim o f formulating substitutes for human milk is to provide an infant formula 
that is as nutritionally close to human milk as possible. Modern milk-based infant 
formula, closely match the macronutrient composition of human milk. However, infant 
formula specifically designed to meet unique nutritional needs, may differ from the 
composition of human milk, for example soya- and goats-milk based infant formula 
[Durrant et al., 1988, Durrant and Ward, 1989].
The production, labelling and marketing of infant formula are required to follow strict 
guidelines within the European Commission [Directive 91/321/EEC] and around the 
World [WHO, 1981]. However, the protein, vitamin and mineral contents of infant 
formula are usually higher than the average levels of these nutrients in human milk in 
order to provide adequate nutrient intakes for all of the infants consuming these 
products. I f  a formula contains the average nutrient level in human milk, then by 
definition half of all infants fed this formula would receive less than they would from 
breastfeeding. Increasing the amount of nutrients to above the average amount in 
human milk ensures that the majority o f infants will receive as much as from human 
milk. It is essential that the addition o f nutrients to infant formula is carefully 
controlled to provide adequate amounts of nutrients, but it is equally as important to 
avoid toxic levels. In addition, the correct ‘bioavailable form’ o f the supplemented 
nutrient must be added to the infant formula, for example iodide and selenite in the case 
o f iodine and selenium.
Alternatives to the breastfeeding of infants have been sought and used since the stone 
age. The earliest known infant feeding vessel was found in Cyprus and is dated 2000 
B.C. [Tsang, 1988]. It was not until the late 19th century that sanitation practices were
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developed by scientists, such as Koch and Pasteur, which enabled the safe feeding of 
milk or milk substitutes to infants. Between 1890 and 1915 a popular feeding method 
proposed by Thomas Morgan suggested that the infant required nourishment tailored to 
their digestive system and that the percentage composition, rather than the amount, was 
the critical factor. This approach led to the use of the term “formula” [Tsang, 1988]. 
Several formulations were developed in the following years based on buttermilk, high 
protein milk, soybean flour and acidified milk. In this period, the first nutritionally 
complete infant formula was made, these were designed to imitate human breast milk as 
closely as possible at that time. Gerstenberger blended various animal and vegetable 
oils, combined with protein and sugar to make Synthetic Milk Adapted, the forerunner 
o f the modern S.M.A. Sobee. ProSobee used soybean as a source o f protein and was 
introduced in 1929 to meet the needs o f cows milk hypersensitive infants.
The quality of human breast milk is controlled by physiological processes and is limited 
by the capacity of the mother to adapt to the stresses of disease, malnutrition, 
dehydration, environmental toxins and hygiene. When these factors are coupled with 
the genetic variability from mother to mother, considerable variability o f the 
composition of breast milk can occur, but within a range to which normal term infants 
can adapt. Modem infant formula undergo strict quality control procedures to comply 
with governmental regulations i.e. European Commission [Directive 91/321/EEC], 
USA [Food and Drug Administration], These regulations define the composition o f 
infant formula, in terms of the nutrients supplied to the infants in predetermined 
amounts and as specified on the label. There are over 30 components in an infant 
formula and therefore, the assurance o f a quality product requires the coordination o f a 
number o f diverse roles within a manufacturing company and effective communication 
with the regulatory authorities.
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1.2 General Chemical Composition o f Human Breast Milk and 
Infant Formula
Human breast milk and infant formula are complex matrices that consist o f a number of 
essential dietary components. Four o f these of these components (trace elements, 
proteins, vitamins and lipids) will be discussed in general terms, with further 
discussions for iodine and selenium in Section 1.4 and 1.5, respectively.
1.2.1 Trace elements
The nutritional importance o f nutrients, including trace elements has been increasingly 
recognised in recent years. This has been partly due to the technical advances in 
analytical and clinical chemistry which have made it possible to measure trace elements 
accurately at very low concentrations within clinical samples (sub-pg/1 or sub-ng/g). 
An increased awareness o f the relationship between dietary trace elements and the 
occurrence o f chronic diseases (e.g. hypertension, cancer, cardio-vascular disease) has 
also contributed to the improved knowledge o f these nutrients. This relationship is 
usually connected with insufficient dietary intakes of nutrients. It is recognised that 
such deficits have important long-lasting effects on infants, because they can alter the 
functioning of most organs. In addition, some research on trace elements and infant 
nutrition has centered on the formulation of infant formula and other dietary products 
[Chierici, 1994].
An adequate supply of trace elements is essential for optimum development o f all 
metabolic functions in the newborn infant. At least seventeen o f the ninety naturally 
occurring elements are classified as trace elements, ten of these (Cr, Co, Cu, F, Fe, I, 
Mn, Mo, Se, Zn) are considered to be essential for the nutrition o f infants, owing to 
their physiological importance [Bratter, 1996]. The absence of an adequate supply of 
these trace elements in the diet results in disturbances in growth, metabolism and 
development o f pathology. Breast milk and cows milk / soya-based milk formula, are 
the only source of these essential trace elements in early infancy. Breast milk is used as 
the benchmark against which infant formula are compared [Renner, 1989, Jensen,
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1995]. It is apparent that many of the nutritionally important trace elements are usually 
less available from infant formula than human breast milk [Hurrel et al., 1989]. 
Consequently, many trace elements are added to infant formula to obtain an equal 
amount o f absorbed nutrients similar to that absorbed from breast milk. Thus trace 
elements are present in infant formula at much higher levels than in breast milk. 
Usually no allowances are made for the trace element content o f the raw material used 
in infant formula and the water used to dilute the formula, potentially leading to large 
variations between geographical regions.
The metabolism and nutritional requirements o f trace elements involve factors such as, 
nutrient-nutrient interactions at the cellular and intestinal level. In addition, specific 
dietary components such as dietary fibre, may inhibit intestinal absorption and therefore 
restrict the utilisation o f the trace elements. Factors such as growth, pregnancy and 
lactation may also interfere with the utilisation or bioavailability o f these minerals and 
trace elements. Bioavailability is defined by the proportion of a nutrient in a food that 
is absorbed and utilised [Renner, 1989]. Utilisation is the process o f transport, cellular 
assimilation and conversion into a biologically active form. Excess, as well as the 
deficiency, o f a trace element may lead to poor health. An improved understanding of 
the mechanisms responsible for the bioavailability of trace elements from human breast 
milk, soy-based and cows-milk-based formula is necessary in order to optimise the trace 
element supply in infant formula with respect to the quantity and quality. The 
identification of dietary components that affect bioavaiiability will enable the 
formulation o f an infant formula more representative o f human breast milk. Hence, the 
high supplementation o f inorganic salts would no longer be necessary [Lonnerdal,
1991].
Speciation affects the bioavailability and toxicity of trace elements. It is defined as the 
process of identification of the chemical forms in which an element is present in food, 
body fluids and tissues. Speciation also refers to the oxidation state and the presence of 
complexes with other elements. It can provide information with regards to how the 
element is metabolised. Very little is known about the mechanism o f absorption of
inorganic trace elements. Most trace elements are taken up by the epithelial cells o f the 
duodenum and small intestine, either by active or passive transport, depending upon the 
individual mineral and the quantity present in the gastrointestinal tract at any time 
[Fairweather-Tait, 1999].
Nutrients that occur in a free form, like soluble ions, are generally easily absorbed, 
whereas those that are organically bound are often poorly absorbed. Manganese and 
chromium are examples of the latter, they readily form stable complexes with ligands, 
which inhibit absorption. Iodine in milk exists as iodide (84%) [Gushurst, 1984], 12% 
of selenium in milk was estimated to be incorporated in the selenium-dependent enzyme 
glutathione peroxidase. A large proportion of selenium is found in two major organic 
forms, selenomethionine and selenocysteine and two major inorganic forms, selenite 
and selenate. A study o f premature infants showed that when selenite was added to 
infant formula, 70% was absorbed and that most of the element was retained 
[Ehrenkranz et al., 1991]. Studies have not been conducted yet on the effect of milk 
and other infant diets on the absorption of iodine [Lonnerdal, 1994].
The chemical form of trace elements also has an influence on its distribution within 
breast milk and infant diets. For example, 5% of selenium has been associated with the 
fat fraction, and could be a component o f the milk fat globule membrane. 
Approximately 80% of the selenium was associated with proteins, whereas a highly 
variable (0 -  40%) fraction was dialysable. A major selenium-containing protein in 
human milk is the selenium dependent glutathione peroxidase, as well as a number o f 
unknown proteins [Milner et al., 1987]. Infant formula are generally supplied with 
inorganic trace elements, whereas in human breast milk only iodine was found to be in 
an inorganic form, in addition to various organic compounds amounting to about 20% 
of the supply of iodine [Bratter et al., 1998].
A number o f factors besides the chemical form of dietary selenium and size of 
supplement intake may influence the distribution o f trace element-containing chemical 
species [Thompson, 1998];
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( 1) dietary factors, other than size and chemical form of the element, may affect the 
distribution among tissues. For example methionine intake influences the 
absorption and distribution o f selenium in rats;
(2) the trace element status o f a subject may influence its speciation, including 
various factors, such as age, gender, smoking, drinking and race may influence 
blood selenium concentrations, leading to changes in selenium speciation, and
(3) the physiological state o f the body, such as lactation [Moser-Veillon et al.,
1992] and pregnancy [Thomson, 1994] may also influence selenium metabolism 
and speciation.
1.2.2 Vitamins
Vitamins are a heterogeneous group o f organic substances that are essential food factors 
o f very high biological activity. They are required in small amounts for the growth and 
maintenance o f normal cell and organ functions. Vitamins must be supplied through the 
diet, since the body is unable to produce them in amounts required for optimal health. 
Vitamins are classified into two groups; the fat-soluble vitamins (A, D, E and K) and 
water-soluble vitamins (C, B i, B 2, B 3, B 6, pantothenic acid, biotin, folic acid and B 12). 
The chemical configuration of water-soluble vitamins allows them to act as coenzymes 
and act as carriers o f some particular chemical grouping. Fat-soluble vitamins function 
as the integral parts o f cell membranes and are similar in structure to steroid hormones 
[Basil and Dickerson, 1996].
Diseases due to vitamin deficiencies have been known for some time, some, such as 
scurvy, pellagra and beri beri were long known by navigators of the 1700’s. Since this 
time, it has been known that these diseases could be cured through dietary means. The 
isolation and identification o f the metabolically essential nutrients only occurred in the 
early part o f the twentieth century. Diseases due to vitamin deficiencies do not develop 
quickly, but actually progress through a slow transition from adequacy to deficiency. 
Dietary deficiency causes a decrease in the amount of a vitamin in circulation, followed 
by a decrease in the cells, resulting in an impairment o f metabolic processes. Some 
tissues retain particular vitamins to a greater degree, whilst others are more susceptible
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to small changes in vitamin availability. For example, the brain is more sensitive to 
vitamin Bi (thiamin), owing to its high consumption o f glucose [Basu and Dickerson,
1996].
1.2.3 Proteins
Cows milk contains three times the protein content o f human milk. Therefore, if  infants 
were fed on cows milk they would need to excrete substantial amounts o f urea, whereas 
when breast-fed the bulk o f the nitrogen is retained for growth. Approximately 20%  of 
the nitrogen in cows milk and breast milk is non-protein nitrogen {e.g. urea, creatine, 
taurine and free amino acids), its biological significance is unclear, but this fraction is 
absent from infant formula [Webb, 1995]. The amino acid taurine is added to infant 
formula, since it is considered to be essential for infants.
The principal proteins in breast milk are whey and casein with an approximate ratio o f 
70 : 30, respectively. Casein is divided into three subgroups; a, p and k casein. Whey 
proteins are divided into six major groups: a-lactalbumin, p-lactoglobulin, lactoferrin, 
serum-albumin, lysozyme and immunoglobulins (A, G and M).
The protein concentration o f breast milk is approximately 12 g/1 when measured as total 
nitrogen. However, 25%  of this is non-protein nitrogen, much o f which is not used for 
nutritional purposes and excreted as urea. Investigations have indicated that a 
significant amount of the whey proteins in human breast milk are not absorbed, hence 
the actual total protein available for absorption becomes approximately 7 g/1 
[Workshop on Current Issues in Feeding the Normal Infant, 1984],
1.2.4 Lipids
Fat or lipids are the main source o f energy for the newborn infant, providing 40 -  50% 
of the total calories in human breast milk or infant formula. Lipids are also essential for 
normal development, since they provide fatty acids which are: ( 1) necessary for brain 
development, (2) an integral part o f cell membranes, and (3) the principle vehicle for
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fat-soluble vitamins and hormones in milk. In contrast to the limited storage capacity 
for carbohydrates and proteins, lipids can be stored in the human body in virtually 
unlimited amounts. Prior to birth, the major source of energy is glucose, whereas fatty 
acids are supplied from maternal circulation as free fatty acids. After birth, lipids are 
supplied mainly in the form of milk triglycerides or triacylglycerols.
Mature human breast milk and infant formula contains approximately 3 to 5% o f fat. 
Milk lipids are contained within membrane-enclosed milk fat globules. The core o f 
these globules consists of triacylglycerols (TGs) which make up 98% of human milk 
fat, other constituents include cholesterol (0.4%) and phospholipids (1.4%) [Chierici, 
1994]. Triacylglycerols are esters o f glycerol, where all three hydroxyl groups are 
esterified with a fatty acid. The physical characteristics o f the milk fat globule, the 
length o f the fatty acid chain and the degree of saturation play a role in infant 
metabolism. The content and composition o f lipids in milk changes during lactation, 
particularly during early lactation (colostrum, secreted 1 to 5 days and transitional milk 
days 6 to 15) and again during weaning. However, mature milk (day 16 to the weaning 
period) maintains a constant lipid composition. The fatty acid content of breast milk 
can vary widely according to the maternal dietary fat intake, which makes the 
determination o f a “normal” fatty acid intake of the breast-fed infant difficult. 
However, despite the different fatty acid profiles, the ‘total” lipid composition remains 
consistent. In particular, the quantity o f long-chain polyunsaturates (LCPs), which are 
major constituents in the structure of the brain, is relatively constant in breast milk 
[Koletzko et al., 1992]. These LCPs are now featured in many o f the infant formula 
available on the UK market.
1.3 Recommended Daily Allowance (RDA)
The Recommended Daily Allowance (RDA) has been defined as ‘the average amount 
o f a nutrient which should be provided per head in a group of people i f  the needs of 
practically all members of the group are to be met’ [WHO, 1987]. The RDA is 
published periodically by different countries and decided by committees, allowing
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scope for varying opinions and in some countries political considerations. These factors 
alone account for large differences in values for the RDA published by different 
countries. The ideal intake for any nutrient is the optimum amount for health, which is 
very difficult to define. Health is a condition in which all the body systems are capable 
of working at optimal levels o f efficiency. They can be used as a basis for assessing the 
adequacy of the calculated intakes of individuals. RDA are to be used for quite specific 
purposes: the assessment o f dietary surveys, planning food supplies, nutritional 
labelling and the calculation of nutrient density [Basu and Dickerson, 1996].
The assessment of RDA values is extremely important and complex in the area o f infant 
nutrition. The RDA for an infant is often calculated via extrapolation from adult data, 
but is continually revised as new techniques become available for the assessment of 
dietary intake. The RDA for iodine is extremely important in infant nutrition. Values 
proposed by the Food and Nutrition Board of the National Academy o f Sciences 
(U.S.A.) in 1989 for infants were; 40 pg/day aged 0 to 6 months, 50 pg/day from 6 
months to one year; 70 pg/day from one to three years. Iodine requirements increase 
with age up to 150 pg/day in adolescents and adults. An additional 25 pg/day for 
pregnant women and 50 pg/day for lactating women is recommended. Similar 
recommendations for iodine intake by infants were made by the American Academy of 
Pediatrics, the European Society for Pediatric Gastroenterology and Nutrition and by 
the Commission o f the European Communities.
The values for the RDA are set via a number of assumptions and observations. The 
iodine intake for adults (150 pg/day) accounts for the daily amount o f hormonal iodine 
degradation in the peripheral tissues not recovered by the thyroid (40 -  100 pg/day). 
This allowance is also required to prevent iodine deficient goiter (minimum of 50 -  75 
pg/day) and provides an extra margin of safety to meet the increased demands by 
natural goitrogens. An iodine intake o f 150 pg/day also corresponds to the daily 
excretion of iodine [Delange, 1993].
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Similar parameters are used to determine the RDA of other essential trace elements. 
However, these values continue to be revised as knowledge of the requirements, uptake, 
metabolism and excretion o f these trace elements is updated. Improvements in the 
capability to accurately determine trace elements also leads to such revisions. The 
differences of “opinion” for the RDA values for trace elements varies, according to the 
literature, as shown in Table 1.1.
Table 1.1: Comparison of RDA in various sources of literature (pg/day).
Reference Year Iodine Selenium
0 - 6  mths 6 - 1 2  mths 0 - 6  mths 6 - 1 2  mths
US Food & Nutrition Board 1980 40 50 - -
WHO 1987 - - 10 15
IAEA / WHO 1989 40 50 10 15
US Food & Nutrition Board 1989 40 50 - -
American Academy of 
Pediatrics
1989 40 90
Eur. Soc. For Ped. Gastro. 
And Nutr.
1989 40 90
Eur. Commission o f the EC 1991 40 90 - -
Flynn 1992 40 50 1 0 - 4 5 1 0 - 4 5
Delange 1993 90 90 - -
Department o f Health -  UK 1995 0-3: 50 
3-6: 60
60
Bratter 1996 40 50 - -
Pennington 1996 - 50 - 15
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1.4 Iodine
Iodine is of particular interest, owing to the difficulty of its analysis in complex 
biological and chemical samples and its essentiality in the diet. Iodine is an essential 
trace element of significant physiological importance, its absence in the diet has led to 
serious conditions that affect approximately one billion people worldwide. These 
conditions are referred to as the ‘Iodine Deficiency Disorders’ (IDD) and are easily 
preventable through the supplementation o f iodine in the diet. However, the levels of 
iodine supplemented must be carefully controlled, particularly in the infant. The iodine 
intake should not exceed 2000 pg/day in adults and 1000 pg/day in infants [Wolff, 
1969]. A high dietary intake o f iodine for prolonged periods is toxic to human health. 
Therefore, accurate and reliable analysis of foodstuffs (e.g. infant formula) and body 
fluids (e.g. human breast milk) is essential to monitor the dietary intake of iodine.
Iodine is discussed in this section in terms o f its; chemistry, source in the environment, 
the history of its discovery, involvement in human health and the implications o f iodine 
deficiency / toxicity.
1.4.1 Chemistry of Iodine
Iodine was discovered by Barnard Courtois in 1811, isolated from seaweed ash, using 
sulphuric acid (H2SO4), whilst recovering sodium and potassium compounds. Iodine is 
a group VII element with a relative atomic mass o f 126.9g. There is only one stable 
isotope, Iodine-127, but 30 radioisotopes are recognised altogether. The artificial 
radioisotope Iodine-131 is an example, with a half-life of 8 days.
Iodine has seven electrons in the outer shell and is able to form one single covalent 
bond per atom and therefore occurs as I2. These molecules are large and relatively 
polarisable, hence interacting to the extent that under ordinary conditions the element is 
not a gas or liquid, but a violet-grey crystalline solid with a slight metallic lustre. 
However, the lattice energy is small and iodine molecules are present in the crystal, and
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iodine sublimes readily. Iodine retains its diatomic molecular condition in gas, liquid, 
and vapour.
Iodine forms compounds with many elements, but is less reactive than other halogens, 
which displace it from iodides. Iodine is also the least electronegative o f the common 
halogens, it has the largest atoms, forms the least stable and most oxidized of the 
halides. It can have oxidation states of -1, +1 , +5, and +7. Iodine has a ground state 
electronic configuration of; [Kr] 4d10 5s2 5p5 and generally occurs as iodide ( f ) ;  or 
iodates (I, V, or VII). Iodides are able to function as ligands and form complexes, for 
example; A1I3, Sil4. Iodates are strong oxidizing agents. The most common compounds 
are the iodides o f sodium and potassium (KI) and their iodates (KIO3).
Iodine and the other halogens chlorine, fluorine, and bromine are poisonous gases. 
However, as with chlorine, the salts or negatively charged ions o f iodine (iodides) are 
soluble in water, and in trace amounts iodine is involved in a number o f important roles 
which are essential to life.
Table 1.2: Summary of the physical properties of Iodine.
Iodine Physical properties
Atomic number 53
Electronic configuration i
00100iCN
Density (g/ml) 4 .9 4 2
Colour of gas Violet
Melting point (°C) 113 .6
Boiling point (°C) 184 .5
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1.4.2 Iodine and the environment
Iodine was present during the primordial development o f the earth. Large amounts 
were leached from the surface soil by glaciation, snow and rain, which subsequently 
found its way to the sea [Hetzel, 1989]. In general, the older an exposed surface soil, 
the less iodine it is likely to contain. These leached areas are mainly mountainous 
areas, such as the Himalayas, Andes, French Alps and China. Iodine deficiency 
generally occurs in regions that are elevated and have high rainfall, with run-off into 
rivers. Therefore, raised levels of iodine are found in the oceans. Iodine in the soil and 
sea occurs as iodide and iodate. Iodide ions are oxidised by sunlight to elemental 
iodine, which is volatile, so that 400,000 tons per year of iodine is released from the sea. 
The concentration of total iodine in seawater is between 50 to 60 pg/1, whereas iodide 
ranges from 30 pg/1 (near the shore and ocean surface) to 1 pg/1 (deep ocean water) 
[Ito, 1997, Mishra et al., 2000]. Iodine in the atmosphere (0.7 pg/m3) is returned to the 
soil by rain (1.8 to 8.5 pg/1), thus completing the cycle [Hetzel, 1989]. However, this 
cycle is slow, so that the soil remains deficient in iodine indefinitely.
Soils generally contain 0.01 -  6 mg/kg iodine, with the highest levels found in shales 
rich in organic matter. Iodine minerals include iodides of some metals, such as Agl, 
Cul, Cu(OH)(I03) and polyhalides, iodates and periodates. All iodine compounds are 
readily soluble and therefore, weathering of rocks result in the release of much o f their 
iodine content. Although iodine is transported readily in water to ocean basins, its 
absorption by carbon, organic matter and clays greatly influence the iodine cycling. 
The oxidation of iodide to iodate and further alteration to elemental iodine may occur in 
soils and also the exchange of volatile iodine compounds between soil and atmosphere 
may be possible. Studies o f iodine distribution in soils have been closely related to the 
occurrence of endemic goiter. However, in certain soils of islands (e.g. Ireland, New 
Zealand, Japan), a higher iodine accumulation, up to 80 mg/kg has been reported. The 
geological origin of the soil has a much greater influence on the iodine content o f plants 
than the distance from oceans, although both effects cannot be separated completely 
[Anke et al., 1995]. Variations in the iodine content of plants are considered to be
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unaffected by soil type. The soluble forms o f iodine are generally more bioavailable for 
plants, therefore terrestrial plants contain less iodine than marine plants which are 
known to concentrate iodine from 53 -  8800 mg/kg (dry weight) [Kebatas-Pendias 
and Pendias, 1984]. Typical iodine concentrations of plants grown in iodine deficient 
soil may be as low as 10 pg/kg compared to 1000 pg/kg (dry weight), in plants grown 
in non-iodine deficient soil [Hetzel, 1989]. Crops can subsequently become deficient in 
iodine in areas o f low soil iodine content. Therefore, humans and animals reliant on 
these crops become iodine deficient, explaining why iodine deficiency is particularly 
prevalent in countries where subsistence farming is dominant.
1.4,3 History of Iodine and human health
The deficiency of iodine in the human diet has led to obvious abnormalities o f the 
human body and behaviour, in the form of a lump in the neck (goiter) and mental 
deficiency (cretinism). These characteristics have aroused interest throughout recorded 
history, dating back to ancient civilisations, such as the Chinese and Hindu cultures, and 
then Greece and Rome. The 19th century marked the beginning o f serious attempts to 
control the problem. However, it was not until the latter part o f the 20th century that the 
necessary knowledge existed for effective prevention and control o f goiter and 
cretinism.
Iodine was first isolated from the ashes o f seaweed Fucus vesicularis by Bernard 
Courtois in 1813. Jean Louis Prevost considered for the first time that goiter was due to 
iodine deficiency. Present-day treatment is based upon the research by David Marine 
who in 1915 stated: ‘endemic goiter is the easiest known disease to prevent’ . The first 
large- scale trials using iodine prophylaxis was conducted in the USA by Marine in 
1916. Iodine was administered as iodised salt (sodium iodide, 0.2g), dramatically 
improving the symptoms o f goiter. Similar successful results were obtained from trials, 
in regions around the world where goiter was prevalent, in particular Italy and 
Switzerland.
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The disappearance of goiter and cretinism has been attributed to the increased dietary 
intake o f iodine, due to the diversification of the diet that has accompanied economic 
development. However, approximately 800 to 1000 million people suffer from or are at 
risk of iodine deficiency despite the associated conditions being preventable. The 
persistence o f iodine deficiency in poorly developed countries, for example in Africa, 
Asia, and South America can be attributed to the reliance on local foods, particularly 
cereals, grown in iodine deficient soil usually in mountainous or hilly regions.
1.4.4 Role of Iodine in human health
A healthy human adult contains stores o f 15 to 25 mg o f iodine; an infant (0 to 6 
months), approximately 0.1 mg [Delange, 1993]. The normal intake in the UK is 100 
to 150 pg/day (adults) and 40 pg/day (infants) (section 1.3). The level of excretion 
from the kidney correlates well with the level of iodine intake, approximately 50 pg/g 
creatine or below is indicative of iodine deficiency [Hetzel, 1989].
Iodine exists in the thyroid as inorganic iodine, in the iodine-containing amino acids: 
monoiodotyrosine (MIT), diiodotyrosine (DIT), thyroxine (T4) and triiodothyronine 
(T3); in polypeptides containing thyroxine and in thyroglobulin. These hormones 
(iodised amino acids) are stored in the thyroglobulin protein as a peptide linkage. It 
accounts for 90% of the total iodine in the thyroid gland. Iodine exists in the blood as 
T4, T3 and inorganic iodine. The trapping o f iodine by the thyroid depends on an active 
transport system termed the “iodine pump”. This mechanism is regulated by the thyroid 
stimulating hormone (TSH). The formation of the thyroid hormones within the 
thyroglobulin molecule is as follows:
Iodine + Tyrosine -> oxidation-^ MIT + DIT -> coupling^  T3 +  T4 (eq 1.1)
The thyroid hormones are responsible for the regulation of metabolic energy (ATP) of 
the body, produced by cellular mitochondria and for setting the basal metabolic rate. 
They influence all functions of the body, nerve and bone formation, reproduction, the 
state of the teeth, nails, hair, and skin, and even speech and mental health. Thyroid and
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thus iodine also has an affect on the conversion of carotene to vitamin A, ribonucleic 
acids to proteins, cholesterol synthesis, and carbohydrate adsorption. Therefore, the 
supply o f iodine can have a large influence on the state o f human health. Table 1.3 
reports the levels o f iodine in a number of body tissues and fluids.
Table 1.3: Concentration of iodine found in various human tissues and body fluids.
Human tissue Concentration of Iodine (pg/ml)
Blood (whole) 1 5 - 7 2
Blood (plasma) 5 8 - 8 5
Blood (serum) 4 5 - 1 0 0
Brain (fresh) 0.02
Scalp hair 0 .0 9 -1 5 .1 0
Bone (fresh) 15
Skin (whole, dry) 0.35
Muscle (skeletal, fresh) 0 .0 1 0 -0 .1 0 4
Thyroid (fresh) 3 1 0 -6 9 6
Urine 0 .0 6 6 -0 .3 8 8
Breast milk 0.045
[Hetzel, 1989]
1.4.5 Prevalence of Iodine in foodstuffs
The average daily dietary intake o f iodine ranges from 65 to 650 pg in the UK, 
compared with the Recommended Daily Allowance (RDA) of 150 pg (for adults) and 
40 pg (for infants) (section 1.3). The levels of iodine in the diet may vary widely, for 
example the iodine content of the soil in which plants are grown, or animals graze upon 
will determine to a certain extent the iodine content of these foodstuffs. The 
supplementation of iodine to foods is a valuable addition to the diet, with iodised salt 
being the most common example. Eggs are a good source when iodine is added to
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chicken feed and bread when iodine is added to dough. Foods that may contain iodine, 
especially when grown in iodine-rich soils, are onions, green peppers, mushrooms, 
peanuts, lettuce, spinach, pineapple, cheddar cheese, and whole wheat bread. Foods 
obtained from ocean water are rich sources o f iodine, such as fish, shellfish, and sea 
vegetables (seaweed, kelp). Sea salt is a natural source of iodine, but is not as effective 
as iodized salt. Alternatively iodine can be obtained from a general vitamin mineral 
supplement.
Table 1.4: Concentration of iodine in foodstuffs from the U.S.
Foodstuff Concentration of Iodine 
(jLXg/lOOg)
Bread (white) 1.8
Cereals 0 .2 - 1 4 .0
Fats and Oils 2 .0 - 4 .0
Fish (freshwater) 1.0 - 2.0
Meat products © I VO to
Poultry 63.5
Eggs 4 .2 -4 7 .8
Salt (iodised) 2 6 5 0 .0 -4 1 6 0 .0
Dairy products 6 .0 - 7 6 .0
Dairy powders 1 2 4 .0 -6 8 6 .5
Cows milk (3.4% fat) (pg/1) 1 2 9 .2 -  1362.2
Infant formula (milk-based) Ol P—
1 1 to bo
(soy-based) 6 .1 -1 3 .7
[Dellaville, 1984]
The iodine concentration of human breast milk is affected by the maternal intake o f 
iodine. In a UK multi-centre study, concentrations were found to be 50 to 60 pg/1 
[Parr, 1991], whereas values in the U.S.A. appeared to be higher at approximately 130 
pg/1 [Bruhne and Franke, 1984]. The iodine intake of formula-fed infants in the
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U.S.A. has been estimated to be 190 pg/day between 6 and 12 months o f age 
[Pennington, 1989], compared with 40 to 130 pg/day for breast-fed infants. Thus, both 
breast-fed and formula-fed infants in the USA have intakes higher than the RDA for 
iodine, which is 40 pg/day at 0 to 6 months and 50 pg/day at 6 to 12 months of age 
[Food and Nutrition Board (USA), 1989].
1.4.6 Deficiency of Iodine in the diet
When the physiological requirements of iodine are not met in a given population 
(adults; <10 pg/day [Hetzel, 1989]), a series of functional and developmental 
abnormalities occur. These include; thyroid function abnormalities and for severe 
iodine deficiency, endemic goiter, cretinism, mental retardation, decreased fertility rate, 
increased perinatal death and infant mortality. These disorders are referred to as the 
Iodine Deficiency Disorders (IDDs) [Delange, 1994]. IDDs affect 800 to 1000 million 
people around the world, including 190 million with goiter and 3.2 million with 
endemic cretinism. Therefore, IDDs are a major public health problem, but have been 
preventable for many years. These disorders are still prevalent due to various socio­
economic, cultural, and political limitations to instigating iodine supplementation 
programmes. As already mentioned, iodine deficiency occurs mainly in mountainous 
and inland regions. At least 800 to 1000 million people are estimated to be affected by 
IDDs, including 60 million in Latin America, 60 million in Africa, and 680 million in 
Asia. IDD is not restricted to undeveloped countries, much of Europe is iodine 
deficient where there is no iodine supplementation programme (e.g. Germany, Spain, 
Italy and many Central European countries, such as the Czech Republic) [Gaitan, 
1989].
The most important target groups are pregnant mothers, foetuses, neonates and young 
infants, since the main implication of IDD is brain damage, with irreversible mental 
retardation, due to the failure o f the thyroid during pregnancy, foetal and early infancy 
development. The mechanism by which the thyroid gland adapts to an insufficient 
supply of iodine is to increase the trapping of iodide and the synthesis o f T3. This
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mechanism is triggered by the increased secretion of TSH, resulting in the appearance 
of goiter, an enlargement o f the thyroid gland. The symptoms o f goiter are much more 
apparent in infants than in adults, owing to the adaptation o f iodine deficiency during 
growth.
Goitrogenic factors in the diet or environment can have the same impact as iodine 
deficiency and have a role in the etiology o f IDD. The most common o f these 
goitrogenic substances is thiocyanate, derived from the metabolism of hydrogen 
cyanide and found in several staple foods (e.g. cassava, maize, cabbage, soybeans, 
cauliflower, peanuts and millet), especially when they are grown in iodine deficient 
soils [Ermans, 1980, Delange, 1982]. Thiocyanate is a powerful goitrogenic agent that 
inhibits the transport of iodide in the thyroid, and at higher doses competes with iodide 
in the complexation of iodide and tyrosine, thus inhibiting the formation of thyroid 
hormones. Cassava is one of the basic food staples in tropical regions, its role in the 
etiology o f goiter, in association with iodine deficiency has been demonstrated in Africa 
[Delange, 1989].
1.4.7 Prevention and treatment of Iodine deficiency
Iodine deficiency is the most common and preventable cause o f mental deficiency in the 
world [Hetzel, 1989] and is still prevalent in Europe. This is probably due to a lack of 
awareness by the public and health authorities. This has subsequently led to the 
absence o f health education programmes in many countries, where the benefits of 
certain diets should have been recommended, for example; seafood, milk and iodised 
salt. Iodination of household salt has not met expectations, due to the inaccurate 
analysis o f iodine in salt [Delange, 1989] and an overestimation o f the household salt 
intake, with it only accounting for 15% o f total salt intake. Therefore, the expansion o f 
the iodisation programme to industrial food production has been recommended 
[Delange, 1994]. The main source of iodine in the diet appeared to have been milk in 
many industrialised countries [Dunn, 1993].
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The effects o f iodine deficiency in Europe, on the main target groups; pregnant women, 
foetuses, neonates and young infants, should involve a programme o f iodine 
supplementation, even though current iodination programmes exist (e.g. salt iodisation, 
fortified food). In addition, recommendations have been made to increase the iodine 
content of infant formula from European recommended levels [Commission of the EC,
1991] of 50 pg/1 milk, to 100 pg/1 for full-term and 200 pg/1 iodine for pre-term infants 
[Delange, 1993].
1.4.8 Iodine toxicity
Although iodine is essential for normal physical and mental development, excess iodide 
can lead to hypothyroidism and goiter. An excess intake of iodine is defined as 2 mg or 
more per day [Delange, 1994]. At these levels the proteolysis and release o f thyroid 
hormone is inhibited, resulting in “iodide goiter”. Major contributors to the excess 
intake o f iodine were; dairy products, grain and cereals, meat, fish, poultry, and sugar. 
In 1978 the dietary intake of iodine in the USA was calculated as 952 pg/day for adults 
[Gaitan, 1989] and children with goiter had higher rather than lower urinary iodine 
excretion [Gushurst, 1984]. The iodine content in food fluctuates according to different 
agricultural practices, through the addition o f iodine to animal feeds, the use of 
iodophors for teat dips and iodine for sterilisation. Iodine also enters the diet through 
food processing procedures, such as food colourings (i.e. erythrosine) and iodate used 
as a stabiliser for baking.
The addition of iodine to salt and milk products, such as infant formula, has reversed 
the effects of iodine deficiency (goiter) in many parts of the world. Iodine toxicity has 
been identifed in areas o f the USA [Gushurst, 1984] as causing the same effects as 
goiter, hence it is termed toxic goiter. This has occurred in Japan, among 6 -  12% of 
the seaweed-eating fishermen consumed 10,000 -  20,000 pg/day o f iodine [Passwater 
and Cranton, 1983]. However, the supplementation o f nutrients to foodstuffs, in 
particular infant formula, is necessary to prevent a large number of deficiency disorders. 
The careful monitoring o f this supplementation is essential to ensure that the correct
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amount o f nutrients is added, in particular the bioavailability o f the various forms of 
iodine.
1.5 Selenium
Selenium is 70th in abundance among the 88 elements that occur naturally in the earth’s 
crust. Selenium was first discovered in the early 1800’s. The essential biological role 
of selenium has only been acknowledged for a relatively short time, after Schwartz and 
Foltz presented evidence in 1957 that the element was essential to human health [Reilly,
1996].
1.5.1 Chemistry of Selenium
Selenium has an atomic weight of 78.96g and an atomic number o f 34. Selenium is 
positioned between sulphur and tellurium in group VIA. Its chemical properties (Table 
1.5) are similar to those of sulphur and tellurium, with corresponding compounds that 
resemble one another. The electronic configuration of selenium ensures that it is 
grouped with the metalloids, which are neither metals, or non-metals, but share 
characteristics o f both.
Table 1.5: Physical properties of selenium.
Selenium Physical properties
Atomic weight (g) 78.96
Valence states 2, 4 ,6
Electronic configuration 2 - 8 - 1 8 - 6
Normal boiling point (°C) 684.9
Normal melting point (°C) 217
Ionisation potential (eV) I (9.75), II (21.5), III (32), IV (43), V (68), VI (82)
[Weast, 1995]
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Selenium compounds may be formed when the biological material it is contained within 
is heated, this reaction and the formation o f hydrogen selenide account for the loss of 
selenium when dry ashing is used to prepare the samples for analysis. The low boiling 
point can also be responsible for atmospheric contamination during certain industrial 
processes involving selenium. Elemental selenium is highly soluble and very stable. 
Under reducing conditions it is formed from both S e 0 2 (selenite) and SeC>3 (selenate). 
Thus, in certain soils, both chemical forms o f the element may become unavailable to 
plants [WHO, 1987].
Selenium is similar to sulphur, in that it can react with metals and gain electrons to form 
ionic compounds containing the selenide ion, Se Selenium forms many inorganic and 
organic compounds, which are similar to those of sulphur. Inorganic compounds o f 
particular interest are the selenides, halides, oxides and oxy acids.
1.5.2 Selenium in the environment
There are natural areas o f deficiency and excess of selenium in soils from different 
regions around the world, indicating that the natural depletion or concentration o f the 
element can occur locally. Most soils contain 0 . 1 - 2  mg/kg o f selenium, but can vary 
from practically zero to 100 mg/kg [Kebata-Pendias and Pendias, 1984]. Such losses 
or build-up can be accounted for by the many pathways through which selenium is 
distributed among geological and biological media, the atmosphere, fresh and seawater, 
and by geophysical activity.
The redox state o f soil greatly affects the availability o f selenium to plants [Kivisaari 
and Vermuelen, 1995]. The presence of certain soil bacteria that are able to oxidise 
elemental selenium to selenite and selenate, suggests that selenium can be released from 
previously unavailable sources for uptake by plants [Satachandra and Heller, 1981]. 
The 1987 World Health Organisation (WHO) report on selenium noted that “while a 
balance may be maintained in the redox state o f selenium throughout the world, there
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are regions where oxidation prevails and others where reduction prevails. Knowledge 
o f these conditions and mechanisms leading to each situation is essential to understand 
the development o f regions of selenium excess or deficiency” [WHO, 1987],
Major disruptions in the natural cycle o f selenium, resulting in the concentration or 
deficiency o f selenium in soils, hence animal feed and foodstuffs, could have serious 
effects on human health. Activities that disrupt the natural cycle o f selenium, such as 
the supplementation o f selenium to animal feed and use o f agricultural fertilisers, are of 
considerable concern [Reilly, 1996].
1.5.3 Selenium and human health
Selenium is an essential trace element that functions as a component o f several enzyme 
systems (e.g. glutathione peroxidase) involved in antioxidant protection and thyroid 
hormone metabolism. The role o f selenium in gene regulation through selenoprotein 
compounds may have an important role in regulating HIV expression, the targeting of 
metastatic cancer cells and drug resistant bacteria, [Rayman, 2000].
Many investigators have studied the affects o f selenium on the development o f tumours. 
As cancer is unlikely to have a single cause, selenium is similarly unlikely to have a 
single mechanism by which the element acts as an anti-carcinogenic agent. Selenium 
does not have a single function in cell metabolism, but is a component of several 
enzyme systems. The antioxidant role o f selenium is thought to reduce the damaging 
effects o f oxygen-derived free radicals, implicated in the development o f emphysema, 
diabetes, multiple sclerosis, rheumatoid arthritis, myocardial infarction, cirrhosis of the 
liver, Parkinson’s disease and conditions exhibiting a compromised immune response 
[Bonorden and Pariza, 1994, Rayman, 2000],
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The body o f an average adult male living in the eastern USA (high selenium region) 
was estimated to contain approximately 15 mg (range 13.0 -  20.3 mg) of selenium 
[Schroeder, 1970]. Adult women in New Zealand, a low selenium region, were 
estimated to contain 6.1 mg (range 4.1 -  10.0 mg) and a 70 kg adult male in Germany, 
6.6 mg o f selenium. Table 6, shows the selenium content of various organs in the 
human body. The whole body retention o f selenium is an average o f discrete processes, 
as each internal organ probably has its own rate of selenium turnover. For example, the
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half-life of Se in rat kidney was 38 days, compared to 74 days in skeletal muscle 
[Thomson and Stewart, 1973], The different selenium concentrations in each organ 
are due to the actual retention time o f the element. This depends upon a number o f 
factors, including the present selenium status, the specific form in which the element is 
ingested and the state of health o f the subject. The concentration o f selenium in whole 
blood (Table 1.7) are indicative of the differences in selenium intake between countries 
in high selenium regions (e.g. USA) and low selenium regions (e.g. New Zealand, 
Scandinavia).
1.5.4 Selenium in body tissues and fluids
Table 1.6: Selenium concentrations in organs (pg/g wet weight).
Country Liver Kidney Skeletal muscle Heart
Canada 0.390 0.849 0.370 -
USA 0.540 1.090 0.240 0.280
Japan 2.300 1.500 1.700 1.900
New Zealand 0.209 0.750 0.061 0.190
Germany 0.291 0.771 0.111 0.170
[Oster, 1988]
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Table 1.7: Whole blood selenium levels (mg/1) of healthy subjects living in different 
countries.
Country Reported levels (range or mean ±  sd)
China 0.027 -  0.440
Finland (pre-1984) 0 .0 5 6 -0 .0 8 1
New Zealand 0.072 ±  0.005
Sweden >0.070
Australia 0.110- 0.210
USA 0 .1 5 0 -0 .3 0 0
[Reilly, 1996]
1.5.5 Presence in foodstuffs
The concentration o f selenium in human breast milk is very dependent upon maternal 
intake. A large part of dietary selenium is in the form of selenoproteins and selenium is 
incorporated into these proteins in proportions corresponding to selenium in the 
environment, i.e. in soil and water. Thus cereals and grass have a selenium content 
reflecting local conditions and grazing animals will have selenium concentrations in 
their milk and meat corresponding to their intake. Lactating women living in low 
selenium areas, such as New Zealand and Finland, usually have a selenium 
concentration in their breast milk of approximately 8 - 1 0  pg/1 [Kumpulainen, 1985], 
whereas breast milk from women in areas reflecting ‘normal’ levels contain 
approximately 15 pg/1 [Smith et al., 1982, Litov and Combs, 1991]. The latter 
compares closely with the findings of Lombeck, who determined that human breast 
milk in the USA contained 1 5 - 2 0  pg/1, compared to European values o f 9 -  15 pg/1 
[Lombeck, 1992]. The concentration o f selenium in human breast milk can be 
increased by supplementation, mothers given organic and inorganic forms of selenium 
showed significantly higher levels than women with an unsupplemented diet. Breast 
milk selenium normally decreases during lactation, probably due to the decrease in the
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concentration of protein in human breast milk [Lonnerdal, 1991]. Studies in the USA 
have indicated that colostrum contains 41 pg/1 of selenium and mature milk 16 pg/1. A 
reduction from 20 pg/1 at 1 month to 15 pg/1 at 3 to 6 months can occur [Smith et al., 
1982, Levardcn, 1987]. Investigators usually use mature milk, or the total milk sample 
from one breast, or average hind and fore milk values [Reilly, 1996].
Until recently, infant formula contained as much selenium as the raw materials 
provided, leading to some variation among manufacturers. In most cases, the selenium 
content of infant formula is lower than in breast milk ( 2 - 6  pg/1) [Kumpulainen, 1987; 
Litov, 1989], Lombeck measured approximately 9 pg/1 in infant formula, representing 
45 -  65% less than the amount measured in human breast milk samples [Lombeck,
1992]. Clinical studies on infants fed cows milk formula showed that fortification of 
formula with selenium in the form o f selenite resulted in a selenium status similar to 
that o f breast-fed infants [Johnson et al., 1993], Therefore, most commercial infant 
formula are generally fortified with selenium to a level of 15 -  20 pg/1. Due to the 
larger volumes ingested by formula-fed infants, their selenium intake is higher than that 
o f breast-fed infants [Lonnerdal, 1991]. In 1989 a joint WHO / IAEA study made 
recommendations for selenium intake from infant formula by extrapolation from adult 
data, with an added factor for growth and safety [WHO, 1989]. Therefore, the USA 
and Australian RDA for infants 0 to 6 months was 10 pg/day and 15 pg/day at 7 to 12 
months.
As discussed previously, the selenium content o f many food products is dependent upon 
the local environment in which the animal feed or crops were grown. Table 1.8 
summarises the concentration of selenium in a number of foodstuffs consumed in the 
UK. These values were obtained as part of a comprehensive study to determine the 
total dietary intake o f trace elements in the UK [Ysart et al., 1999].
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Table 1.8: Selenium in food products included in the 1994 UK Total Diet Study.
Foodstuff Selenium
(mean concentration, mg/kg fresh weight)
Bread 0.04
Cereals 0.03
Meat products 0.12
Offal 0.42
Poultry 0.15
Fish 0.39
Oils and Fats 0.01
Eggs 0.19
Milk 0.02
Dairy produce 0.05
Nuts 0.29
[Ysart et al,, 1999]
1.5.6 Selenium deficiency
The loss of selenium-glutathione peroxidase (Se-GSHPx) activity in selenium 
deficiency can explain the occurrence o f many selenium responsive diseases associated 
with peroxidative damage to the cell constituents. Such diseases usually occur when 
there is a concurrent vitamin E deficiency.
There are many consequences o f selenium deficiency, such as changes in hepatic 
glutathione S-transferase activity and drug metabolising activities. Selenium deficiency 
affects a wide range o f enzyme activities and metabolic processes and also causes 
changes in thyroid hormone metabolism, where type I and II thyroid deiodinases are 
inhibited [Arthur and Beckett, 1989]. As well as affecting thyroid metabolism 
selenium deficiency decreases the iodine, T3 and T4 concentrations in the thyroid gland. 
Therefore, selenium deficiency could exacerbate iodine deficiency, which also has the
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effect of lowering iodine, T3 and T4 concentrations in the thyroid [Arthur, 1992]. The 
inter-relationships between selenium, thyroid hormones and iodine metabolism will be 
discussed in section 1.6.
1.5.7 Prevention and treatment of Selenium deficiency
There is uncertainty as to the dietary requirements o f selenium for optimal health 
[Arthur et al., 1997] as illustrated in Table 1.1. The inconsistencies reported in the 
literature on the relationship between dietary intakes and forms o f selenium and 
biochemical status can be explained by the difficulties in assessing selenium status 
[Fairweather-Tait, 1997]. The fact that different forms of selenium are absorbed and 
metabolised differently, further complicates the issue [Fairweather-Tait, 1999]. For 
example, a WHO / IAEA / FAO expert group used Chinese data and suggested 40 and 
30 pg/day for men and women, respectively, assuming that only two thirds of 
glutathione peroxidase (GPx) expression was required. If  there was a requirement for 
saturation o f GPx activity in the platelets, rather than the plasma, as a measure o f 
selenium repletion then 80 -  100 pg/day should be considered. Whilst evaluating 
dietary requirements, the following factors should be considered: the form of selenium 
ingested affects the response of selenoenzymes, the concentration o f some 
selenoenzymes is affected by scarce selenium supply, there is significant variation 
(p<0 .01) between individuals in the response to supplementation (requirements will 
differ within the same population), and adaptation to low selenium intake can occur by 
sparing excretion. Serum or plasma selenium has been suggested as a useful indicator 
of status in populations with low intake. Levels of selenium that saturate the activity of 
plasma GPx are sufficient for the enzymic or antioxidant role, but are insufficient to 
optimise the immune response and reduce cancer risk.
A functional indicator of selenium status is being sought, but selenium has a number of 
biochemical roles. These different roles may require a range o f indicators according to 
the status or disease studied [Rayman, 2000]. Planned trials, such as PRECISE 
(Prevention of Cancer by Intervention with Selenium) and SELECT (Selenium and 
Vitamin E Cancer Prevention Trial) are being conducted to assess the optimal nutrition
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level of selenium for the prevention o f certain diseases. Until the trials have been 
completed and a minimum intake can be defined, an upper limit o f 400 -  450 pg/day 
(adults) has been recommended [WHO, 1996].
1.5.8 Selenium toxicity
Selenium was originally labelled as a toxin and carcinogen, its positive aspects have 
only recently been established. The exaggerated fear o f selenium toxicity occurred due 
to a number o f cases of selenium poisoning in the US Midwest, prior to the Second 
World War. Rural communities consuming locally grown food were most affected with 
a number o f symptoms o f ill health ranging from bad teeth, damaged nails, to other less 
clearly defined conditions, especially in those people with high levels o f selenium in 
their urine. Despite the failure o f the Food and Drug Administration to prove that oral 
administration o f selenium caused cancer, it was classified as a carcinogen and 
restricted in animal feeds and the human diet [Reilly, 1996].
The Food and Nutrition Board of the US National Academy o f Sciences had set 50 -  
200 pg/day o f selenium as a safe intake for adults [Food and Nutrition Board, 1980]. 
Studies in China [Yang, 1989] suggested intakes of up to 750 pg/day o f selenium, as 
being safe in regions naturally high in selenium. A level of 500 pg/day was proposed as 
an acceptable upper limit in Japan [Sakurai and Tsuchiya, 1975]. The US 
Environmental Protection Agency (US EPA) has suggested an oral reference dose 
(RfD) for selenium of 350 pg/day for a 70 kg adult male.
It is apparent that there are many conflicting views with regard to a safe upper limit for 
selenium intake, with no clear consensus. The intake of selenium causing toxicity to 
infants is not known with certainty, but it is recommended that infant formula should 
provide a maximum of 45 pg/day selenium intake [Levander et al., 1989]. 
Extrapolation from adult studies suggests that 75 -  160 pg/day could have harmful 
affects on infants. Although there have been no known cases o f selenosis in humans in 
high selenium areas o f the USA, human breast milk was reported to supply as much as
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47 pg/day of selenium. On this basis, it was suggested that infant formula already 
contained adequate levels o f selenium to provide an intake o f 10 -  45 pg/day 
[Levander et at,, 1989]. However, further investigations into the bioavailability and 
chemical stability o f various selenium compounds that could be used to supplement 
infant formula is required.
1.6 Relationship Between Iodine and Selenium in Human Health
Severe selenium deficiency has been documented in Northern Zaire, previously 
identified as one of the most iodine deficient regions in the World, characterised by the 
predominance o f myxoedemateous cretinism. This condition has been attributed to the 
deficiency o f both trace elements. Severe selenium deficiency has been described in 
other parts o f the world, resulting in infantile cardiomyopathy (Keshan disease) and an 
osteoarthropathy (Kashin-Beck disease). The supplementation o f selenium in these 
regions has proved beneficial in these conditions [Sokoloff, 1985, WHO 1987], 
although these studies did not provide an indication of the effect o f selenium on thyroid 
metabolism. Selenium deficiency has been shown to inhibit type I deiodinase activity 
[Beckett, 1989, Meinhold, 1991] and has also resulted in increased serum T4 values. 
Type I deiodinase was recently proved to be a selenium-containing enzyme in which the 
celenocysteine residue is essential for the enzyme activity [Behne, 1990, Berry, 
1991a].
There is some disagreement as to whether selenium exerts an influence on type II 
deiodinase. Beckett showed that selenium deficiency exerted an influence on 
deiodinase type II activity [Beckett, 1989], whilst Golstein and Contempre proved 
otherwise [Golstein, 1988 and Contempre, 1991]. Nevertheless, whatever the 
mechanism by which selenium affects thyroid function, Contempre showed that 
selenium could play a definite role in thyroid metabolism in humans [Contempre, 
1991]. Selenium deficiency, as identified in Central Africa and other parts o f the world, 
is severe enough to induce a disruption in thyroid hormone metabolism. Furthermore, 
since deiodinase and glutathione peroxidase activities are decreased at a similar stage of
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selenium deficiency, changes in thyroid hormone metabolism, as well as impaired 
peroxide metabolism should be considered [Arthur, 1992],
The inhibition of deiodinase type I in selenium deficiency impedes the catabolism of 
thyroid hormones, diminishes the iodide loss by the kidney and promotes the economy 
of iodine and thyroid hormones. Coupled with a possible increase in hormone synthesis 
in the thyroid gland, this could reduce the importance o f iodine deficiency [Contempre, 
1991b]. Therefore, selenium supplementation alone could involve a complex change 
in thyroid metabolism. Contempre suggested that selenium supplementation should be 
taken without concomitant iodine supplementation, at least until further studies have 
been undertaken. Without this consideration selenium supplementation might 
exacerbate, rather than improve thyroid hormone disorders [Contempre, 1991].
1.7 Methods o f Iodine and Selenium Analysis in Biological 
Samples
As discussed in section 1.6, iodine and selenium have been known to be essential to 
human nutrition for many years. The assessment of RDAs for iodine and selenium 
requires accurate and reliable determination, particularly in the field o f infant nutrition. 
Many methods o f analysis have been utilised in this aim; colourimetric, catalytic 
methods, Neutron Activation Analysis (NAA) and X-Ray Fluoresence Spectrometry, 
have been employed for the determination o f iodine and selenium in milk and other 
biological materials. Mass spectrometric isotope dilution techniques have been 
developed for the determination o f iodine in such matrices and were especially used for 
the certification o f standard reference materials. Inductively Coupled Plasma Mass 
Spectrometry (ICP-MS) has been used for the determination of iodine in milk involving 
wet chemical sample decomposition. However, Durrant was unable to determine iodine 
concentrations below 361 pg/1 [Durrant et al., 1988, and Durrant and Ward, 1989]. 
Most o f these methods are either time or sample consuming. However, ICP-MS 
remains a powerful tool for multi-trace element analysis.
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Since 5% of selenium in milk is found within the milk fat globule [Lonnerdal, 1997] 
and 20% of iodine is present in the organic phase of milk [Bratter et al., 1998], 
discrepancies in the current analysis o f these trace elements in milk is probable. This is 
o f course assuming that the trace element content of lipids is not accounted for and also 
that the lipids may affect the stability of the iodine and selenium signal measured. The 
removal or degradation of the lipid component of milk may in effect ‘release’ the iodine 
and selenium bound in this form. Traditional decomposition methods, such as 
microwave digestion and open / closed acid digestion (Chapter 2 & 3) o f infant formula 
and human breast milk, may not have removed or degraded their lipid content 
sufficiently. Hence, the sample tubing, pneumatic nebuliser, injector and skimmer 
cones of the ICP-MS instrument become blocked through the build-up o f lipids at these 
points. This affects the stability o f the iodine and selenium signal, resulting in 
inaccurate measurements. This concern has been investigated in Chapter 2 and 3.
Many sample preparation procedures have been investigated for the analysis of iodine 
in infant formula and human breast milk, by ICP-MS. For example; dilution with 
ammonia solution [Baumann, 1990], dilution in tetramethyl ammonium hydroxide 
(TMAH) [Cho et al., 1989], closed wet chemical decomposition [Durrant and Ward,
1989], microwave acid decomposition [Raghunadha and Chatt, 1991, Larsen and 
Ludwegsen, 1997, Knapp et al., 1998], dry / wet ashing, Schoniger combustion and 
extraction with TMAH [Knapp et al., 1998]. Many of these procedures have required 
follow-up investigations and have been discussed in Chapter 2.
Iodine and selenium are particularly difficult trace elements to analyse by ICP-MS, for 
many reasons. Both elements have a relatively high first ionisation energy; 10.45 and 
9.8eV, respectively, resulting in only 29% of iodine being ionised in the plasma source 
o f the ICP-MS and approximately 30% for selenium [VandeCasteele and Block, 
1994]. This implies that the sensitivity for their analysis is reduced. Iodine is also 
extremely problematic in terms o f its memory effects. Iodine has an affinity to surfaces 
within the ICP-MS instrument for relatively long periods, resulting in carry-over
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between analyses. This could be substantial enough to effect a series o f analyses, since 
up to 50% of a 5 pg/1 iodine standard solution remained in the instrument after two 
minutes. Therefore, a washout procedure has been developed to remove the memory 
effects between each analysis (Chapter 2).
Iodine is monoisotopic, therefore 100% of the iodine signal is measured at mass 127. 
Selenium has six isotopes o f varying natural abundance. The choice o f isotope for 
analysis must consider the natural abundance and potential interferences that may effect 
the signal of one or more of the selenium isotopes. These interferences comprise of; 
matrix effects, isobaric and mass spectral interferences, and the formation o f polyatomic 
ions.
1.7.1 Speciation analysis
Discussions thus far have considered the ‘total’ analysis of iodine and selenium by ICP- 
MS. However, speciation analysis in trace element research, through the use o f ion 
exchange chromatography, has recently become an area of great interest [Thompson, 
1998, Bratter et al, 1998]. This means o f analysis has enabled the study o f the binding 
pattern of trace elements in infant formula and human breast milk, and the relationship 
between trace elements in human breast milk and maternal dietary intake. The binding 
pattern o f iodine and selenium to proteins in human breast milk was investigated by 
Bratter through the coupling o f ion exchange chromatography and ICP-MS [Bratter et 
at., 1998]. This technique will also be utilised in a similar manner to provide species 
information for iodine and selenium (Chapter 4).
Approximately 80% of iodine in milk is present as inorganic iodide [Gushurst, 1984, 
Bratter et al., 1998], with approximately 20%  occurring in the organic phase o f milk 
and a small amount occurring as iodate [Bratter et at., 1998]. Selenium in the diet is 
present as organic and inorganic forms. 80% is associated with the protein fraction 
[Lonnerdal, 1997], mainly selenomethionine in plant foods and selenocysteine in foods 
o f animal origin (e.g. milk). The inorganic forms, selenite and selenate probably do not 
occur naturally in food, but are often used as supplements (e.g. infant formula)
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[Fairweather-Tait, 1999]. Further investigation of the potential for trace element 
speciation is required to determine the distribution and form of iodine and selenium in 
infant formula and human breast milk.
1.8 Aim and Objectives o f this Thesis
A fundamental requirement o f all analytical measurements is the need to ensure quality 
in terms of accuracy and precision. For trace and ultra-trace element analysis of 
biological samples a major problem involves the pre-analysis steps o f sample 
dissolution / digestion. Traditionally for techniques such as Inductively Coupled 
Plasma Mass Spectrometry (ICP-MS), the sample must be in a liquid form for sample 
nebulisation and contain a dissolved solids content of < 1% (to prevent the blockage of 
sample tubes, interface cones / skimmers). Therefore, biological reference materials 
and samples are digested using mineral acid mixtures or combinations o f acids and 
peroxides in conjunction with open / closed digestion facilities (water baths, ovens, 
heating blocks, microwave). Unfortunately, for most biological materials these pre­
analysis steps can cause problems that will directly affect the quality o f the resultant 
measurements. In particular, body fluids (e.g. breast milk) and foodstuffs (e.g. infant 
formula) can contain many ultra-trace elements, with high levels of lipids. After using 
nitric acid and / or hydrogen peroxide digestion mixtures the sample can still contain 
traces of undigested lipids. It is generally assumed that this component of the digested 
sample does not influence the sample introduction efficiency and signal sensitivity of 
the instrument. However, these points have been observed using traditional sample 
decomposition techniques, resulting in significant changes to nebuliser efficiency and 
signal stability, both o f which affect accuracy and precision.
The aim of this thesis is: to provide accurate and precise total / speciation analysis of 
iodine and selenium in human breast milk and infant formula, using Ion 
Chromatography and Inductively Coupled Plasma Mass Spectrometry (IC- / ICP-MS). 
Therefore, the following objectives were required in order to meet this aim:
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(1) optimisation, calibration and validation of ICP-MS total analysis for iodine and 
selenium, including the reduction o f memory effects for iodine;
(2) development and evaluation o f enzymatic procedures should produce an 
alternative and more specific means o f digesting the lipid content o f human 
breast milk and infant formula sample decomposition. These may involve the 
use o f a series o f enzymes or the coupling of enzyme digestion followed by acid 
or alkali dissolution. The development o f protocol for enzymatic digestion 
(enzymolysis) will encompass the evaluation of ‘ideal’ conditions for this 
procedure namely, pH, temperature, time, amount o f substrate, additives and 
enzyme. The efficiency of enzymolysis will be monitored by measuring the free 
fatty acid (FFA) content o f the sample using, capillary gas chromatography 
(GC). The FFAs present in human breast milk and infant formula are usually 18 
to 24 carbons in length (Cig to C24). After decomposition o f the sample lipid 
content this carbon chain length should be reduced, resulting in an increase in 
the FFAs with a lower chain length. On this basis, the influence of the lipids on 
the signal stability o f the ICP-MS should be minimised, through improvements 
in the precision and accuracy o f ‘total’ iodine and selenium measurements;
(3) development of iodine and selenium speciation analysis, by the coupling o f ion 
exchange chromatography to ICP-MS should indicate the form in which these 
trace elements occur in human breast milk and infant formula, and
(4) this research will be investigated by determining the ‘total’ and ‘species’ content 
o f human breast milk and infant formula samples, which have been collected 
from various regions around the World (UK, North / South America, Africa, 
Oceania). Problems associated with the dietary intake / requirements o f certain 
trace elements, notably iodine and selenium vary greatly between these regions. 
Data from the analysis of both forms o f infant nutrition should reveal differences 
in trace element composition between regions and the type o f nutrition.
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Chapter 2
Analytical Methodology 
(Total Elemental Analysis)
CHAPTER 2 - ANALYTICAL METHODOLOGY 
(TOTAL ELEMENTAL ANALYSIS)
2.0 Introduction
This section encompasses the analytical procedures used for the accurate and precise 
analysis o f human breast milk and infant formula. The principal technique used for 
ultra-trace element determination was Inductively Coupled Plasma Mass 
Spectrometry (ICP-MS). The sample preparation methods (i.e. dry ashing, open 
vessel / microwave digestion and enzyme digestion) were mainly used for the 
preparation o f a sample solution with a reduced matrix effect on the accuracy and 
precision of ICP-MS measurements. Alternative analytical techniques were used to 
provide a method comparison (NAA), additional species information (Ion 
Chromatography-ICP-MS (Chapter 4)) and a system for monitoring the 
effectiveness o f enzyme digestion (i.e. gas chromatography (free fatty acids), 
creamatocrit (total fat) and biuret test (total protein)) (Chapter 3).
2.1 Review o f the Analytical Sequence
Prior to the analysis o f trace elements in human breast milk and infant formula, the 
analytical sequence must first be considered. This includes: sample collection, 
sample preparation, instrumentation, calibration and validation. These key areas 
have been evaluated by reviewing the scientific literature in the field o f trace 
element (total / speciation) analysis for iodine and selenium in human breast milk 
and infant formula.
2.1.1 Sample collection of human breast milk and infant formula
The samples under investigation include: human breast milk from the UK and USA 
and infant formula from around the World, consisting of cows- / goats- / soya- based 
milk for infants from birth to 12 months o f age.
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Human Breast Milk
The composition o f human breast milk is known to vary as lactation progresses over 
a period o f weeks and months. However, it has also been stated that the 
composition can vary during a 24 hour period due to diurnal variations. In addition, 
the content has been observed to vary between left and right breast and due to 
cleaning procedures (or lack of) prior to expressing milk [Negretti de Bratter et al., 
1995, Reilly, 1996]. Therefore, a composite sample from both breasts was collected 
at the same time o f day, using an appropriate cleaning procedure.
Table 2.1: Human breast milk collected at certain points during lactation, with the 
time o f sampling recorded. (N.B. All 1st child / age o f mother 22 -  32)
Subject Country of Origin W eek (Time of day)
S UK 1 ( 12.00)
MW UIC 1 (11.30), 2 (11.00), 3 (10.30), 4 (12.15), 5 (14.00), 
6 (10 .30), 7 (15 .00), 13 (12.00)
D UK 2 (12.00), 4 (13.00), 10 (12.30), 12 (12.30)
TT USA 1 (10.30), 2 (12.00), 3 (11.00), 4 (13.00), 5 (13.30), 
6 (14.00)
Infant formula
Commercial infant formula were purchased directly from stores [Bratter et al., 
1998, Sanchez et al, 1999], in order to obtain a cross section o f products available 
to the general public in the UK and around the World (Table 2.2). Infant formula 
was stored in sealed containers under ambient conditions to maintain sample 
integrity. The method in which the concentration of trace elements was shown on 
the label o f infant formulas varied between manufacturers. For example,
concentrations were cited as pg/lOOg, pg/30ml, pg/100ml or not at all for iodine and 
selenium. Only 9 o f the 37 infant formulas investigated cited values for selenium. 
Therefore, labelled concentrations were converted to pg/kg or pg/1 to enable 
comparison with measured values. Concentrations for infant formula without 
labelled values were calculated from the guidelines provided for the reconstitution 
of milk powder.
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Table 2.2: Infant formula obtained from the UK and around the World.
Concentrations shown are labelled on the container and refer to the 
concentration o f iodine or selenium in the powder (pg/kg) or 
reconstituted formula (pg/1).
Infant Formula Country of 
Origin
Base
material
Iodine Selenium
pg/kg Pg/1 Pg/kg Pg/1
Cow +  Gate Plus UIC Cows milk 682 100 NG 19
Cow +  Gate Premium UIC Cows milk 682 100 NG 19
Cow +  Gate Step-up UIC Cows milk 702 110 NG 19
Cow +  Gate Wysoy UK Soya 907 130 NG NG
SMA Gold UIC Cows milk 675 100 NG 14
SMA White UK Cows milk 718 100 NG 14
SMA Progress UIC Cows milk 700 120 NG 14
SMA Wysoy UK Soya 1090 120 NG 14
Farleys 1st milk UK Cows milk 350 45 NG NG
Farleys 2nd milk UK Cows milk 750 100 NG NG
Farleys follow-on UK Cows milk 670 100 NG NG
Farleys Infasoy UIC Soya 610 84 NG NG
Boots 1 UK Cows milk 733 75 NG NG
Boots 2 UK Cows milk 816 72 NG NG
Boots Follow-on UK Cows milk 995 86 NG NG
Milupa from birth UK Cows milk 549 91 NG NG
Milupa forward UK Cows milk 668 124 NG NG
Aptamil 1st UK Cows milk 659 100 NG NG
Aptamil 2nd UK Cows milk 549 91 NG NG
HIPP organic follow-on UIC Cows milk 700 112 NG NG
Nanny UK Goats milk 600 79 NG NG
Ninho 1 Brazil Cows milk NG NG NG NG
Ninho 2 Brazil Cows milk NG NG NG NG
NAN 1 Brazil Cows milk 760 100 NG NG
NAN 2 Brazil Cows milk 1000 140 NG NG
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Table 2.2: (continued)
Infant Formula Country of 
Origin
Base
material
Iodine Selenium
fig/kg fig/1 fig/kg fig/1
NAN PRE Mexico Cows milk 500 66.7 NG NG
NAN 1 Mexico Cows milk 760 100 NG NG
NAN 2 Mexico Cows milk 1000 133.3 NG NG
NAN HA Mexico Cows milk 410 100 NG NG
Prosobee Mexico Cows milk 786 101.4 NG NG
S-26 Columbia Cows milk 357 100 NG NG
al- 110 South Africa Cows milk 769 100 NG NG
Isomil South Africa Cows milk 250 33 NG NG
Lactogen 1 * Malawi Cows milk 760 100 NG NG
Lactogen 2 ^Malawi Cows milk 230 33 NG NG
Nurture Premium New Zealand Cows milk 400 50 130 17
Nurture Follow-on New Zealand Cows milk 420 60 120 17
* Lactogen 1 and 2 manufactured in South Africa and Zimbabwe, respectively. 
However, both Lactogen 1 and 2 were purchased in Malawi.
NG -  value not given by manufacturer.
2.1.2 Sample preparation (Total elemental analysis)
The trace element analysis of biological materials can be extremely difficult, since 
inductively coupled plasma mass spectrometry (ICP-MS) has traditionally required 
the sample to be in a liquid form for solution nebulisation. The sample must contain 
a dissolved solids concentration of less than 1%, to prevent the blockage o f the 
nebuliser, ICP sample tube, cones and skimmers. Therefore, biological, materials 
are commonly digested using alkali or mineral acid combinations, acids / peroxides 
in conjunction with open or closed digestion facilities (water baths, ovens, heating 
block, microwave). The “schoniger combustion” and leaching with tetramethyl 
ammonium hydroxide (TMAH) [Knapp et al., 1998], sodium dodecyl-sulphonate 
(SDS) or enzymes [Sanchez et al., 1999] have been investigated for the treatment of 
human breast milk and infant formula, with subsequent trace element analysis, 
particularly iodine. Gelinas investigated the combustion of milk samples in an
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oxygen stream [Gelinas et al. , 1998b] and Gu compared the use o f oxygen 
combustion with peroxydisulphate oxidation for iodine determination o f milk 
samples [Gu et al., 1997]. In addition, triton X-100 has been used as a dispersant 
for direct nebulisation o f infant formula and milk samples into an ICP-AES 
instrument [Lee and Finlayson, 1986] or by pH adjustment with dilute ammonia 
[Vanhoe et al., 1994a]. Hua used a tertiary amine : EDTA dispersant for direct 
nebulisation o f infant formulas into an ICP-OES instrument [Hua et al., 2000].
The acid or acid mixture chosen for sample dissolution of infant formula and human 
breast milk depends upon the sample matrix, its trace element content and 
compounds present. Common reagents that have been used include; HC1 [Rayman 
et al., 1996], HCIO4 [Barclay et al., 1995] and HNO3 [Rao and Cliatt, 1991, Rao 
and Chatt, 1993, Larsen and Ludwegsen, 1997, Knapp et al, 1998]. Mixed acid 
solutions have also been utilised; HNO3 / HCIO4 [Larsen and Ludwegsen, 1997, 
Knapp et al., 1998] PI2SO4 / K2S2O8 [Knapp et al., 1998]. Hydrogen peroxide 
(30% PI2O2) has a strong oxidising ability which increases in acidic solution 
[Matusiewicz et a!., 1989].
Tetramethyl ammonium hydroxide (TMAH) is a tertiary amine solution that has 
become the most commonly employed reagent for the digestion o f infant milk 
powder and human breast milk [Cho et al., 1984, Radlinger and Heumann, 1998, 
Feclier et al., 1998, Casiot et al., 1999, Larsen et al., 1999, Sanchez et ah, 1999]. 
It has been suggested that the tertiary amine solution enhances the selenium ion 
signal and decreases polyatomic chloride interferences in the direct ICP-MS analysis 
o f biological samples [Nobrega et al., 1997], A combination of TMAH and KOH 
for sample dilution has been successfully employed for the analysis o f iodine 
[Sturup and Buchert, 1996, Langford and Crews, 2000]. Although this 
procedure has been cited as providing good results for iodine and copper 
determinations, other elements are difficult to quantify due to polyatomic 
interferences or analyte insolubility in alkaline solution [Nobrega et al., 1997].
Sample dissolution with 0.5% v/v ammonia solution has been proposed as a rapid 
method of preparing milk samples for the analysis of iodine by ICP-MS [Baumann,
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1990]. Ammonia solution has been reported to reduce the influence o f memory 
effects for iodine, compared to sample dissolution in HNO3. The latter can result in 
the selective evaporation of iodine as HI or I2, causing lion-quantitative recoveries 
and serious memory effects in the ICP-MS introduction system. This phenomenon 
can be reduced by oxidising iodide to iodate (e.g. H20 2, 0.5% ammonia, TMAH), to 
prevent the selective evaporation of iodine from milk sample digests [Vanhoe and 
Allemeersch, 1993, Gelinas et al., 1998b].
In general, an effective digestion procedure should result in the complete dissolution 
of the sample, using reagents of a high purity to prevent reagent contamination. 
Analyte loss through adsorption to vessel walls or losses through volatility must be 
minimised. Ultimately, the reagents used in the digestion procedure should not 
interfere with subsequent analysis. A number of traditional procedures for the 
sample preparation of human breast milk and infant formula have been evaluated, 
these include: dry ashing, open vessel dissolution (HN03 or TMAH), microwave 
dissolution and enzymolysis.
2.1.2.1 Dry ashing
Dry ashing has been commonly used for the ashing o f biological materials. The 
procedure involves placing the sample in a crucible and heating within a muffle 
furnace at a fixed temperature (450 - 550°C), resulting in an involatile ash. Dry 
ashing is a simple procedure, but has many disadvantages:
( 1) volatile elements (e.g. iodine) can be converted into volatile species and 
may be partially lost, limiting the ashing temperature,
(2) contamination via dust particles from other vessels or the furnace wall,
(3) oxidising and reducing conditions vary throughout the ashing procedure.
2.1.2.2 Open vessel digestion
Open vessel digestion systems often comprise of a heating block 011 which the 
digestion vessels are placed. Glass digestion vessels were utilised which had a 
narrow neck at their top (kjeldahl vessels) to reduce the loss o f vapour and potential 
volatile elements. However, it is possible that an open vessel system will result in 
lower recoveries of trace elements than a closed system.
45
2.1.2.3 Microwave digestion
Microwaves are a form of electromagnetic radiation o f lower energy (longer 
wavelength) than infrared radiation. The frequency most commonly used in 
laboratory microwave systems is 2450 MHz, as set by international convention for 
use in industrial, scientific and medical purposes [Vandecasteele and Block, 1994]. 
Microwaves consist o f oscillating electric and magnetic fields at right angles to each 
other. The oscillating electric field heats liquids exposed to microwave energy. 
Two mechanisms are involved in the heating o f liquids: dipole rotation and ionic 
conduction. Polar molecules tend to align their dipole moments with the microwave 
electric field. The constant change in the field results in the molecules rotating back 
and forth, causing them to collide with other nearby molecules and generate heat. 
Therefore, microwave dissolution is dependent upon the direct coupling of 
electromagnetic radiation with the mineral acids used in decomposition. The 
microwave dissolution technique allows for rapid acid dissolution, via the high 
heating capability. Microwave systems can be used with open systems and also 
closed systems. Closed systems enable higher temperatures to be reached, with a 
number of additional advantages; no volatilisation or losses of elements; shorter 
reaction times (often by a factor of 3 -  10) and improved decomposition; nitric acid 
can be used as the reagent for most digestions; blank values are decreased because 
of the reduced reagent quantities; and no contamination from external sources.
The MARS 5 system consists o f a microwave power unit with variable power output 
o f 0 -  1200 watts (frequency 2450 MHz at 1200 watts). Microwave energy is used 
to heat samples. Compounds such as water and other polar liquids absorb 
microwave energy rapidly. A sample placed inside a digestion vessel with a polar 
liquid or ionic solution (usually acid) is subjected to rapid heating and elevated 
pressures, causing the sample to dissolve or digest in a relatively short period o f 
time, compared to traditional wet digestion techniques.
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2.2 Instrumentation
Iodine and selenium have become recognised as essential trace elements for the 
development o f the infant. Their accurate determination has presented problems, 
since they have high first ionisation energies, are volatile elements, give rise to 
memory effects and in the case o f selenium, have a number o f isotopes which are 
inhibited by interferences (ICP-MS).
Iodine in milk samples was traditionally measured via ion selective electrode and 
neutron activation analysis (NAA). These techniques have largely been replaced by 
inductively coupled plasma mass spectrometry (ICP-MS), capable o f accurately 
determining both iodine and selenium at low-pg/1 levels in milk samples. In recent 
years, emphasis has been placed on the ‘species’ or form that the trace element is 
present in the sample, providing a greater understanding o f the distribution o f these 
‘species’ and bioavailability. Speciation analysis can been performed by the 
coupling of high pressure liquid chromatography (HPLC) or ion chromatography 
(IC) to ICP-MS (Chapter 4). A number o f these techniques have been evaluated 
experimentally and are discussed in further detail.
2.2.1 Inductively coupled plasma mass spectrometry (ICP-MS)
ICP-MS has been the principal analytical tool used in this research. It has become 
an increasingly utilised technique for trace elements, with applications in 
environmental and medical research. This is due to the instruments high sensitivity, 
large linear dynamic range, multi-element and multi-isotopic capabilities, with high 
sample throughput. However, this technique can be prone to spectroscopic and non- 
spectroscopic interferences, which can influence the analysis o f many elements to 
varying degrees. The majority o f these interferences are well documented and can 
be corrected.
ICP-MS was developed from the research of Date and Gray and Houk involving the 
use of a d.c. plasma (DCP) coupled to a mass spectrometer [Houk et al., 1980, 
Houk, 1986, Date and Gray, 1989]. This instrument comprises of a sample 
introduction mechanism, the ion source (ICP), interface, quadrapole mass
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spectrometer and detector consisting o f either a channel electron multiplier (CEM) 
or a Faraday cup detector. ICP-MS is a simultaneous multi-element technique, 
providing linearity over several orders of magnitude [Jarvis et al., 1992, 
Vandecasteele and Block, 19931.
ICP-MS has become widely applied to the analysis of ultra-trace elements in 
biological samples [Durrant et al., 1988, Durrant and Ward, 1989, Vanhoe et al., 
1989, Vanhoe et al., 1989a, Ward et al., 1990J. In particular, ICP-MS has become 
the most effective technique for the trace element analysis of iodine and selenium in 
human breast milk and infant formula, due to the low levels (low-pg/1) present.
Figure 2.1: Finnigan M AT Sola ICP-M S instrument [Dudding, 2000].
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2.2.1.1 Sample introduction
The most common form of sample introduction is by the generation of an aerosol 
using a pneumatic nebuliser. There are several types of nebuliser available; cross- 
flow, glass frit, grid-type, ultrasonic, babington-type and a V-groove nebuliser. 
These types o f nebulisers can only be used for solutions containing less than 0.1 -  
1% dissolved solids [Williams and Gray, 1988]. The solution to be nebulised is 
usually pumped to the nebuliser using a peristaltic pump. The solution is pumped 
through polymeric tubing (polyvinyl chloride) and connecting tubing (teflon) at 1 -  
2 ml/min to the nebuliser. These materials are manufactured to a high degree of 
purity, in order to minimise contamination.
Cross-flow nebulisers operate by directing a stream of gas across the mouth of a 
capillary, which is immersed in the sample solution. The reduction in pressure 
causes the solution to be drawn up the tube and shattered into droplets. Glass frit 
and grid-type nebulisers operate by ruiming the sample over a glass frit or metal 
grid. The nebuliser gas passes through the frit or grid at high velocity, splitting the 
sample solution into fine droplets. These nebulisers have a higher transport 
efficiency than pneumatic nebulisers, due to the fine droplets produced, although 
they cannot tolerate salt deposition if  solutions with high solid contents are 
aspirated. Ultrasonic nebulisers pass the sample solution over the surface of a 
transducer plate, which vibrates at high frequency to produce fine droplets from the 
solution. This system can increase the transport of the sample into the ICP by 10 -  
15%. However, the aerosol must be desolvated to prevent solvent vapour from 
disturbing the plasma. Sample solutions that contain a high concentration of 
dissolved solids are often passed through a Babington-type nebuliser or more 
commonly and for this work, a V-groove nebuliser is used. The latter involves the 
pumping of the solution through a large sample orifice that runs down a V-groove 
over a pin-hole gas orifice, where the high velocity of nebuliser gas breaks the 
solution into droplets.
Aerosols that are generated by a nebuliser are directed through a spray chamber that 
is constructed from glass or an inert polymer. The spray chamber prevents larger 
droplets from reaching the plasma and causing it to flicker, resulting in imprecision.
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The bulk of droplets are approximately 2 - 5  pm in diameter when the aerosol exits 
the spray chamber. This results in a sample transport system that is inefficient (1 -  
2%). The aerosol is directed from the spray chamber through the injector tube, 
which forms part o f the quartz torch and then into the base o f the ICP, forming an 
annular or doughnut-shaped plasma. The aerosol is then desolvated, decomposed 
and atomised, and the atoms subsequently ionised in the ICP [Evans et al., 1995].
2.2.1.2 Hydride generation
Elements such as selenium, arsenic, antimony and tin form hydrides that are gaseous 
at room temperature. This chemical property enables the use o f hydride generation 
as a means of sample introduction to the ICP-MS. The advantage of using this 
method of sample introduction is the reduced effect o f potential polyatomic 
interferences and the enhancement of the analyte signal. In effect sensitivity is 
improved for these elements. Hydrides are formed according to the following 
equation:
NaBH4 +  3H20  +  HC1 ->  H3B 0 4 +  NaCl +  8H+ --En+— » EHn +  xPI2 (eq 2.1)
E is the hydride forming element, n is its oxidation state and x is equal to !4(8-n). 
GBC produce a system (HG3000) for this type o f sample introduction based on the 
acid-borohydride reaction.
2.2.1.3 Inductively Coupled Plasma (ICP)
The ICP is the most common plasma and is the ionisation source used in ICP-MS. 
The ICP is generated through the coupling o f energy from a radiofrequency (Rf) 
generator into a suitable gas (i.e. argon). This produces a magnetic field, which is 
induced through a water-cooled copper coil situated a few millimetres from the tip 
of concentric quartz torch. The radiofrequency is normally supplied at a frequency 
o f 27 -  49 MHz, resulting in a magnetic field along the axis of the torch. An outer 
channel conducts 1 5 - 1 7  1/min of argon, to sustain the plasma and isolate the quartz 
tube from high temperatures. The inner channel conducts the auxiliary argon gas at 
approximately 1 1/min and is used for starting the plasma and transport of the sample 
into the plasma. A spark from a Tesla coil loads the gas with electrons, which
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accelerate in the magnetic field to reach energies sufficient to ionise gaseous atoms. 
Subsequent collisions with other gaseous atoms, causes further ionisation, so that the 
plasma becomes self-sustaining. This phenomenon occurs instantaneously. The 
magnetic field results in a horizontal flow of ions and electrons. The neutral argon 
is heated by collisional energy exchange (ohmic heating), maintaining a temperature 
o f 8000 K. The forward power (Rf) energy used to sustain the plasma is only 
coupled to the outer region of the plasma. Ionic species are formed in this region 
and then thermally transferred to the centre. This results in a heating o f the plasma 
and the characteristic bright discharge, known as the ‘skin effect'. The skin effect 
results in an ICP that is more energetic in the outer region, which makes it ‘optically 
thin'. Unlike flames, emission from the centre will not be re-absorbed by unexcited 
atoms in the outer regions [Evans et al., 1995].
Sample Aerosol 
in Argon
Figure 2.2: Inductively Coupled Plasma (ICP) [Dudding, 2000].
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Figure 2.3: Inductively Coupled Plasma (Finnigan MAT Sola)
Argon is the most commonly used plasma gas for ICP-MS, owing to its high first 
ionisation energy (15.75 eV). However, argon-based polyatomic interferences can 
influence the analysis o f elements such as, selenium, arsenic and bromine. Helium 
can be used as an alternative plasma gas, but the relatively low temperature (2500K) 
can result in dissociation problems [Wellington et al,, 1983]. The cost o f Helium is 
also a prohibitive factor.
The load-coil and the plasma present a low electrical impedence to the R f generator, 
which supplies their power. The R f generator requires a matched load between the 
coupling line and the load coil. This avoids high potentials from the reflected power 
and provides efficient energy transfer. The reflected power must be reduced to less 
than 10 watts to maintain an efficient plasma power o f 1 to 1.5 kW.
2.2.1.4 Sampling interface and vacuum system
The transport o f ions from the plasma (at 1 atmosphere) to the quadrapole analyser 
(at 1 x 10°  mbar) is achieved using a series o f  cones, which guide the ion beam 
through to the quadrapole. It is essential that the quadrapole is maintained under
52
vacuum conditions, otherwise the ion beam may collide with residual gas molecules 
and be deflected from the intended pathway. The Finnigan MAT Sola uses three 
cones (sampling, skimmer and accelerator), through which the pressure is lowered. 
The relatively small apertures o f the cones act as differential pumping apertures.
The sampling cone is the first in the series and is situated approximately 14 mm 
from the end of the torch (sampling depth) and has an aperture of 1.1 111111. The 
second cone is the skimmer, positioned 8 mm behind the sampling cone and has an 
aperture of 0.8 111111. The interspace between these two cones is evacuated using a 
rotary pump to maintain a pressure of 2 to 3 mbar. This enables the expansion o f the 
sampled ion beam. The third cone is situated 8 111111 behind the skimmer cone and 
has an aperture o f 1 111111. A negative charge is applied to the accelerator cone, 
which focus the ions passing from the skimmer cone. The intermediate housing 
between the skimmer and accelerator cones is evacuated by a turbomolecular pump 
to maintain a vacuum of 1 x 10' mbar. A further turbomolecular pump maintains 
the vacuum in the quadrapole housing, with a smaller turbomolecular pump 
maintaining a higher vacuum (1 x 10'5 mbar) in the collector housing where the 
electron multiplier is located. The three turbomolecular pumps are backed up by a 
second rotary pump.
2.2.1.5 Ion lenses
When the ion beam has been transported through the interface system, it passes into 
the quadrapole housing. The number o f ions continuing towards the mass 
spectrometer is maximised using electrostatic ion lenses. Each of the ion lenses 
consists of a number of electrodes with adjustable applied potentials. The 
adjustment of the applied potential enables the ion lenses to direct the ion beam to 
the mass spectrometer, thus improving sensitivity.
The ion lens system in the Finnigan MAT Sola is based on Turner optics, which 
achieves an improved transmission profile over other systems. The ion beam exits 
the interface system and is deflected off-axis and re-aligned to exit the optics 
parallel to the entry beam before entering the quadrapole. To obtain maximum ion 
transmission through the lens unit, it must have the ability to transmit ions of
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differing mass with the same efficiency. However, ions o f different mass have 
different ionisation energies and will not have the same path through the system. 
This can result in variations in the sensitivity throughout the mass range when only 
one set o f ion lens conditions is used. Multi-element analysis is still possible 
without a significant loss o f sensitivity [Finnigan, 1993, Dudding, 2000].
2.2.1.6 Quadrapole mass analyser
The quadrapole consists of four metal rods suspended parallel to and equidistant 
from the axis o f the ion beam. These rods should ideally have a hyperbolic cross 
section. Opposite pairs are connected together, to one pair a positive direct current 
(d.c) is applied and to the other a negative potential. An equal and opposite 
radiofrequency (Rf) is also applied to each pair of rods, with the effect o f narrowing 
the ion beam, allowing ions of low energy to pass through the quadrapole. This 
effect and the d.c. pole bias enable the transport o f higher masses than would 
otherwise be possible. Adjustment of the R f / d.c. ratio enables the selection o f a 
m/z (mass to charge) ratio to pass through the quadrapole. Ions outside o f this range 
are deflected towards the rods where they are neutralised.
2.2.1.7 Data acquisition
Ions that pass through the quadrapole are detected by one of two detection systems; 
the ChanneltronrM electron multiplier or the Faraday cup, depending upon the 
intensity o f the ion beam.
The Channeltron Electron Multiplier (CEM) (Figure 2.4) consists of an open glass 
tube with a cone at one end, positioned off-axis to provide maximum sensitivity. 
The interior surface is coated with a semi-conducting lead oxide material. A high 
negative potential (-3 kV) is applied to one end o f the coating, whilst the other end is 
connected to earth. The resistance varies throughout the tube, therefore when a 
potential is applied across the tube, a continuous gradient o f potential is present 
within the tube. A positive ion exiting the quadrapole is attracted to the negative 
potential at the entrance o f the cone. It then collides with the interior coating o f the 
cone, resulting in the emission of a secondary electron. The varying potential inside 
the tube draws the secondary electron through the tube. Each time they collide with
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the interior coating, emitting further secondary electrons. There can be a discrete 
pulse o f up to 10s electrons [Dudding, 2000] at the collector as a direct result o f one 
ion entering the cone. It is essential that the CEM is kept under vacuum pressure (5 
x 10° torr), otherwise spurious charges can occur within the detector chamber. The 
CEM detector is robust, can have a long life (typically 6 - 1 8  months), high 
electrical gain and fast response, low background count rates and a tolerance to high 
vacuum pressures. However, the CEM has a low tolerance to the high currents 
generated from strong ion beams, which are restricted to less than 106 ions/sec 
[Dudding, 2000]. The Faraday detector is used for high ion counts.
The Faraday cup (Figure 2.4) consists o f a metallic plate, maintained at a relatively 
high potential, which enables ions to be captured. Ions exiting the quadrapole pass 
through a collimator slit and through one or more suppressor grids or electrodes 
prior to striking the faraday cup. The potential of the suppressor electrode reduces 
the loss of ions from the cup by returning ions that are emitted during bombardment.
Amplifier and Discriminator 
for Ion Counting
Figure 2.4: Channel Electron Multiplier and Faraday detector [Dudding, 2000],
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2.2.1.8 Interferences
The measurement of an analyte signal by ICP-MS can be influenced by three 
interferences: (1) spectroscopic, (2) non-spectroscopie and (3) matrix effects. All of 
these phenomena can lead to the enhancement or suppression of the analyte signal.
(1) Spectroscopic interferences - Sample introduction to the Finnigan MAT Sola 
ICP-MS is by pneumatic nebulisation o f an aqueous solution. When pure water 
is nebulised, Ar, O, H and N atoms are the key elements present in the plasma. 
These atoms ionise to form Ar+, 0 +, H+, and N+ ions and can be found in 
background spectra. In addition, some polyatomic ions are found in the 
background spectra, e.g. l7[OH]+, ls[OH]+, l9[OH3]+, 32[ 0 2]+, 4, [ArH]+, 56[ArO]+ 
and [Ar2] . The low abundance isotopes o f these four elements are also an 
additional consideration (i.e. 36Ar+: 0.34% abundance) for background peaks in 
the spectra. The majority o f important background peaks are observed below 
mass 81. A low resolution instrument cannot separate peaks present due to 
polyatomic ions from those that are singly charged ions with the same mass, e.g. 
36[ArO]+ and 80[Ar2]+ are interferences that affect the main isotopes o f 56Fe+ and 
80Se+.
However, the sample is generally dissolved in an acid solution, rather than pure 
water. Therefore, additional polyatomic ions are formed. Only the 
concentration o f nitrogen increases in the plasma when nitric acid is used. Due 
to its high ionisation energy (14.53 eV), nitrogen yields small peaks from 
positive ions. Nitric acid is therefore an ideal acid for use in PSN-ICP-MS. 
Other acids, such as hydrochloric, sulphuric and phosphoric, cause problems 
due to their isotopic composition and lower ionisation energies o f P (10.49 eV), 
S (10.36 eV) and Cl (12.97 eV). For sulphuric acid, 64[S 0 2]+ and 64[S2]+ 
coincide with 64Zn+, and for hydrochloric acid, 77[ArCl]+ coincides with 7?Se+. 
Such coincidences reduce detection limits, but can often be overcome by 
j choosing another isotope, e.g. 82Se+ instead of 77Se+, although 82Se+ has a lower
natural abundance, an isobaric interference (82Kr, 11.6%) and a potential 
polyatomic [40Ar2H2]+.
_____________________
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Isobaric interferences are due to the isotopes of another element having the 
same mass number. Indium is the only element with an isotope free from 
isobaric interference. Unlike background spectra, mass spectra from an ICP do 
consist o f peaks only attributable to atomic ions. When S, P, Cl are present in a 
sample, polyatomic interferences are more difficult to account for, especially 
when using a blank correction. Other elements in the sample may yield ions in 
the form: M2+, MO+ (oxide), MOH+ (hydroxide), MH+ (hydride) and ArM+ 
(argide). Mass spectral interferences arise when these are produced from major 
elements in the sample and they may interfere with the determination of trace 
elements of the same mass. Vanhoe investigated the importance o f spectral 
interference with respect to the analysis of biological materials [Vanhoe et al., 
1994]. Table 2.3 lists elements in human serum and particularly infant formula 
(IF), that may form polyatomic ions and the elements which they may affect. In 
cases, such as human serum and infant milk formula where trace elements are 
determined in a concentrated matrix, ions such as, P03+ and ArNaO+, may also 
require consideration.
Table 2.3: Polyatomic ions that interfere with the determination of trace elements in 
serum and infant formula
Element Polyatomic ions Elements subject to interference
Ca CaO+, CaOH+, C a02+ Fe, Ni, Co, Zn, Ge
Cl C1N\ C10+, C10H+, C102+, Cl2+, 
ArCl+
Ti, V, Cr, Fe, Mn, Zn, Fe, As, Se
P PO+, POH+, P 0 2+, ArP+, P 0 3+ Ti, Cu, Zn, Ga, Br
K KO+, ArK+, K20 +, ArICO+ Mn, Br, Mo
C C 0 2+, ArC+, C 0 3+ Ca, Sc, Ti, Cr, Ni
Na Na2+, Na2H+, Na20 +, ArNa+, 
ArNaO+
Ti, Ni, Cu, Br
S SO+, SOFT, S 0 2+, S 0 2H+, ArS+, 
S 0 3+
Ti, Cr, Zn, Cu, Ge, Br, Se
VandeCasteele and Block, 1994, Ward et al, 2000]
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A number of possible hypotheses have been presented for the origin of 
polyatomic ions. Firstly, polyatomic ions may be formed in the plasma. 
However, the temperature o f the plasma is so high (approximately 8000 K), that 
incomplete dissociation to MO+ ions is unlikely. Another possible source o f 
polyatomic ions is in the ‘boundary layer’ formed around the edge o f the 
aperture of the sampling cone, behind the cone / skimmer,- or in the ion lenses 
[VandeCasteele and Block, 1994].
(2) Non-spectroscopic interferences -  involve the suppression or enhancement of 
an analyte signal by non-spectroscopic interferences can occur through sample 
transport, ionisation, ion extraction and ion throughput [Dudding, 2000].
(3) Matrix effects -  are an important limitation on the intensity o f the ion signal for 
PSN-ICP-MS. Matrix effects can be reduced by limiting the analyses o f 
solutions containing less than 1% dissolved solids. At 0.1% o f dissolved solids 
interferences are smaller and can be corrected for (although there is less sample 
to analyse). The influence of matrix is dependent upon the analyte element, the 
matrix, operating conditions and the instrument used. Instrumental parameters, 
such as the aperture sizes of the sampling and skimmer cones, the carrier gas 
flow, R f power and the sample uptake rate may all have an observed matrix 
effect. Although suppression o f the analyte signal is often considered, 
enhancement is also possible.
The most apparent matrix effect occurs through the blockage of the aperture of 
the sampling cone. The deposition o f salt leads to a decrease in the aperture 
diameter, reducing the sensitivity and signal gradually over time. However, 
even when no deposition occurs, matrix effects are observed in high salt 
concentrations. This can be attributed to ionisation suppression, whereby the 
introduction o f an easily ionised element (e.g. alkali or alkaline earth element) 
into the plasma contributes to the electron density in the plasma. Therefore, the 
ionisation equilibrium (M<±>M+ +  e") is shifted, resulting in the reduced 
ionisation of the analyte element. Another explanation for the matrix effect is 
based upon the space charge effect, which occurs after the extraction of the
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beam from the plasma. Only positive ions are transmitted to the spectrometer, 
so that the ion beam leaving the skimmer cone acquires a high density of 
positive ions. In the absence o f a matrix Ar+ and 0 + are mainly observed. 
However, when a matrix is added the number of positive ions in the extracted 
beam is increased, as positive ions from the matrix (e.g. Na+) are also present. 
These ions repel analyte ions, resulting in an increased space charge and an ion 
beam that is less easily focussed by the electrostatic lenses and passes less 
easily through the apertures in the lens system.
Several methods are used to correct for or overcome matrix effects. These 
involve: dilution, matrix-matching, use of internal standards, standard addition; 
and isotope dilution. Dilution is the simplest of these methods to reduce matrix 
effects, but it also decreases sensitivity, thereby increasing the detection limits. 
Matrix matching involves the addition o f the matrix to the standards, allowing a 
correction for matrix effects. However, this cannot easily be applied to complex 
matrices o f varying composition, for example human serum, infant milk 
formula. The use of internal standards involves the addition o f an element in 
equal concentration, to each sample and standard. The ratio between the analyte 
and internal standard signal can be used as a method for correcting random 
fluctuations of the signal and systematic variations o f the signal in samples and 
standards due to matrix effects. However, the signal for the internal standard 
should be influenced in the same manner as for the analyte signal and should 
have a mass number close to that of the analyte [VandeCasteele and Block, 
1994].
2.3 Analytical Figures o f Merit
Fundamental aspects of the analytical procedure include the cost-effectiveness, ease 
of operation, rate of sample throughput, multi-element capabilities, safety and in 
particular the analytical figures of merit. These include; accuracy, precision, 
detection limit, linear dynamic range (LDR), selectivity and sensitivity.
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2.3.1 Accuracy and precision
Accuracy is defined as the proximity to the true value [Miller and Miller, 1988]. 
Precision is a measure o f the reproducibility o f  independent measurements within a 
batch o f analyses and repeatability between batches. Precision is usually 
represented as relative standard deviation (rsd);
(Mean /  Standard Deviation) x 100 (eq 2.2)
Accuracy and precision are equally important and can both be affected by error. 
Systematic errors influence accuracy, since all measurements are affected, whereas 
precision is influenced by random errors, which affect individual measurements. 
Random errors may be envisaged as causing positive or negative deviations about 
the population mean. Systematic errors arise as a displacement o f the mean from the 
true value. Two forms o f systematic error should be considered. Firstly, persistent 
bias may affect the analytical system over a long period o f time and affect all data. 
This may be difficult to identify if the bias is small in relation to random error and 
may only be identifiable after the instrument has been in operation for a long time. 
This could be tolerated if the bias is maintained within defined limits. A  second 
type o f bias can be introduced by a system failure (e.g. mistaken use o f the wrong 
size o f pipette). This form o f bias is less tolerable, but can be detected at the time o f  
occurrence, since the bias is often large. The definition o f what is a random or 
systematic error is dependent on the time scale over which the system is viewed. 
Long-term changes in a positive or negative direction could be viewed as long-term 
random effects. Alternatively, if a short-term view were applied, the same errors 
could be described as changes in bias. Calibration drift is a good example o f this 
scenario, within a batch o f analyses it is a form o f bias. However, it increases the 
spread o f results o f replicate analyses, thus it may be observed as contributing to 
random error [Sherlock et a l., 1985, Thompson, 1988, Analytical Methods 
Committee, 1995]. The view o f analytical performance should be based upon the 
potential consequences o f data use.
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2.3.2 Limits of detection
The limit o f detection o f an analyte can be described as the concentration that gives 
an instrumental signal significantly different from the background (blank) signal. 
IUPAC (International Union o f Pure and Applied Chemistry) recommended that the 
limit o f detection (X l) should be defined as the analyte concentration giving a signal 
equal to the mean blank signal, X B, plus three (k) standard deviations o f the blank,
SB.
X L =  X B ±  kSB (eq 2.3)
When defining the limit o f detection, an analyte signal should not be reported as 
present when it is actually absent, but equally a low analyte signal should not be 
reported as absent when it is present. Therefore, the possibility o f each o f these 
errors must be minimised using, a sensible criteria for defining the limit o f detection. 
Using a k value o f three, there is a probability that 99.87%  o f results fall within the 
limit o f detection, assuming normal distribution [Analytical Methods Committee, 
1987].
The limit o f quantitation is used as an alternative method o f determining limits o f  
detection, when additional confidence in the measured signal is required (e.g. 
commercial or statutory analyses). This is recommended at X B ±  10SB [Potts, 
1987].
2.3.3 Linear dynamic range (LDR)
A  quantitative analytical technique should show a linear relationship between 
increases in analyte concentration and analyte signal over a particular concentration 
range. The upper and lower limits o f this range are known as the linear dynamic 
range. With the Finnigan M A T  Sola ICP-MS instrument, measurements are 
possible over 8  orders o f magnitude. The broad linear dynamic range facilitates the 
analysis o f a wide elemental concentration range, reducing the need for either 
dilution or pre-concentration o f the sample.
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2.3.4 Selectivity and sensitivity
The selectivity o f a technique refers to the ability to distinguish between the analyte 
signal and a possible interferent signal. This can be quantified as a ratio o f response 
between the analyte and interferent signal. Sensitivity, is the ability to differentiate 
between two samples o f a different concentration, defined as “the ratio o f  change in 
instrument response to a change in analyte concentration [Miller and Miller, 1988]. 
For example, the concentration o f analyte required for 1% absorption is used for 
atomic absorption spectrometry (A A S ), whereas ICP-MS uses the signal count for a 
particular isotope at a certain concentration.
2.3.5 Calibration and validation
Prior to measurements being made on actual samples, some form o f external 
calibration is required, followed by validation o f the measurements.
Calibration employs a series o f standard solutions o f known analyte concentration, 
in order to obtain accurate determination o f a sample with an unknown 
concentration. A  signal response for each standard is plotted as a calibration curve, 
from which the concentration in the sample can be calculated.
Validation o f analytical measurements is important to prove the suitability o f  
methodology for providing useful analytical data. The performance parameters o f  
the method should be compared with the requirements for the analytical data. 
Accordingly, the establishment o f firm requirements for the data is a prerequisite for 
method selection and validation. If the data requirements are not considered, 
analytical measurements can be unnecessarily expensive if the method chosen is 
more accurate than required, inadequate if the method is less accurate than required. 
A  valid method is necessary, although data obtained by several laboratories on the 
same test sample using the same methodology may exhibit a high degree o f  
variability. Data obtained by a valid method used in a quality assurance programme 
should enable the assignment o f limits o f uncertainty that can be used to judge the 
validity o f the data. Certified reference materials play a key role in the validation o f  
analytical measurements. A  planned sequential analysis o f reference materials in a 
quality assurance programme can assess the quality o f data output and thus validate 
the overall aspects o f the analytical procedure [Taylor, 1983, Mesley et al., 1991].
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Methods o f validation used in this work include;
(1) Certified reference material (CRM) -  a reference material with certified 
analyte values, accompanied by a certificate or documentation issued by the 
certifying body. There are a number o f CRMs available for milk powder and 
infant formula. The CRM  used for this study was from the National Institute o f  
Standards and Technology (Gethersburg, M A , U SA ) Certified Reference 
Material (NIST CRM ) 1549 non-fat milk powder. Certified values for a range 
o f trace elements, including iodine and selenium are given in Table 2.4.
Table 2.4: Certified values for NIST C R M -1549 non-fat milk powder.
Trace elements Concentration (mg/kg)
Antimony 0.00027
Cadmium 0.0005
Calcium (W t % ) 1.30
Chlorine (W t % ) 1.09
Chromium 0.0026
Copper 0.70
Fluorine (0 .2 0 )
Iodine 3.38
Iron 1.78
Lead 0.019
Magnesium (W t % ) 0 .1 2
Molybdenum (0.34)
Phosphorus (W t % ) 1.06
Potassium (W t % ) 1.69
Selenium 0 . 1 1
Sodium (W t % ) 0.497
Sulphur (W t % ) 0.351
Tin (<0 .0 2 )
Zinc 46.1
* values in brackets are not certified, W t %  - percentage dry weight.
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(2) Inter-laboratory comparison -  certified reference materials or samples are 
analysed in different laboratories using the same technique. This method o f  
validation was used when comparing microwave and ICP-MS instruments 
(Section 3.4).
2.4 Method Development (ICP-M S)
The principal inductively coupled plasma mass spectrometer used in this work was 
the Finnigan M A T  Sola ICP-MS (Finnigan, Hemel Hempstead, U K ) fitted with a V -  
groove nebuliser. The machine was designed, built and manufactured by Patrick 
Turner of Turner Scientific prior to being purchased by Finnigan. An alternative 
ICP-MS instrument (Perkin Elmer Elan 5000 ICP-MS, Perkin Elmer, U K) was used 
for an inter-laboratory comparison.
2.4.1 Chemicals and reagents
Samples and standards were prepared using nitric acid (Aristar™, BDH, Poole, UK) 
or tetramethyl ammonium hydroxide (TM AH ) (BDH, Poole, UK). Dilutions were 
made using distilled deionised water (D D W ) with a resistivity o f 18 M QcnT1. D D W  
was obtained from an Elgastat UHQ water dispenser (Elga Ltd, High Wycombe). A  
wash solution consisted o f H 2 SO 4  and triton X -1 0 0  (BDH, Poole, UK).
Analytical standard solutions for indium, germanium, antimony and selenium were 
supplied as 1000 mg/1 solutions (Aristar™, Plasma emission standard, BDH, Poole, 
UK). A  stock solution o f 1000 mg/1 o f iodine was prepared by the dissolution o f  
solid iodine (Aristar™, BDH, Poole, UK) in either 5%  H N 0 3 or 1%  TM A H .
2.4.2 Instrument optimisation (Finnigan M A T  Sola)
The analytical performance o f the ICP-MS instrument in terms o f accuracy, 
precision and freedom from interferences is dependent upon various operating 
parameters. These include; choice o f isotope, sample uptake rate, spray chamber 
temperature, plasma gas flow rates and to a greater extent the nebuliser flow rate 
(NFR) and forward power (Rf).
64
2.4.2.1 Isotope selection and interference correction
Iodine has one naturally occurring isotope, Iodine - 127. Selenium has five naturally 
occurring isotopes, selenium - 76, 77, 78, 80, 82. The choice o f isotope for analysis 
depends upon the natural abundance and the presence o f overlapping isobaric or 
polyatomic interferences (Table 2.5).
Table 2.5: Isotopic abundance and potential interferences for Iodine and Selenium.
Isotope Abundance(% ) Possible interferences
1 - 1 2 7 1 0 0 -
Se -  76 9.0 (Ge 7 .8% ), •“ Ar4 “Ar+, 4 0 A rj6 S+
S e - 7 7 7.5 '!<’Ar4 uArH+, 4 uAr3 /Cl+
Se -  78 23.5 (Kr 0 .4% ), 3 8 Ar4 UAr+
Se -  80 50 (Kr 2 .3% ), 4 0 Ar4 0 Ar+, “ S 0 3+
Se -  82 9.0 (Kr 11.6% ), 4 UAr4 °ArH2+, 3 4 S 0 3+, 5 lBrH+*
[VandeCasteele and Block, 1994, Ware et al., 2000]
* Bromine impurity in HC1 when hydride generation used [Rayman, 1997].
Iodine is not effected by such interferences, whereas many o f the selenium isotopes 
are unsuitable for analysis due to overlapping interferences (Table 2.5). Although 
8 2 Se+ has relatively low abundance, it is often the preferred choice o f isotope owing 
to less influence from interferences. A  washout solution o f 5%  H 2 SO 4  /  0 .5%  Triton 
X -1 00  (see memory effects) was used to reduce the memory effect o f iodine, which 
also led to a 10 to 20-fold increase in the 8 2 Se+ signal, when compared to 1%  T M A H  
or 5%  HNO 3 . Therefore, a 5 %  H N O 3 solution was passed through the instrument 
after the washout solution in order to reduce both the iodine and selenium memory 
effects between samples. It should be noted that no significant memory effects were 
produced from samples prepared in T M A H  and that a 1%  T M A H  solution was 
sufficient to reduce iodine and selenium background measurements to similar levels 
achieved by the washout solution for samples prepared in HNO 3 .
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2.4.2.2 Nebuliser flow rate (NFR) and forward power (Rf)
The nebuliser flow rate controls the amount o f sample that reaches the plasma, 
influences subsequent effects on stability and energy o f the plasma and controls the 
speed at which the generated ion species enter the cone and skimmer apertures. The 
forward power represents the incident power o f the radiofrequency generator. Both 
the NFR and forward power were optimised by passing a 5 pg/1 iodine standard 
solution through the Finnigan M A T  Sola ICP-MS instrument. The NFR was varied 
from 0.80 to 1.20 1/min, with 0.05 increments and the forward power from 1.30 to 
1.50 kW , with 0.05 increments. The optimised NFR for iodine when analysing 
standards in HN O 3  was 1.00 1/min and 0.95 1/min for TMAFI solutions. The forward 
power was optimised at 1.40 kW  for HNO 3 solutions and 1.50 k W  for TM A H  
solutions.
2.4.2.3 Sample uptake rate
Pneumatic nebulisation (V-groove) was chosen as the method for sample 
introduction, since it is suitable for samples with a high dissolved solids content. 
The rate o f sample uptake was controlled by using a Gilson Minipuls 3 peristaltic 
pump and set at 1.5 ml/min.
2.4.2.4 Sampling depth
The distance from the load coil to the front o f the sampler cone is known as the 
sampling depth. It must be sufficient to allow maximum dissociation and ionisation 
o f the analyte ions without being so large as to allow recombination o f the species. 
For the Finnigan M A T  Sola instrument, this depth was set at 14 111111. Work 
performed by Hoiiick suggested that little effect was observed upon the sample 
count rate when varying the sampling depth provided that it is initially set at an 
appropriate depth [Horlick et al., 1985] (unlike the nebuliser flow rate and forward 
power).
66
2.4.2.5 Spray chamber temperature
The cooling o f the spray chamber reduces the amount o f water introduced into the 
plasma by the condensation o f larger aerosol droplets. This decrease in available 
oxygen significantly reduces the formation o f polyatomic interferences. The 
temperature o f the spray chamber was maintained at 2°C.
2.4.2.6 Scan parameters
There are five scan parameters that must be set prior to sample analysis:
(1) detector mode -  can be either Faraday (for ion counts >  106) or multiplier,
(2 ) channels -  the number o f steps per amu in which ion counts are measured,
(3) dwell time -  amount o f time per channel that ions are counted,
(4) passes -  number o f repetitions per channel,
(5) scans -  number o f repetitions for the entire mass range studied.
When deciding upon the values for these parameters, consideration must be given to 
the accuracy, precision and speed o f analysis. Investigations undertaken by 
Dudding showed that a significant lowering o f the precision (rsd) was seen between 
1 0  and 1 0 0  passes and 1 0 0  to 2 0 0  passes, with a doubling o f the analysis time. 
Using 10 scans as opposed to 3 showed a lowering o f the rsd as is the situation with 
16 channels, compared to 8  channels. The dwell time o f 2 milliseconds was 
considered to be appropriate owing to its overall influence on the analysis time 
[Dudding, 2000].
Table 2.6: Parameters used for the CEM  detector (Iodine and Selenium analysis).
Parameter Value
Detector 1 0 0  passes
Channels 8
Scans 3
Dwell time 2 ms
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2.4.2.7 Summary of ICP-MS operating parameters
The optimisation o f the ICP-MS parameters performed on iodine standard solutions 
has demonstrated that although ICP-MS can be used for the analysis o f a number o f  
elements across a wide mass range, sensitivity can be compromised. For maximum 
sensitivity, each element must have individual operating parameters manually 
optimised prior to analysis. However, the use o f modern instruments, such as the 
Perkin Elmer Elan 5000 instrument performed this optimisation process 
automatically.
Table 2.7: Operating parameters for the Finnigan M A T  Sola ICP-MS instrument.
Operating parameters
Nebuliser flow rate (NFR) (1/min) 1.0 (H N 0 3) and 0.9 (TM AH )
Forward power - R f (kW) 1.4 (HNO 3 ) and 1.5 (TMAPI)
Uptake rate (ml/min) 1.5
Spray chamber temperature (°C) 2
Sampling depth (mm) 14
Y  steer 5.60
Y  deflection 2.80
X  deflection 6.08
Extraction 2.83
Filter 1 0 . 0
Pole Bias 4.50
Match 7.90
Focus 5.68
Discriminator 0.80
Multiplier voltage 6 .5 - 7 .0
Resolution 34
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2.4.3 Memory effects / Washout procedure
There is a possibility o f an element remaining in the instrument from one sample 
analysis and giving rise to an erroneously high signal in the next sample analysis. 
This occurrence is known as the memory effect, for certain elements a complete 
stripdown of the ICP-MS instrument from source to detection is required to reduce 
background levels. Iodine has a long residence time in the ICP-MS instrument and 
can lead to memory effects that give inaccurate iodine values. Therefore, a wash 
procedure was developed to reduce the influence of memory effects for iodine, 
between individual sample analyses. A  variety o f wash solutions were tested 
following a 2 minute aspiration o f a 5 pg/1 iodine standard solution (prepared in 1%  
H N O 3 ) through the ICP-MS instrument. The wash solutions were passed through 
the instrument after the iodine standard for up to 16 minutes. The aim o f the wash 
procedure was to reduce the iodine signal to background levels within a reasonable 
time limit, since the wash solution was to be passed through the ICP-MS instrument 
after each sample.
Fifteen solutions were investigated as a wash solution, the iodine signal was 
measured every 2  minutes whilst the wash solution was passed through the 
instrument. A  solution o f 5 %  H 2 SO 4  /  0 .5%  triton X -100  effectively reduced the 
iodine signal to the greatest extent ( -4 .5 %  o f the signal prior to washout) at 2 
minutes (Figure 2.5).
A s mentioned above, the 5%  H 2 SO 4  /  0 .5%  triton X -100  wash solution increased the 
selenium signal. The washout solution was passed through the instrument for 4 
minutes followed by 5%  HN O 3 for 1 minute to ensure that the iodine and selenium 
signals were reduced to background levels.
Samples prepared in TM A H  did not exhibit significant memory effects for iodine. 
Both iodine and selenium signals could be reduced to background levels by passing 
a 1% T M A H  solution through the ICP-MS instrument for 4 minutes.
69
(5 pg/1) in the ICP-MS instrument (T X  -  triton X -100).
2.4.4 ICP-MS calibration
For iodine and selenium analysis, calibration was performed using five standard 
solutions; 0, 1, 5, 10, 25, 50 pg/1 in 5 %  H N O 3 or 1% TM AH . The correlation 
coefficient (r2) value for a linear correlation o f  data points should be greater than
0.99. This value is calculated in Microsoft Excel by plotting concentration against 
signal intensity. The concentration o f  H N O 3 or TM AH  was equivalent to the 
concentration o f these reagents in samples after dilution.
2.4.4.1 Calibration o f  software
Prior to the analysis o f  standard solutions or samples, the software used for 
identifying individual analyte signals must be calibrated. This is achieved by 
passing a solution containing a range o f standards ( 1 0 0  pg /1) from low to high mass 
range through the ICP-MS instrument and running the mass calibration program. 
This process ensures that the analyte signal is measured at the correct mass number. 
This is an essential process to be conducted before each set o f  analyses. Failure to 
follow this procedure can lead to large discrepancies in the accurate measurement o f  
the analyte signal.
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2A4.2 Internal standardisation
During ICP-MS analyses, it is common for signal drift to occur over time. Signal 
drift is corrected by employing internal standardisation, which involves the addition 
o f another element to the sample matrix at a constant concentration. Drift in the 
sample signal is corrected by a ratio with the signal o f the internal standard. There 
are a number o f fundamental requirements for the selection o f an element as an 
internal standard:
( 1 ) it must be absent from the sample matrix,
(2 ) it should have a similar m /  z ratio as the analyte o f interest,
(3) it should have a similar ionisation potential to the analyte o f interest,
(4) and should be mono-isotopic or have an isotope o f high abundance.
Table 2.8: Internal standards used for ICP-MS.
Isotope Ionisation potential 
(eV)
Abundance
,4Ge 7.9 36.3
" ’ In 5.8 95.7
,21Sb 8 . 6 57.2
82Se 9.8 8.7
u '\ 10.5 1 0 0 . 0
[Micromass Ltd, 1999]
Indium and germanium have been used to correct for the analysis o f iodine and 
selenium in infant formula and breast milk prepared in nitric acid, whereas antimony 
was found to provide a more stable signal to correct against when samples were 
prepared in TM A H . The internal standard applied to T M A H  sample solutions was 
prepared in a solution o f 0 .1%  KOH . This prevented the build-up o f carbon on the 
injector tube and the need for regular cleaning o f the injector tube.
The correction for instrumental sample drift and background measurements involves 
calculations using ratios o f the blank (background signal from instrument or matrix), 
standards, sample and sample digest blank against the internal standard. The 
following example explains this procedure using the data in Table 2.9.
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(1) Calculation o f the ratio o f blank (matrix), sample and sample digest blank 
against the internal standard.
i.e. sample signal /  internal standard signal (column 2 /  column 3 =  column 4),
(2) Subtract blank (matrix) from all standards and samples (column 5),
(3) Calculation o f the concentration o f samples from the calibration curve using 
the equation o f the trendline (column 6 ),
(4) Subtract blank digest concentration from sample concentration to correct for 
contamination or carryover during sample preparation (column 7),
(5) Correct for sample dilution factors or reconstitution o f samples in solution, 
concentrations pg/kg or mg/kg fresh weight to 2  decimal places.
Table 2.9: Example for the correction o f data, using the internal standard. 
Calculation o f concentrations (pg/1) from calibration curve.
1. Sample 
Description
2. Sample 
signal
127 j
counts per 
second 
(cps)
3. Internal 
Std signal 
115In 
(cps)
4.Ratio
o f
I2 7 I /
115In
5. Subtract 
blank 
(matrix) 
from all 
stds/sample
6 . Calculate 
conc. o f  
samples 
calib curve 
(gg /1)
7. Subtract 
blank digest 
(1.2615)
from samples
(ftg/1)
Blank
(matrix)
150 150000 0 . 0 0 1 0 0 . 0 0 0 0
Std 1: 0 .5pg/1 450 145000 0.0031 0 . 0 0 2 1
Std 2: 1 pg/1 1 0 0 0 148000 0.0068 0.0058
Std 3: 5 pg/1 4500 147000 0.0306 0.0296
Std 4: 10 pg/1 9500 146000 0.0651 0.0641
Blank 250 148000 0.0017 0.0007
Milk digest 1 8700 142000 0.0613 0.0603 9.4769 8 . 2 2
Milk digest 2 8800 141000 0.0624 0.0614 9.6461 8.39
Milk digest 3 7600 142000 0.0535 0.0525 8.2769 7.02
Milk digest 4 9100 143000 0.0636 0.0626 9.8307 8.57
Blank digest 1150 145000 0.0079 0.0069 1.2615 0 . 0 0
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2.4.5 Analytical figures of merit
The analytical figures o f merit were determined using the Finnigan M A T  Sola ICP- 
M S instrument under the conditions described in Table 2.7.
2.4.5.1 Sensitivity
A  solution containing 5 pg/1 o f iodine in 5%  HN O 3 or 1%  T M A H  was used to 
perform the optimisation o f the ion beam transmission through the mass 
spectrometer. Continual aspiration o f the standard solution and monitoring o f the 
signal output for 127I and 82Se enabled the electrostatic lenses to be tuned to give the 
optimum signal. Under optimum conditions, with internal standardisation and blank 
correction, a sensitivity o f 1800 cps at 1 pg/1 for 127I and 300 cps at 1 pg/1 for 82Se is 
attainable. Between each set o f analyses the ion lenses and other operating 
parameters were checked to ensure that an optimum signal was obtained. This did 
result in changes in some o f the operating parameters, particularly the multiplier as 
its performance degraded over time.
2.4.5.2 Detection limit
The limit o f detection (LOD) obtained by the Finnigan M A T  Sola ICP-MS for 
iodine and selenium was obtained by measuring the blank signal 10 times. Using 
the mean value plus 6  times the standard deviation (mean +  6 a), the detection limit 
was calculated as 1 pg/1, for both iodine and selenium. This follows the 
recommendations o f Potts in using mean LOD as a suitable measure for a detection 
limit [Potts, 1987].
2.4.5.3 Linear dynamic range
Standard solutions o f iodine and selenium were prepared at concentrations o f 1, 5, 
10, 25, 50 and 100 pg/1. The ion counts were measured for each solution and the 
raw counts per second (cps) were plotted against concentration. The plot showed a 
linear relationship for both iodine and selenium over 3 orders o f magnitude. This 
range is adequate for the expected concentrations in human breast milk and infant 
formula.
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2.4.6 Summary: Instrumental parameters in this study 
This section has covered the development o f a method for the analysis o f iodine and 
selenium at trace levels in human breast milk and infant formula, using ICP-MS. 
The optimisation o f instrumental parameters, washout procedures and internal 
standardisation are summarised in Table 2.10.
Table 2.10: Summary o f ICP-MS method development.
ICP-MS parameter
Nebuliser Flow Rate (1/min) 1.0 (H N 0 3) and 0.9 (TM A H )
Forward Power (kW ) 1.4 (H N 0 3) and 1.5 (TM A H )
Scan Parameters 8  channels - 100 passes - 2 ms - 3 scans
Wash Solution H N 0 3 -  5%  H 2 S 0 4 /  0 .5%  Triton X -1 00  
T M A H - 1 %  T M A H
Internal Standards HNO 3 - , 4 Ge+, “ 5 In+ 
T M A H  - 121 Sb+
Calibration l2 7 I+ /  8 2 Se+: 1 - 1 0 0  jj.g/1
Sensitivity l2T  -  1800 cps /  8 2 Se+ -  300 cps
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Chapter 3
Iodine and Selenium ‘Total’ 
Analysis of Human Breast Milk 
and Infant Formula
CHAPTER 3 -  IODINE AND SELENIUM ‘TOTAL’
ANALYSIS OF HUMAN BREAST 
MILK AND INFANT FORMULA
3.0 Introduction
An evaluation o f traditional sample preparation methods for human breast milk and 
infant formula, with subsequent measurement o f ‘ total’ iodine and selenium by 
ICP-MS was performed. In addition, alternative sample preparation methods have 
been investigated through the method development of:
(1) open vessel dissolution with tetramethyl ammonium hydroxide (T M A H ), and
(2) enzymolysis (with /  without subsequent dissolution with TM A H ).
A ll human breast milk and infant formulas were digested using; (a) H N O 3 -H 2 O 2  
(microwave and open vessel) and (b) tetramethyl ammonium hydroxide (TM AH ). 
Digestion with H N O 3 was not the preferred method for iodine and selenium 
determination as discussed in Section 3.2. Data for sample digestions, using H N O 3 
(microwave and open vessel) are presented in Appendix A .I . Open vessel 
dissolution with T M A H  and the use o f enzymolysis as a pre-digestion step for 
T M A H  dissolution provided improved accuracy and precision for iodine and 
selenium determinations in human breast milk and infant formula. The number o f  
samples digested using enzymolysis was limited due to the prohibitive cost o f the 
enzymes and necessary reagents. Therefore, only representative samples from the 
U K , South America and Africa were prepared using enzymolysis /  T M A H  for 
sample dissolution. Enzymolysis was also coupled to H N O 3 -H 2 O 2  open vessel 
dissolution, but did not result in complete digestion o f human breast milk and infant 
formula and produced poor accuracy and precision for iodine and selenium 
measurements. Data for enzymolysis /  H N O 3 -H 2 O 2  is presented in Appendix A .I .
Total iodine and selenium measurements for human breast milk and infant formulas 
are presented in Section 3.3. Iodine and selenium levels measured in human breast 
milk have been evaluated over time and compared to infant formulas. A  comparison
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o f the iodine and selenium content measured in infant formula was made with the 
labelled values provided by manufacturers, between types o f infant formula and 
between regions around the World.
3.1 Sample Preparation Method Development
Traditional methods o f sample preparation for the dissolution o f human breast milk 
and infant formula, with subsequent analysis o f iodine and selenium, were 
investigated (section 2.1.2). These have involved the use o f dry ashing, open vessel 
digestion (HNO 3 or T M A H ) and microwave dissolution. Each o f these methods has 
been evaluated using published experimental conditions or modified versions. 
These methods will be scrutinised according to their ability to complete sample 
dissolution, analyte recoveries, accuracy, precision, stability o f analyte signal, time 
taken and ease o f use.
3.1.1 Chemicals and reagents
Human breast milk samples and infant formulas are summarised in section 2.1.1. 
The trace element composition o f certified reference material N IST-C R M  1549 non­
fat milk powder (National Institute o f Standards and Technology, Gethersburg, M A , 
U SA ) are listed in section 2.1.4. Reagents used for the dissolution o f samples were:
(1) 6 9%  H N O 3  Aristar™ (BDH, Poole, U K ),
(2) 30%  H 2 0 2  (BDH, Poole, UIC) and
(3) 2 5%  T M A H  (BDH, Poole, UK).
Dilutions were made using distilled deionised water (D D W ) with a resistivity o f 18 
M Q c n f . D D W  was obtained from an Elgastat UHQ water dispenser (Elga Ltd, 
High Wycombe, UK).
3.1.2 Dry ashing
A  sub-sample o f 0.125 ±  0.001 g o f  infant formula was ashed in a muffle furnace at 
450°C  for 240 minutes.
Ashed samples were then dissolved in 5 ml o f 69%  HNO 3 and diluted with D D W  to 
5%  H N O 3 with D D W .
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3.1.3 Open vessel dissolution
H N O 3 - 0.5 ±  0.001 g o f infant formula was placed into 100 ml kjeldahl tubes. 10 
ml o f 69%  HN O 3 (Aristar™, BDH, Poole, UIC) and 0.5 ml o f 30%  H 2 0 2  (BDH, 
Poole, U K ) was then added to the sample. The reaction mixture was left to stand for 
approximately 15 minutes, prior to heating. The kjeldahl tubes were then placed on 
a heating block and heated to 200°C  (the temperature was increased gradually) for 
120 minutes. Once the kjeldahl tubes had cooled, samples were diluted to 100 ml 
with D D W  and transferred to polypropylene containers.
The method was modified when digesting just the soluble whey fraction 
(centrifugation o f reconstituted infant formula: 3g in 2 0  ml deionised water) and 
enzyme digest solutes. 3 ml o f sample was placed in the reaction vessels with 5 ml 
o f 69%  H N 0 3 and 1 ml o f 30%  H 2 0 2. The reaction mixture was then heated to 
90°C  for 120 minutes. All sample digests were diluted with deionised water to 5%  
H N O 3 .
T M A H  -  0.5 ±  0.001 g o f infant formula and 3 ml o f deionised water (or 3 ml o f  
milk solution was placed into 100 ml Kjeldahl tubes and then 2 ml o f 2 5%  T M A H  
(BDH) was added. The sample mixture was mixed thoroughly and heated to 70°C  
for 240 minutes. After cooling, digests were diluted to 2 .5%  T M A H  with deionised 
water. Certified reference materials (NIST CRM  1549 non-fat milk powder) were 
digested in each batch o f digests for both T M A H  and H N 0 3 procedures.
3.1.4 Microwave dissolution
Microwave digestion conducted at the ICP-MS Facility, University o f Surrey, U K, 
utilised the CEM  M A R S 5, microwave digestion unit. The instrument used in 
Norway was the Milestone Laboratories Microwave System (M LS 500). The 
operating procedure o f both instruments differed, in that the M A R S 5 system 
operated at up to 1200 W , compared to 600 W  for the M LS 500 instrument.
A  sub-sample o f 0.5 ±  0.001 g o f sample was weighed directly into PTFE lined 
reaction vessels. 10 ml o f 69%  H N 0 3  (Aristar™, BDH, Poole, U K ) and 0.5 ml o f
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3 0%  H 2 O 2  (BDH, Poole, UIC) was then added. The reaction mixture was left to 
stand for approximately 15 minutes before the lids were placed onto the reaction 
vessels, in order to prevent a build-up o f excess pressure during heating. The 
reaction mixture was heated to a maximum o f 210°C  or 195 psi, gradually over a 
period o f 30 minutes (the time period for the M LS 500 instrument was increased, to 
account for its lower heating capability). The reaction vessels required a minimum 
cooling period o f at least 30 minutes, to allow the safe removal o f the reaction vessel 
lids. The samples were diluted to 5 %  H N O 3 with deionised water. The reaction 
vessels were cleaned using 10 ml o f 5%  HNCfy heated using a pre-set wash program 
and then rinsed with pure water. Certified reference material, C R M  1549 non-fat 
milk powder was digested with each batch.
3.1.4 Summary o f traditional sample dissolution methods 
The traditional methods o f sample preparation for human breast milk and infant 
formula that have been evaluated, are compared using iodine (Table 3.1) and 
selenium (Table 3.2) measurements for 1 human breast milk (H BM ), 4 infant 
formula and 1 NIST CRM  1549 non-fat milk powder.
Table 3.1: Comparison o f iodine values (pg/kg) for traditional methods o f sample 
preparation.
Sample Ashing Open
H
Vessel
N 0 3
Open Vessel 
T M A H
Microwave
H NO 3
whey complete
sample
whey complete
sample
Cow +  Gate Plus 
(n -  1)
na 1272 1036 995 798 ± 29 
(n = 5)
1157
NIST CR M  1549 
*(3380 pg/kg) 
(n = 8 )
1049 ± 
371
1827 ±  
437
1069 ±12 1162 ± 
240
3250 + 
160
*1233 ±121
H BM  S (pg/1) 
(n = 2 )
na 11a 133 na 140 + 13 na
na -  not analysed, * - certified value, 11 =  5.
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Table 3.2: Comparison o f selenium values (pg/kg) for traditional methods o f sample 
preparation.
Sample Ashing Open
H
Vessel
NO3
Open Vessel 
TM A H
Microwave
H NO 3
whey complete
sample
whey complete
sample
Cow +  Gate Plus 
( n = l )
na 2045 74 600 182+14  
(n = 5)
2231
NIST CRM  1549 
* ( 1 1 0  pg/kg)
(11 = 8 )
na 2 0 0  + 
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415 + 288 72 + 53 342 + 8 *391 +228
H BM  S (pg/1) 
( n = l )
11a na na na 41 +3 na
na -  not analysed, * - certified value, n =  5.
A  comparison o f the traditional sample preparation techniques shows that the iodine 
values obtained for NIST CRM  1549 differ greatly. Dry ashing did not provide a 
stable signal, owing to the poor dissolution o f the reference material. Subsequent 
analyses were not possible due to the blockage o f sample tubing. Digestion with 
H N O 3 provided poor recoveries o f iodine from NIST CRM 1549, hence poor levels 
o f accuracy for both open vessel (whey: 54% , complete sample: 32% ) and 
microwave digestion (37% ). Digestion with TM A H  provided an improved recovery 
o f the iodine signal from the digestion o f the complete sample (whey: 34% , 
complete sample: 96% ), with reasonable precision (<5% ). The digestion o f the 
soluble whey fraction provided poor accuracy and precision. Sample data for the 
dissolution o f the soluble whey fraction is presented in Appendix A .2 . Table 3.2 
shows that poor accuracies were obtained for selenium measured in NIST CRM  
1549. Sample dissolution with HNO 3 led to selenium levels that were 3 to 4 times 
higher than the certified value, with poor levels o f precision. Dissolution with 
T M A H  provided good precision levels (<  5% ), but poor accuracy for whey (65% ) 
and the complete sample (311% ). Total selenium data presented for all human 
breast milk and infant formulas digested with TM AH  (section 3.3) was corrected
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using the certified value (110 pg/kg) for NIST CRM 1549 non-fat milk powder. 
Further improvements in the recovery rates and signal stability have been attempted 
by the development of enzymolysis for the dissolution of human breast milk and 
infant formula (Section 3.2).
The use of acid or alkali digestion in open, or closed microwave vessels, or dry 
ashing, which is normally followed by acid dissolution of the ash can lead to several 
disadvantages. These digestion procedures can be hazardous, introduce a risk of 
contamination or lead to elemental losses through volatilisation. In addition, these 
procedures do not provide complete dissolution of the human breast milk or infant 
formula, leaving a layer of fat or protein in the sample digests. The high 
concentrations of salts, lipids and proteins adversely affect the stability of the ICP- 
MS signal and cause a downward drift in sensitivity, leading to poor precision and 
accuracy. This drift is mainly due to partial blockages of different parts of the 
instrument, such as the sample tubing Figure 3.1, nebuliser, sample injector tube, 
sampler, skimmer or accelerator cones. The reduction of non-dissolved solids in 
sample digests was reduced through the development of enzymolysis in section 3.2.
Figure 3.1: ICP-MS sample tubing -  fat deposition from infant formula digested 
with HNO 3 .
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3.2 Enzyme Sample Method Development
The problems discussed above, associated with blockages within the ICP-MS  
instrument have been avoided by removing the fat and protein through an extraction 
procedure (e.g. TM A H , SDS), centrifugation and /  or filtration [Negretti de Bratter 
et a l., 1995, Bratter et al., 1998]. However, Sanchez found that whey (supernatant) 
obtained after centrifugation o f fresh milk or reconstituted milk powders contained 
more than 95%  o f the iodine initially present in the milk samples investigated. 
Infant formulas were the exception, in which only 15 -  50%  o f the total iodine was 
measured in milk whey. The addition o f SDS (sodium dodecyl sulphonate) to milk 
improved the recovery o f iodine into the whey fraction. Human breast milk samples 
exhibited an increase o f 1 0  -  2 0 % , but for infant formula the amount o f iodine 
recovered in the whey fraction was twice that in the samples not incubated with 
SDS. Irrespective o f sample origin, more than 85%  o f iodine initially present in 
milk could be recovered in the supernatant (whey) after ultra-centrifugation. 
Enzymolysis o f the macromolecular species present in milk can result in an 
improved recovery o f ‘ total’ iodine into the aqueous phase, as seen for SDS 
[Sanchez et al., 1999].
The use o f enzymes provides a specific targeting o f the lipid and protein 
components under conditions that are less likely to lead to the loss o f analytes, in 
particular iodine through volatilisation (i.e. lower temperature and pressure). In 
comparison to acid digestion techniques, enzyme systems are less likely to impact 
upon the speciation o f an element prior to sample analysis. Although, Sanchez 
experienced some difficulties in measuring iodine species by SEC-ICP-MS (broad 
iodide signal) following enzymolysis with a mixture o f lipase and pronase, but 
found improvements in the measurement o f copper and zinc, through the 
decomposition o f milk proteins. An increase in the number o f low molecular metal- 
containing species was observed [Sanchez et al., 1999]. Enzymatic hydrolysis has 
been used for speciation analysis o f selenium-enriched yeast. The enzymatic yeast 
hydrolysate indicated that 80%  o f selenium existed as three forms: inorganic 
selenium, selenocysteine and selenomethionine [Gilon, 1995]. High recoveries o f
selenium were obtained using enzymolysis: 92%  [Gilon, 1995], 90%  [Bird, 1997] 
and 85%  [Casiot et a 1999].
Enzymolysis has also been successfully employed in the treatment o f  blood serum 
samples, using pronase and resulting in a 4 0%  reduction in the level o f plasma 
protein. The majority o f these proteins were broken down into smaller polypeptides. 
This reduction in plasma protein enabled a high degree o f instrument stability (ICP- 
M S) during the continuous analysis o f blood serum over 3 hours [Abou-Shakra et 
a l., 1997].
A  number o f factors can influence the success o f enzymolysis: pH, temperature, 
time, enzyme /  substrate concentration, buffers and additives. Due to the prohibitive 
costs o f reagents (e.g. enzymes) these parameters were selected from previously 
published investigations [Sternberg, 1972, Linfield et al., 1984, Chen and Pen, 
1991, Tanaka et al. 1992, Patel et al., 1996, QunSun and O’Connor, 1999]. In 
addition, the use o f additives to form a micro-emulsion system, containing reverse 
micelles. A  reverse-micellar medium is the micellar solution o f a surfactant in an 
organic solvent, where the enzyme and water are solubilised in the core o f the 
micelles and water-insoluble substrate is solubilised in the bulk solvent. Lipase 
reactions in such media have several advantages over reactions in aqueous systems. 
These include increased reaction rates, increased thermal stability, lower costs and 
lower reaction volumes. They also provide good protection from microbial 
contamination, substrate /  product inhibition, greater tolerance to changes in pH and 
possibility for the re-use o f the enzyme. The use o f a natural surfactant, soybean 
lecithin and milk fat substrate as a non-polar substrate has been reported as a novel 
solvent-free reverse- micellar medium for the hydrolysis o f milk fat [Chen and Pen, 
1991, Patel e t a l ,  1996].
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3.2.1 Enzymes
Enzymes used were obtained from Sigma Aldrich and included;
(1) lipase from Candida rugosa (alternative name; Candida cylindracea), sn-1,2,3 
active on short chain fatty acids [QunSun and O’Connor, 1999],
(2) protease from Mucor miehei hydrolyses peptide bonds with an aromatic amino 
acid as carboxyl donor [Sternberg, 1972],
(3) pronase isolated from Streptomyces griseus, is non-specific, breaking peptide 
bonds o f all proteins present [Bird, 1997].
3.2.2 Evaluation o f experimental procedures
The evaluation o f experimental procedures using enzymes, involved different 
combinations o f enzyme systems, amount o f enzyme /  substrate, length o f time for 
reaction and use o f a reverse micellar medium. Experiments were conducted on 
three separate occasions, namely E l , E2 and E3:
(El) Experiment 1 utilised enzymes Candida rugosa and Mucor miehei. All 
enzymes and buffer solutions were obtained from Sigma Aldrich, U K.
A  sub-sample o f 7.8 ±  0.001 g o f infant formula (or 1 ml breast milk) was 
reconstituted in 45 ml o f BIS-TRIS (Sigma Aldrich, U K ) buffer (pH 6.5). An  
aliquot o f 5 ml o f enzyme solution (3 mg/ml prepared in P 0 4-Citrate buffer pH 
5.0) was then added to the substrate mixture in a polypropylene container. 
Quantities used were equivalent to preparation instructions provided by the 
manufacturers on the infant formula containers. Infant formulas used in 
experiment 1 are listed in Table 3.3.
The reaction mixture was placed in a water bath at 37°C  for 24 hours. 
Enzymic activity was halted, by raising the temperature o f the waterbath to 
65°C  for 15 minutes. Aliquots o f 3 ml were then removed and digested with 
either TM A H  or H N O 3 . A  further 3 ml was centrifuged at 13,000 rpm, the 
supernatant was removed and filtered (0 . 2  pm) for subsequent analysis. 
Inhomogeneity o f the samples presented problems when removing extracts for 
further digestion (TM A H , H N O 3 ), a large proportion o f the solid content 
adhered to the sides o f the reaction container.
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Figure 3.2: Traces of enzyme digest adsorbed to the surface of containers.
Table 3.3: Infant formulas used in experiment 1 (El), with their sample 
identification and experimental conditions.
Sample Sample Experimental conditions
El/1 Cow + Gate Plus 3 mg/ml: M. miehei
El/2 Cow + Gate Plus 5 mg/ml: M. miehei
El/3 Cow + Gate Plus 3 mg/ml: C. rugosa / M. miehei
El/4 Cow + Gate Plus 3 mg/ml: C. rugosa / M. miehei
El/5 Cow + Gate Plus 3 mg/ml: C. rugosa
El/6 NANI 3 mg/ml: C. rugosa
El/7 NANI 3 mg/ml: C. rugosa
El/8 I so mil 3 mg/ml: C. rugosa
El/9 Isomil 3 mg/ml: C. rugosa
El/10 HBM S 3 mg/ml: C. rugosa
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(E2) Experiment 2 utilised an additional enzyme, pronase K  (Streptomyce griseus). 
Samples were prepared as in E l , but in smaller quantities (0.624 ±  0 .0 0 lg  
infant formula in 3 ml buffer or 3 ml breast milk +  1 ml enzyme solution). 
Rather than removing the extracts from the enzyme digest for subsequent 
alkali /  acid digestion (E l), the smaller quantities enabled the enzymolysis o f  
separate digests for each subsequent sample preparation procedure. In this 
way, the complete enzyme digest was treated, including solid material adhered 
to the surface o f the container. The conditions for enzymolysis were as for E l, 
although the enzyme solution consisted o f 5 mg/ml o f Candida rugosa and 
mucor miehei, with 10 mg/ml pronase K. An aliquot o f  1 ml o f the enzyme 
digest was removed after 24 hours to monitor the degree o f lipid digestion, via 
the determination o f free fatty acids using gas chromatography (GC-FID, 
section 2.6.3.1). The free fatty acid content o f one enzyme digest was 
monitored by removing 0.5 ml extracts for analysis at; 2, 4, 6  and 24 hours. 
The free fatty acid content o f all enzyme digests was measured at 0 and 24  
hours. Samples used in experiment 2 are listed below.
Table 3.4: Human breast milk and infant formulas used in experiment 2 (E2), with 
their sample identification and experimental conditions.
Sample Sample Experimental conditions
E2/1 Cow +  Gate Plus 5 mg/ml: 3 enzymes
E2/2 Cow +  Gate Plus 5 mg/ml: 3 enzymes
E2/3 Cow +  Gate Plus 5 mg/ml: 3 enzymes
E2/4 NIST C R M  1549 5 mg/ml: 3 enzymes
E2/5 H B M S 5 mg/ml: 3 enzymes
E2/6 N A N I 5 mg/ml: 3 enzymes
E2/7 Isomil 5 mg/ml: 3 enzymes
E2/8 Cow +  Gate Soya 5 mg/ml: 3 enzymes
E2/9 Cow +  Gate Plus 5 mg/ml: C. rugosa
E2/10 Cow +  Gate Plus 5 mg/ml: Pro tease K
E2/11 Cow +  Gate Plus 5 mg/ml: M . miehei
E2/12 Reagent Blank 5 mg/ml: 3 enzymes
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(E3) Experiment 3 utilised the same experimental conditions and quantities as for 
experiment 2. However, the influence o f lecithin in reverse micellar enzyme 
digestion was investigated. Approximately 20 m M  lecithin was added to cow  
+  gate plus infant formula and human breast milk, Subject S. The human 
breast milk and infant formula used in experiment 3 are listed in Table 3.4.
Table 3.5: Human breast milk and infant formulas used in experiment 3 (E3), with 
their sample identification and experimental conditions.
Sample Sample Experimental conditions
E2/1 Cow +  Gate Plus 5 mg/ml: 3 enzymes
E2/2 Cow +  Gate Plus 5 mg/ml: 3 enzymes
E2/3 Cow +  Gate Plus 5 mg/ml: 3 enzymes +  lecithin
E2/4 H BM  S 5 mg/ml: 3 enzymes +  lecithin
E2/5 H B M D 1 5 mg/ml: 3 enzymes
E2/6 H B M D 1 5 mg/ml: 3 enzymes
3.2.3 Measurement o f enzyme digestion efficiency
The success o f enzymatic hydrolysis has been monitored using three techniques;
( 1 ) creamatocrit * total ’ fat method,
(2) gas chromatography with flame ionisation detection (GC-FID) for free fatty 
acid determination, and
(3) biuret method for ‘ total’ protein.
3.2.3.1 Creamatocrit ‘total fat’ method
The Gerber test [BS 696, 1989] has traditionally been used for the determination o f  
the total fat content in milk and milk products. However, the reagents (sulphuric 
acid and amyl alcohol) and high temperatures (80°C) involved are potentially 
hazardous to the laboratory worker and environment. The Creamatocrit method has 
been used for this work to estimate the total fat content o f human breast milk and 
infant formula. This method is rapid, cheap, safe and simple to use. It has been 
applied to the measurement o f total fat in biological samples (e.g. breast milk) in 
clinical practice, research and epidemiological studies [Lucas, 1978, Collares et al.,
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1997] and in the dairy industry [Goncalves, 1999]. Collares obtained a satisfactory 
correlation (0.968) between the Gerber and Creamatocrit methods, providing strong 
evidence for the use o f the Creamatocrit method [Collares et al., 1997].
Capillary tubes were filled with milk samples and centrifuged at 13,000 rpm for 5 
minutes using a Micropuls microcentrifuge. To prevent the cream layer setting at an 
angle the tubes were removed immediately after the centrifuge had stopped and 
placed vertically. The cream layer was measured with vernier calipers to the nearest 
0.5 mm. The fat content is calculated as the ratio between the fat layer (FL) and the 
length o f the total sample (TL) (eq 3.1).
%  Fat =  FL /  TL x 100 (eq 3.1)
The total fat content o f human breast milk and infant formula was measured before 
and after enzymolysis. The reduction in the ‘ total’ fat content is illustrated in 
Figures 3.3, 3.4 and 3.5. A  summary o f the data is tabulated in Appendix B. 1.
enzyme systems; El (Table 3.3), E2 (Table 3.4) and E3 (Table 3.5).
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Figure 3.4: % Reduction o f total fat from a range o f infant formulas, using enzyme 
systems outlined in El (Table 3.3) and E2 (Table 3.4).
Figure 3.5: %  Reduction o f total fat from human breast milk, using enzyme systems 
outlined in E2 (Table 3.4) and E3 (Table 3.5).
88
3.2.3.2 GC-FID analysis o f free fatty acids
The creamocrit method for total fat determination showed that enzymolysis reduced 
the overall fat content o f human breast milk and infant formula. Further 
investigation o f changes in their lipid content has been undertaken by monitoring the 
free fatty acid (FFA) content before and after enzymolysis. The determination o f  
FFAs in human breast milk and infant formula is a complex procedure, owing to the 
wide range o f FFAs present and the need for sample clean-up prior to analysis. Gas 
chromatography is a common technique used for the study and determination o f  
FFAs in human breast milk and infant formula [Deeth et al., 1983, Shantha, 1992, 
Patel et al., 1996, QunSun and O’Connor, 2000].
Most o f the FFAs in milk are present in the fat /  aqueous interphase and have both 
the polar characteristics o f the carboxyl (COOH) group, whose dissociation is 
determined by pH and the apolar characteristics o f the hydrocarbon chain. Milk 
with a common acidity range contains approximately one-third o f FFA are found in 
the aqueous phase, one-third in the membrane o f the fat globule and one-third in the 
core o f the fat globule [IDF, 1991]. Jensen suggested that human breast milk 
contained FFAs from C ]2 to C22 [Jensen et a l ,  1979, Jensen, 1995], this differs to 
alternative determinations o f Cis to C22 [Innis, 1992, Koletzko et al., 1992], Infant 
formulas contain a variety o f saturates, mono- /  polyunsaturates in the range o f Cjg 
to C22 [Espagne Committee on Nutrition, 1991, Jensen et at., 1992, Innis, 1992, 
Jensen, 1995],
Free fatty acids (C 6 ,s>io>1 2>1 4>1 6 , 1 8>2 0 ,2 2 2^ 4 ) were analysed using a Perkin Elmer 8500  
gas chromatograph with flame ionisation detection (FID). A ll o f the free fatty acid 
standards analysed, were eluted within 22 minutes, using the parameters in Table 
3.6.
Prior to fitting the column to the GC-FID instrument it was necessary to deactivate 
the glass liner in the injector to enable the determination o f free fatty acids. This 
was achieved by soaking the glass liner in silanising reagents: 10%  solution o f  
TM CS (trimethylchlorosilane) for 2 hours and then 10%  H M DS  
(hexamethyldisilazane) for 2 hours. Both solutions were prepared in toluene. The
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glass liner was rinsed with toluene after each solution and finally rinsed with 
methanol before installation into the GC-FID. The glass liner was then dried at 
150°C for 15 minutes, prior to fitting the column.
Table 3.6: Gas chromatograph parameters for the analysis o f free fatty acids.
Gas Chromatograph parameters
Column BP21 25 111 x 0.32 mm (SGE, Croydon)
Oven temperature 130 -  240°C
Ramping rate from 5 minutes 10°C  /  mill
Detector temperature 280°C
Carrier gas flow rate 2 0  psi
Injection volume 0.5 pi
Free fatty acid standards were prepared by dissolution in chloroform (Table 3.7). 
An aliquot o f 0.5 ml o f enzyme digest was dissolved in 0.5 ml o f chloroform and 
centrifuged at 13,000 rpm for 5 minutes. A  sample o f 0.5 pi was taken from the 
supernatant and injected into the GC-FID instrument. The syringe was flushed with 
chloroform after each injection.
Chromatograms for the free fatty acid standards were placed in Appendix B.2.1 (C 6 , 
Os, Cio, C 1 2), B .2.2 (C 1 4 , C i6 , Cis) and B.2.3 (C 20 5 C 2 2 , C 2 4 }  Changes in the free 
fatty acid composition o f human breast milk and infant formula are represented in 
Figures 3.6 and 3,7. A  summary o f free fatty acid data for each human breast milk 
and infant formula is tabulated in Appendix B.2.4.
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Table 3.7: Free fatty acid standards used for their determination in human breast
milk and infant formula.
Free Fatty Acid Run Time (minutes)
C6:o Caproic acid 1.40
Cg o Caprylic acid 2.95
Cio:o Capric acid 6.55
Ci 2 0 Laurie acid 9.40
Ci4 o Myristic acid 11.28
Ci6:o Palmitic acid 12.98
Ci so Stearic acid 14.53
C20:0 Arachidic acid 15.95
C22 0 Behenic acid 17.55
C24 0 Lignoceric acid 19.95
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Figure 3.6: Change in the free fatty acid composition of Cow + Gate Plus infant 
formula following enzymolysis.
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Figure 3.7: Change in free fatty acid composition for Human Breast Milk (HBM ) 
following enzymolysis.
3.2.3.3 Biuret ‘ total protein’ method
The efficiency o f  enzyme digestion in the removal o f  protein from infant formula 
and human breast milk was evaluated using the biuret method. Firstly, the biuret 
reagent was prepared using: 5 g CuS0 4 .5 H 2 0  (BDH, Poole), 12 g ED TA disodium 
salt (BDH, Poole), 2 g potassium iodide (BDH, Poole) and 400 ml o f  distilled water. 
1 ml o f  enzyme digest was added to 2  ml o f  biuret reagent and the solutions were 
left at room temperature for at least 20 minutes. A  purple colour appeared as a 
result o f  the reaction between the -C O N H - groups o f the protein and copper 
sulphate. The concentration o f  protein in the sample is directly related to the 
reaction and was measured using a U V  spectrophotometer at 739 nm. The protein 
content o f  the human breast milk and infant formula was compared before and after 
enzymolysis. The change in their protein content is represented as the percentage 
change in signal (Figures 3.8, 3.9 and 3.10). A  summary o f  data is presented in 
Appendix B.3.
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Figure 3.8: %  Reduction o f total protein in Cow + Gate Plus infant formula, using 
enzyme systems El (Table 3.3), E2 (Table 3.4) and E3 (Table 3.5).
Figure 3.9: %  Reduction o f total protein in representative infant formulas, using 
enzyme systems El (Table 3.3) and E2 (Table 3.4).
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Figure 3.10: %  Reduction o f total protein in human breast milk, using enzyme 
systems E2 (Table 3.4) and E3 (Table 3.5).
3.2.4 Summary o f enzyme digestion
The development o f an enzyme digestion procedure resulted in the use o f 3 enzymes 
discussed in section 3.2.2. The experimental conditions used for enzymolysis are 
summarised in Table 3.8.
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Table 3.8: Summary o f  experimental conditions for the enzymolysis o f human breast
milk and infant formula.
Experimental conditions
Sample 0.624g infant formula +  3ml BIS-TRIS (pH 6.5) or 
3ml human breast milk
Enzyme solution 
(3 enzymes)
5 mg/ml lipase + 1 0  mg/ml pronase in 1ml PO4 - 
Citrate (pH 5.0)
Waterbath temperature 37°C  (65 °C for 15 minutes to stop reaction)
Time for reaction 24 hours
The measurement o f ‘ total’ fat (section 3.2.3.1) in human breast milk and infant 
formulas before and after enzymolysis provided more conclusive evidence for the 
success o f enzymolysis. Cow +  Gate Plus exhibited a reduction o f ‘ total’ fat o f  
between 40 and 100%  for the different enzyme systems investigated. Other infant 
formulas exhibited a 20 to 100%  reduction in their ‘ total’ fat content. Human breast 
milk, showed a 70%  and 90 to 100%  reduction for subject S and D, respectively. 
The use o f a reverse micellar system (addition o f lecithin) did not appear to improve 
the capability o f the enzymes to reduce the fat or protein content o f human breast 
milk and infant formula. The addition o f lecithin at higher concentrations may 
improve the efficiency o f enzymolysis. However, owing to the prohibitive cost o f  
enzymes /  reagents this procedure has not been repeated.
The predominant free fatty acids (FFA) present in milk, are C2 0  -  C 2 4 . Therefore a 
shift from the C 2 0  -  C 2 4  FFA to smaller FFA units was expected following 
enzymolysis. This was generally the case, however some mixed results were 
obtained for the analysis o f human breast milk and due to different enzyme 
conditions (El to E3). This is illustrated in Figures 3.6 and 3.7. For example, Cow  
+  Gate Plus exhibited an increase in FFA from C 6  to C 10 and a decrease from C 12 to 
C 2 4  in E l. This followed the expected result o f enzymolysis. However, E2 
produced a decrease in C i6  and C 2 o> but an increase in C 6 to C 12 and C 2 2 , C 2 4 . E3
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showed a decrease in FFA from C6  to C 2 0  and an increase in C22, C 2 4 . Similar 
conflicting results were observed for human breast milk. Therefore, in order to 
determine the success o f  enzymolysis the method evaluating the change in the ‘ total’ 
fat content o f these samples may provide more information.
The change in the total protein content o f human breast milk and infant formulas 
provided conclusive evidence, with respect to the removal o f  proteins through 
enzymolysis (section 3.2.3.3). Cow +  Gate Plus infant formula exhibited a reduction 
o f total protein o f between 60 to 100%  for the various enzyme systems. Other infant 
formulas showed a reduction o f 50 to 100%  in their total protein content. Human 
breast milk for both subject S and D exhibited almost a complete removal o f the 
total protein content.
From these results it is apparent that the enzymolysis procedure was successful in 
removing the fat and protein content o f human breast milk and infant formula. 
However, further development is required to obtain the complete removal o f  the fat 
content and provide evidence o f the procedures reproducibility. Owing to the 
expense o f performing the enzymolysis this could not be investigated further. 
However, to ensure the complete dissolution o f the human breast milk and infant 
formulas for trace element analysis by ICP-M S, enzymolysis was followed by an 
additional step. These additional steps included:
( 1 ) centrifugation /  filtration (speciation analysis), or
(2) open vessel dissolution with either HNO 3 or TM AH .
3.2.5 Enzymolysis /  T M A H  and open vessel dissolution with T M A H  
A n evaluation o f the impact that enzymolysis had upon the measurement o f iodine 
and selenium in human breast milk and infant formula will be made. Results for 
samples prepared by enzymolysis and T M A H  dissolution will be compared to the 
single step method for T M A H  dissolution (Table 3.9).
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Table 3.9: Iodine and Selenium concentrations in representative samples.
Sample Enzymolysis / T M A H T M A H
Iodine
(fig /k g )
Selenium
(fig /k g )
Iodine
( f ig /k g )
Selenium
( f ig /k g )
C+G  Plus 675 176 798 182
C +G  Soya 750 192 860 192
Isomil 240 41 276 54
N A N I 90 127 814 90
NIST CR M  1549 
(I2  3380, Se 110 pg/kg)
2990 186 3 2 5 0 +  161 342 +  8
Human Breast Milk S 141 pg/1 28 pg / 1 140 pg /1 41 pg /1
Human Breast Milk D1 70 pg/1 8  pg / 1 95 pg/1 16 pg /1
The certified reference material NIST CR M  1549 non-fat milk powder was used to 
compare both sample preparation techniques. The iodine content o f CR M  1549 
prepared by the single step T M A H  method (n =  4) was 3250 ±  160 pg/kg, 
equivalent to 96%  o f the certified value (3380 ±  20 pg/g). The accuracy o f the 
enzymolysis /  T M A H  method (n =  1) was slightly less at 2990 pg/g o f  iodine, 
equivalent to 89%  o f the certified iodine value. This result compares favourably 
against enzymic extraction efficiencies for trace elements o f 61 -  82% , obtained by 
Zheng [Zheng et al., 1998]. The selenium levels measured in N IST CRM  1549 
were 3 times higher than the certified value for T M A H  dissolution. Enzymolysis /  
T M A H  provided improved accuracy for selenium (169% ), but the measured value 
was still significantly higher than the certified value (110 pg/kg). Although, this 
measurement (186 pg/kg) was in close agreement with the selenium concentrations 
measured by Amarasiriwardena in NIST CRM  1549 (170 ±  20 pg/kg) 
[Amarasiriwardena et al., 1997]. However, since NIST CRM  1549 was a non-fat 
milk powder it was not suitable to monitor the efficiency o f enzymolysis using 
lipases. The prohibitive cost o f the enzymes also prevented repeat enzymolysis o f  
NIST CRM  1549. Therefore, Cow +  Gate Plus infant formula was used to compare 
sample preparation by enzymolysis /  T M A H  (n =  4) and the single step T M A H
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method (n =  4). The enzymolysis /  T M A H  method produced improved precision 
(2 .06% ) for iodine measurements in Cow +  Gate Plus (675 ± 1 4  pg/kg) compared to 
the T M A H  method (798 ± 3 1  pg/kg). Although, the precision o f iodine 
measurements for the T M A H  method was adequate, 3 .92%  (<5% ). The reverse 
trend occurred for selenium measurements, where the TM A H  method (182 ±  8  
pg/kg) produced superior precision (4 .33% ) compared to the enzymolysis /  T M A H  
method (176 ±  23 pg/kg) with a precision o f 12.75%.
The accuracy o f iodine and selenium measurements in Cow +  Gate Plus infant 
formula should also be considered when evaluating the efficiency o f the 
enzymolysis /  TM A H  and single step TMAPI methods. However, this relies upon 
the labelled values provided by the manufacturer. These values should only be used 
as a guide since there is some uncertainty associated with the labelled values, owing 
to a lack o f traceability between the labelled concentrations and instructions for 
reconstituting the infant formula in solution. The iodine and selenium 
concentrations provided by the manufacturer o f Cow +  Gate Plus were 682 and 130 
pg/kg, respectively. The enzymolysis /  TM A H  produced the greater accuracy 
(iodine: 99% , selenium: 135%) compared to the single step T M A H  method (iodine: 
117% , selenium: 140%), although both o f the methods produced consistently high 
selenium measurements.
The paired t-test has been used to evaluate whether measured iodine and selenium 
values produced from the enzymolysis /  TM A H  method, are significantly different 
from the single step TM A H  method. The critical value for t is 3.18 (P =  0.05), 
above which the difference between the two sample preparation methods is deemed 
significant. The t-test follows equation 3.2, where po is the mean difference 
between methods, n is the number o f samples and gd is the standard deviation o f the 
differences [Miller and M iller, 1983].
t =  P d  V(n /  g d) eq (3.2)
There is a significant difference between the two methods since the calculated t 
values (Iodine: 25.90, selenium: 9.20) are greater than the critical t value o f 3.18.
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Therefore, the performance o f the two sample preparation methods was significantly 
different.
3.2.6 Summary o f sample preparation procedures evaluated using ‘real’ 
samples (total elemental analysis)
Traditional methods o f sample preparation have serious drawbacks with regard to 
signal stability, accuracy and precision o f trace element measurements by ICP-MS. 
The dry ashing o f infant formula was particularly unsuccessful, after introducing 2 
to 3 samples the ICP-MS, the instrument had to be shutdown in order to clean the 
ICP sample tubing, nebuliser and injector. Sample dissolution with H N O 3 (open 
vessel and microwave) did not completely breakdown all o f the sample components, 
since fat deposits were present after cooling o f the sample digest (Figure 3.11). 
Dissolution with TM A H  (open vessel) was more successful in terms o f signal 
stability, accuracy and precision. However, the sample was not completely digested 
with some protein /  fat deposits remaining in the sample digest (Figure 3.12 and 
3.13).
Enzymolysis provided a useful procedure for reducing the fat and protein content o f 
the milk samples. However, enzymolysis did not produce a clear solution that is 
necessary for nebulisation introduction into the ICP-MS (Figure 3.12 and 3.13). The 
enzyme digests required further treatment by either centrifugation /  filtration or 
dissolution with HN O 3 /  TM A H . Centrifugation /  filtration provided a clear solution 
after enzymolysis, but some sample components were discarded and thereby 
excluded from the total assay. Follow-up dissolution with HNO 3  and particularly 
T M A H , provided clear solutions without the possible loss o f sample material 
(Figure 3.12 and 3.13). Therefore, it was proposed that:
(1) for ‘ total’ elemental analysis by ICP-MS the method used consisted o f  
enzymolysis (C. rugosa, M. miehei, P rotease K) and subsequent dissolution with 
T M A H , and
(2) for speciation analysis -  enzymolysis (C. rugosa, M. miehei, P rotease K) with 
centrifugation and filtration.
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Figure 3.11: Infant formula prepared by HNO3 dissolution (open vessel).
Figure 3.12: Cow +  Gate Plus infant formula comparison o f  sample preparation 
procedures, ( 1 ) enzymolysis /  centrifugation /  filtration, (2 ) 
enzymolysis /  T M A H , (3) centrifugation /  T M A H , and (4) TM AH
dissolution.
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Figure 3.13: Human breast milk -  comparison o f  sample preparation procedures,
(1) enzymolysis /  centrifugation /  filtration, (2) enzymolysis /  TM AH , 
and (3) TM AH  dissolution.
3.2.7 Quality control / validation (total elemental analysis)
Quality control is an extremely important tool for ensuring the quality and reliability 
o f data. Cost-intensive environmental pollution or the diagnosis and therapy o f  
patients may be inaccurate without sufficient quality or reliability o f  data. A  quality 
control procedure should be implemented in all types o f  analysis beginning with the 
planning stage o f experimentation through to the extensive research o f scientific 
literature, which can be adapted to the actual element and matrix o f  interest, in order 
to avoid errors.
It is recognised that effective quality control procedures are essential if analysis is to 
produce data that is ‘ fit for purpose'. The control o f  random error may be achieved 
by replication o f analysis or by using certified reference materials (CR M ) alongside
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sample materials for controlling systematic errors. The outcome o f the control 
analyses forms the basis o f a decision regarding the acceptability o f the data. 
Interpretation should be based on objective statistical criteria, where possible. The 
results o f control analyses should be viewed primarily as indicators o f  the 
performance o f the analytical system, rather than a guide to the errors associated 
with individual test results. Hence, changes in the apparent accuracy o f control 
measurements are usually taken to signal changes in the system but cannot be 
assumed to indicate an identical change for data obtained for test materials analysed 
at the same time. Quality control can determine with a high a probability that data is 
o f an appropriate quality. It can monitor the quality o f data at closely timed 
intervals or as a continuous part o f the analytical process. Where the performance 
falls outside acceptable limits, the data produced can be rejected and after remedial 
action the analysis repeated. However, quality control can exclude the possibility o f  
certain errors:
( 1 ) quality control is only a measure o f statistical certainty;
(2 ) it is usually difficult to detect sporadic outliers due to short-term disturbances 
in the analytical system or mistakes made with individual samples, and
(3) quality control cannot detect errors that arise from particular samples falling 
outside the scope o f method validation.
Despite these limitations, quality control is the principal method for ensuring that 
good-quality data is released from the laboratory, when properly executed 
[Analytical Methods Committee, 1995].
The use o f quality control in an analytical procedure required a number o f  
considerations:
(1) Analytical procedure -  sources o f  error from matrix effects, spectral and 
mass interferences, polyatomic ions, peak overlapping and incorrect 
background correction may be significant and must be corrected for (section 
2.4.2.1).
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(2) Laboratory -  the training o f personnel, servicing o f equipment, calibration of  
balances, pipettes and other measurement devices, the general cleanliness o f  
benches, glassware, and laboratory equipment are all vital factors in 
maintaining reliable data,
(3) Calibration ~  the calibration o f analytical instruments using solutions o f  
known concentration and purity is a necessary prerequisite for correct 
calibration. Internal standards are useful for monitoring the performance o f  
an instrument dining the whole analytical procedure and allow corrections to 
be made in the event o f instrumental drift,
(4) Method validation -  ‘ the process o f defining an analytical requirement and 
confirming that the method under consideration has performance capabilities 
consistent with what the application requires’ [L G C , 1999]. Method 
validation is essential for the attainment o f reproducible and accurate data. 
This can be achieved by the comparison o f the same analytical technique, 
using different methods o f operation /  laboratory or by the comparison o f  
different techniques i.e. ICP-MS and N A A . Statistical processing must 
consider the degree o f accuracy, precision and therefore the reliability o f  
data. Certified reference materials are generally used for the process o f  
method validation.
3.2.7.1 Certified reference material (CRM )
Certified reference materials (CRMs) are invaluable in a quality control programme. 
Confirmation o f the target value can prove the reliability o f the results from 
unknown samples and can be used to check calibrant solutions. CRM s also offer a 
measure o f traceability, in terms o f losses or contamination during the analytical 
procedure and particularly during sample preparation. The application o f two 
methods aids the achievement o f the ‘ true’ result, if both methods confirm the CRM  
values. Michalke suggested that at least 10%  o f analytical expenditure should be 
committed to CRM  analysis, particularly for speciation analysis. CR M  materials are 
produced by several institutions; SM & T (EU), NIST (U SA), NIES (Japan), NRCC  
(Canada) and IA E A  (International body). The certification process requires three 
different methods from experienced laboratories for each single step in the analytical 
procedure leading to the same results [Michalke, 1999],
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3.2.7.2 CRM  used for analysis o f human breast milk and infant formula 
NIST CR M  1549 non-fat milk powder was used for this work, the analytes and 
certified values are summarised in section 2.1.4.
3.2.7.3 Interpretation o f certified reference material data
NIST CR M  1549 non-fat milk powder (NIST, Gethersburg, M A , U SA ) was used to 
monitor the efficiency o f sample preparation and subsequent analyses. For example, 
each batch o f 12 samples digested using open vessel dissolution contained one NIST  
C RM  1549, to provide information about the reproducibility o f the procedure and 
potential elemental losses through volatilisation. During sample analysis, the trace 
element composition o f NIST CRM  1549 was measured on each occasion that 
analytical measurements were made, in order to monitor the repeatability o f the ICP- 
M S instrument. In addition, the trace element content o f NIST CR M  1549 was 
measured every 10 sample analyses to monitor the reproducibility o f  the ICP-MS  
instrument. This aspect was not a problem when using the Finnigan M A T  Sola ICP- 
M S instrument. However, the Perkin Elmer Elan 5000 ICP-MS instrument used in 
Norway experienced some problems with the reproducibility o f  the iodine signal. 
This was largely due to previous analyses o f seaweed (2 to 3 months before), which 
resulted in initial high background levels o f iodine and subsequent instability o f  the 
iodine signal. In this instance, the analysis o f NIST CRM  1549 proved to be a 
useful tool for the correction o f iodine levels measured in human breast milk and 
infant formula, by the Perkin Elmer Elan 5000.
3.2.7.4 Inter-laboratory comparison
An inter-laboratory comparison was performed by the evaluation o f the ICP-MS  
instrument (Finnigan M A T  Sola) o f  Surrey University and the ICP-MS instrument 
o f the Agricultural University o f  Norway (Perkin Elmer Elan 5000). Samples were 
prepared by microwave digestion (H N O 3 ) at Surrey University and used for the 
comparison o f the ICP-MS instruments. In addition, separate microwave 
instruments from each laboratory were compared and digests were analysed by the 
Surrey University ICP-MS instrument. NIST CRM  1549 non-fat milk powder was 
used for the comparison o f iodine values (Table 3.10).
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The microwave instrument used at Surrey University provided slightly better 
accuracy and precision than the Norwegian microwave. However, recoveries were 
low at only 36%  and 35%  for Surrey and Norway, respectively. The Norwegian 
ICP-MS showed good accuracy, owing to the correction o f iodine values against 
NIST CRM  1549. This was necessary due to the poor calibration curve obtained 
and poor iodine signal stability o f the Norwegian ICP-MS.
Table 3.10: Inter-laboratory comparison o f ICP-MS and microwave instruments, at 
the University o f Surrey and Agricultural University o f Norway.
NIST CR M  1549 
(Iodine 3380 ±  20 pg/kg)
Iodine concentration (pg/kg)
Surrey Norway
ICP-MS instruments (1 1  =  6 ) 1230 ± 1 2 1 3190 ± 4 4 0
Microwave instruments (n =  6 ) 1230 ± 121 1190 ± 3 4 0
N .B . Final value after T M A H  dissolution was 3250 ±  160 pg/kg.
3.2.7.5 Spike recovery
The loss o f iodine through the sample preparation procedure was evaluated by 
spiking a reagent blank with standard solutions o f iodine (100 pg/1 H N O 3  and 50 
pg/1 TM A H ). The use o f HNO 3 in open vessel digestion showed a recovery o f 55% , 
whereas T M A H  produced a recovery o f 92%  o f the spiked iodine signal. The use o f  
T M A H  clearly showed higher recovery rates than for FINO3 , owing to the lower 
temperature used for the TM A H  procedure, hence reduced loss o f iodine through 
volatilisation. In addition, Cho suggested that the use o f T M A H  improved the 
ionisation o f iodine, thereby improving the efficiency o f the plasma [Cho et a l. , 
1984].
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The use o f NIST CRM  1549 non-fat milk powder (Iodine: 3380 ±  20 pg/kg) 
indicated that open vessel with T M A H  dissolution produced higher recovery rates 
for the iodine signal and improved accuracy (96% , 3250 ±  160 pg/kg). This figure 
compares favourably to reported iodine levels for NIST CRM  1549 non-fat milk 
powder, in the scientific literature. For example; T M A H  dissolution (3360 ±  70 
pg/kg) [Nobrega et a i , 1997], isotope dilution (3260 ±  100 pg/kg) [Haldimann et 
al., 2000], (3376 ±  5 pg/kg) [Gramlich and Murphy, 1989]. Oxygen combustion 
(3390 ±  140 pg/kg), peroxydisulphate oxidation (3400 ±  230 pg/kg) [Gu et al., 
1997], schoniger combustion (3270 ± 1 8 0  pg/kg), oxygen combustion (3260 ±  100 
pg/kg), tertiary amine extraction (3370 ±  30 pg/kg) [Geiinas et al., 1998, Gelinas et 
al., 1998b].
The inter-laboratory comparison showed that the Surrey microwave instrument 
provided a slightly better performance than the Norwegian microwave, in terms o f  
recovery rates for the iodine signal from NIST CRM  1549. The Norwegian ICP-MS  
instrument provided better accuracy (94% ) than the Surrey instrument (36% ) for 
iodine in NIST CRM  1549. However, all iodine measurements made by the 
Norwegian ICP-MS were corrected against the NIST CRM  1549 value, owing to 
poor signal stability, hence the better accuracy cannot be compared to the Surrey 
ICP-MS fairly. An inter-method comparison was attempted using Neutron
• 1T 1
Activation Analysis ( I), at the Agricultural University o f  Norway. Iodine was 
only detected in 3 o f 48 infant formulas analysed, owing to interferences, such as 
sodium which are present at high levels in infant formula.
Open vessel with T M A H  dissolution, produced higher recovery rates (92% ) for the 
spiked iodine signal, compared to the methods that utilised H N O 3  (55% ). 
Enzymolysis followed by open vessel dissolution with T M A H  indicated even higher 
recovery rates (103% ) than the single step TM A H  method.
3.2.7.6 Summary of quality control
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3.2.8 Summary of method development
A  number o f conclusions could be drawn from the optimisation o f the ICP-MS 
instrument for ‘ total’ iodine and selenium analysis and the development o f  
enzymolysis for the sample clean-up o f human breast milk and infant formula:
(1) reduced memory effects for ‘ total’ iodine analysis by ICP-MS enabled greater 
sensitivity and a greater lineal* dynamic range,
(2 ) improved recovery o f iodine in spiked samples prepared by enzymolysis 
compared to the traditional methods that utilised HN O 3 and T M A H ,
(3 ) enhanced signal stability, thus precision o f data as a result o f the reduced 
solids content o f the ‘ digested’ sample,
(4 ) reduced ‘run-time’ due to a reduction o f memory effects and improved sample 
clean-up (Figures 3.11 and 3.12), therefore less instrument downtime for 
cleaning ICP-MS components,
(5) greater accuracy for NIST CR M  1549 non-fat milk powder iodine data using 
T M A H  compared to HN O 3 and enzymolysis /  TM A H . However, the 
enzymolysis /  T M A H  method provided improved accuracy and precision for 
iodine in a ‘real’ sample (Cow +  Gate Plus infant formula), than the single step 
T M A H  method. Enzymolysis /  T M A H  also provided improved accuracy for 
the measurement o f selenium in NIST CRM  1549, compared to the single step 
TM A H  method.
It is recommended that the enzymolysis /  TM A H  method be used for the sample 
preparation o f all human breast milk and infant formulas, with subsequent analysis 
o f ‘ total’ iodine and selenium by ICP-MS. However, owing to the prohibitive cost 
o f purchasing enzymes and the necessary reagents this was not possible and is 
recommended for future work. Therefore, iodine and selenium measurements will 
be performed on samples prepared by the single step T M A H  method, since it 
provided far superior accuracy and precision for iodine and selenium than the 
traditional methods that utilised HNO 3 . The single step T M A H  method is also a 
relatively inexpensive method when compared with the use o f enzymes for sample 
dissolution.
107
3.3 ‘Total’ Iodine and Selenium Measured in Human Breast 
Milk and Infant Formula
The ‘total’ iodine and selenium content o f human breast milk and infant formula 
was determined by the dissolution o f these samples with tetramethyl ammonium 
hydroxide (TM A H ) and subsequent analysis by ICP-MS. Selenium levels measured 
in human breast milk and infant formulas, were corrected using the value measured 
for NIST CRM  1549 and the certified selenium concentration (section 3.2.5). Iodine 
and selenium concentrations measured in human breast milk are discussed with 
regard to; changes in the elemental composition during lactation (time), comparisons 
to infant formulas and to values stated in the scientific literature (Section 3.3.1). 
The measured iodine and selenium content o f infant formulas are compared to; 
labelled values provided by the manufacturers, between types o f formulas (e.g. cows 
milk- /  soya-based), between regions around the World and with values stated in the 
scientific literature (Section 3.3.2).
3.3.1 Iodine and selenium in human breast milk
Human breast milk samples were collected over a number o f weeks (except Subject 
S) from 3 subjects in the U K  and 1 subject in the USA. Samples were collected 
according to the criteria in Section 2.1.1. Figures 3.14 and 3.15 summarise the 
iodine and selenium levels in the human breast milk o f all subjects over a period o f 7 
weeks, with week 1 commencing after 7 days.
The breast milk o f all subjects contained similar iodine concentrations in the first 
week (115 ±  13 pg/1). Subjects M W  and TT exhibited a similar trend in their iodine 
content over the 7 week period, including Subject D until week 4. An increase in 
the iodine concentration was observed from week 1 to 2 , a general decrease from 
week 3. Selenium concentrations (Figure 3.15) showed a gradual decline over the 7 
week period for Subjects M W  and D (UK). The breast milk o f Subject TT  
contained approximately 5 times the level o f selenium measured in Subjects M W  
and D for week 1. Subject TT exhibited a large decline in its selenium content 
between weeks 1 and 2. The fluctuations in the selenium content o f breast milk
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Subject TT (U SA) contrasted greatly with the gradual decline observed for U K  
breast milk (M W , D).
Table 3.11: Iodine and Selenium concentrations (pg/1) in human breast milk.
Samples are identified by, subject, stage o f lactation (week) and the 
time of day when samples were collected (n =  19).
Human breast milk Iodine Selenium
Subject Week Time (ftg/1) (pg/1)
TT 1 10.30 119 175
TT 2 12.00 137 32
TT 3 1 1 . 0 0 101 11
TT 4 13.00 39 73
TT 5 13.30 66 69
TT 6 14.00 62 6
M W 1 11.30 114 50
M W 2 1 1 . 0 0 166 25
M W 3 10.30 61 20
M W 4 12.15 37 21
M W 5 14.00 36 20
M W 6 10.30 88 0
M W 7 15.00 56 0
M W 13 12.00 73 79
D 1 12.00 95 16
D 2 13.00 106 7
D 3 12.30 93 6
D 4 12.30 169 13
S 1 12.00 140 41
Figures 3.14 and 3.15 do not include details o f analytical variance, since most o f the 
samples were analysed in singlicate. However, the breast milk from subject S was 
analysed in duplicate and exhibited a variance o f 9%  (iodine) and 7 %  (selenium).
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Figure 3.14: Comparison o f  Iodine concentrations in human breast milk (All 
Subjects) over a period o f  7 weeks (TT -  U SA ; M W , D, S -  UK).
Figure 3.15: Comparison o f  Selenium concentrations in human breast milk (All 
Subjects) over 7 weeks (TT -  U SA; M W , D, S - UK).
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3.3.2 Measured and published values for iodine and selenium 
An overall downward trend for iodine and selenium levels in H BM  was observed as 
lactation progressed in all o f the subjects. This pattern compares well with previous 
studies by Elthom, who predicted the downward trend in H B M  iodine levels by 
monitoring the effect o f pregnancy and lactation on the thyroid hormone levels in 
the mother [Elthom et al., 2000], In addition, mature milk has been stated as 
containing lower selenium levels than transitory milk and transitory milk lower 
selenium levels than colostrum milk. This fact could be due to the changes in the 
protein content o f H BM , since most o f the selenium in milk is associated with the 
protein fraction. The selenium content o f H BM  and therefore the selenium intake o f  
the infant is assumed to be dependent upon the maternal intake. However, the 
amount o f selenium in milk must be influenced by other factors, such as 
bioavailability and interactions with other nutrients or trace elements [Lonnerdal, 
1991, Alaejos et al., 1995]. Mature H BM  from the U SA  has been reported as 
containing 8 - 3 4  pg/1 selenium, which compares favourably to 6  pg/1 at week 6  for 
Subject TT (U SA). U K  mature H BM  was reported to contain 8 - 1 9  pg/1 selenium, 
compared to 0 -  20 pg/1 measured in weeks 5 - 7  for Subject M W  (UK) [Flynn, 
1992]. Smith observed a similar downward trend in selenium concentrations from 
41 pg/1 in colostrum milk to 15 pg/1 in mature milk [Smith et a l., 1982], The 
selenium content o f H BM  generally stabilises after 4 weeks at between 10 and 30 
pg/1 [Jensen, 1995]. The mean iodine content o f mature H BM  from the U S A  and 
Europe was reported as 21 -  281 pg/1 and 70 -  90 pg/1, respectively [Flynn, 1992]. 
The same trend was observed for iodine where the H BM  o f Subjects TT (U SA) and 
M W  (UK) contained 119 and 114 pg/1, respectively in colostrum milk, 39 and 37 
pg/1, respectively after 4 weeks. This follows the general decline o f iodine 
concentrations during lactation suggested by Johnson [Johnson et al., 1990].
Caroli compiled a list o f worldwide studies that evaluated the iodine and selenium 
content o f HBM . These studies were conducted by the Organisation for Economic 
and Commercial Development in 1986, World Health Organisation in 1989 and the 
European Commission in 1979. Mean iodine concentrations o f H B M  were between 
41 -  168 pg/1 and 1 0 - 6 2  pg/1 for selenium. H BM  samples analysed from the U K  
and U S A  were both within these reported ranges for iodine and selenium. Although,
i l l
the selenium concentration measured in H BM  from the U S A  was almost 3 times 
higher than the highest value cited by Caroli [Caroli, 1994]. Levels o f iodine and 
selenium in H BM  reported in the scientific literature are summarised in Table 3.12.
Table 3.12: Comparison o f reported levels o f Iodine and Selenium in H BM  in the 
scientific literature and measured values in this study.
Scientific
literature
Year Region Iodine
(Eg/1)
Selenium
(Eg/1)
DHSS (in Jensen, 
1995)
1977 UIC 70 N G
Smith et al. 1982 World N G 15
Bruhne and Franke 
(in Jensen, 1995)
1983 California, U SA 142 N G
Bruhne and Franke 1984 U SA 130 N G
Kumpulainen 1985 Finland /  New  
Zealand
N G 8 - 1 0
Etling 1986 Italy 9 - 1 4 9 N G
Levarden 1987 U SA N G 16-41
Litov and Combs 1991 World N G 15
Parr 1991 U K 5 0 - 6 0 N G
Flymi 1992 U K
U SA
7 0 - 9 0
21-281
0 - 2 0
8 - 3 4
Lombeck 1992 Europe
U SA
N G
N G
9 - 1 5
15 -20
Caroli 1994 World 41-168 10 -6 2
Gokmen et al. 1995 Europe 59-159 N G
Picciano 1998 World 15-150 7 - 3 3
Bratter et al. 2000 Europe 
South America
29-161
101-307
12 -2 0
3 1 -5 3
* Measured H BM 2001 U K
U SA , California
95-132
119
1 6 - 5 0
175
N G  -  value not given.
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3.3.3 Comparison of human breast milk and infant formula
To compare the iodine and selenium concentrations o f human breast milk and infant 
formula, the latter must be considered in its reconstituted liquid form. In addition, 
samples o f both types from the U K  will be compared. For human breast milk, the 1st 
week (1 1  =  4) and infant formula the 1st Feed (covers 1 -  6  weeks) (1 1  =  5) are to be 
used for the comparison. The values used for iodine and selenium are 
concentrations measured and cited in Table 3.11 (human breast milk) and Table 3.13 
(infant formula: correction for liquid form, conversion from pg/kg to pg/1).
The mean concentration o f iodine measured in 1st Feed infant formula (Table 3.13) 
was 8 6  ±  40 pg/1, ranging from 43 -  158 pg/1. In comparison, the mean iodine 
concentration measured in human breast milk (1st week) was 117 ±  15 pg/1, ranging 
from 95 -  140 pg/1. Therefore, (based on 4 samples) human breast milk contained 
3 6%  more iodine than infant formula. The variation in iodine concentrations for 
human breast milk (95 -  140 pg/1) was significantly lower than for infant formula 
(43 -  158 pg/1). Human breast milk also contained a higher mean selenium 
concentration (36 ±  14 pg/1) than infant formula ( 1 6 + 1 1  pg/1). However, there was 
a greater variation in the selenium concentrations measured in human breast milk 
( 1 6 - 5 0  pg/1), compared to infant formula (3 -  32 pg/1).
3.3.4 Iodine and selenium in infant formula
Table 3.13 represents iodine and selenium concentrations measured in all o f the 
infant formulas and labelled values on the containers provided by the manufacturers. 
In most cases, the concentration o f iodine and particularly selenium, were not 
immediately apparent. This was due to the various methods o f presenting 
concentration data, used by the manufacturer. For example, values were presented 
as pg/lOOg, pg/30ml, pg/100ml or not at all. In order to compare each and every 
infant formula, units were converted to the same unit, pg/kg. The concentration 
values given for a solution were converted to pg/kg o f infant formula milk powder 
using the instructions for preparing the feed, provided 0 1 1  the label. However, a 
number o f methods for preparing the feed were given, owing to the age or weight o f  
the infant. It was not always clear to which preparation procedure the labelled
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concentration value was related. To simplify this problem, the first preparation 
procedure was used (i.e. 0 - 2  weeks o f age, 3.5 kg infant weight). In addition, 
preparation procedures listed the number o f scoops (provided in the container) o f 
infant formula to be used per feed. The size o f each ‘ scoop’ varied between infant 
formulas, the weight o f infant formula in each ‘ scoop’ was not stated on every 
container, in these cases the weight o f each ‘ scoop’ was measured.
Table 3.13: Iodine and Selenium concentrations (pg/kg) in infant formula for 
measured values and labelled values provided on the product 
containers (n =  37).
Infant Formula Measured values Labelled values
Iodine
(Pg/kg)
Selenium
(Pg/kg)
Iodine
(pg/kg)
Selenium
(Pg/kg)
Cow +  Gate Plus 798 ±  29 1 8 2 + 1 4 682 130
Cow +  Gate Premium 657 126 682 130
Cow +  Gate Step-up 706 216 702 1 2 1
Cow +  Gate Wysoy 860 192 907 133
S M A  Gold 452 139 675 95
S M A  White 511 139 718 1 0 1
S M A  Progress 764 137 700 82
S M A  Wysoy 310 116 1090 127
Farleys 1st milk 265 35 350 N G
Farleys 2nd milk 383 51 750 N G
Farleys follow-on 319 1 0 1 602 N G
Farleys Infasoy 271 108 554 N G
Boots 1 633 32 733 N G
Boots 2 567 74 816 N G
Boots Follow-on 298 56 995 N G
Milupa from birth 953 191 549 N G
Milupa forward 869 169 6 6 8 N G
Aptamil 1st 673 46 659 N G
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Table 3.13: (continued)
Infant Formula Measured values Labelled values
Iodine
(pg/kg)
Selenium
(Pg/kg)
Iodine
(pg/kg)
Selenium
(pg/kg)
Aptamil 2nd 518 24 549 N G
HIPP organic follow-on 8 8 6 61 700 N G
Nanny 774 99 600 N G
Ninho 1 1047 429 N G N G
Ninho 2 591 143 N G N G
N A N  1 814 90 760 N G
N A N  2 1388 129 1 0 0 0 N G
N A N  PRE (mex) 1578 132 500 N G
N A N  1 (mex) 513 85 700 N G
N A N  2 (mex) 1003 1 2 0 1 0 0 0 N G
N A N  H A  (mex) 729 95 615 N G
Prosobee 1245 6 6 786 N G
S-26 388 1 2 357 N G
al- 1 1 0 268 87 769 N G
Isomil 276 54 258 N G
Lactogen 1 744 77 730 N G
Lactogen 2 290 52 230 N G
Nurture Premium 465 143 400 130
Nurture Follow-on 459 158 420 1 2 0
N G  -  not given
3.3.4.1 Measured and labelled iodine concentrations 
Table 3.14 summarises the iodine concentrations measured in infant formula 
collected from the U K  and around the world. In addition, the iodine concentrations 
provided by the manufacturers o f infant formula are also cited. For the purpose o f  
summarising the data, the infant formula has been grouped into three types o f infant 
formula: 1st feed, follow-on and soya-based infant formula. Figure 3.16 Illustrates 
the mean and range o f iodine concentrations for both measured and labelled values,
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within each type o f infant formula from the UK. Infant formula collected from 
around the World are illustrated as a group o f regions in Figure 3.16, due to the 
small number o f infant formulas collected from each region.
Table 3.14: Iodine concentrations (pg/kg) measured in infant formula and labelled 
values provided by the manufacturers.
Region 1st Feed Follow-on Soya
U K
Measured
Labelled
592 ±  229 (n =  5) 
598 +  138 (n =  5)
567 +  203 (n =  7) 
705 +  141 (n =  7)
478 ±  270 (n =  3) 
7 8 2 ± 3 1 5 ( n  =  3)
South America
Measured
Labelled
1111 + 2 8 4  (n =  4) 
653 +  111 (n =  3)
893 +  355 (n =  5) 
8 5 0 ± 1 6 2 ( n  =  4)
388 ( n = l )  
357 ( n = l )
Africa
Measured
Labelled
5 0 6 ± 2 3 8  (n =  2) 
750 +  20 (n =  2) t-O 
Is)
o 
o
11 
11 276 ( n = l )  
258 (1 1 =  1)
Oceania
Measured
Labelled
465 ( n = l )  
400 ( n =  1)
459 ( n = l )  
420 ( n = l )
no sample
N .B. 6  samples were excluded, since they could not be defined into groups o f infant 
formula (e.g. Boots 2).
The iodine concentrations shown in Table 3.14 exhibit a slight reduction in the 
iodine concentrations measured in infant formulas (all regions) from the 1 st feed to 
follow-on and from the follow-on to soya-based formulas. In addition, 1st feed 
infant formulas from South America contained almost double the iodine 
concentration compared to other regions. Figure 3.16 illustrates the range o f mean 
iodine concentration measured in all types o f infant formula from the U K  (478 -  592 
pg/kg). These values were significantly lower than for infant formulas collected 
from around the World (1000 pg/kg). This trend was not observed for labelled 
values, where mean iodine concentrations from the U K  and around the World were 
between 600 -  800 pg/kg.
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type o f infant formula.
The paired t-test has been used to evaluate whether measured iodine values are 
significantly different from labelled iodine values. The critical value for t is 3.18 (P 
=  0.05) with a 95%  confidence interval. Should the calculated t value be greater 
than t critical, the null hypothesis is rejected and the differences between measured 
and labelled iodine values is deemed to be significant. The paired t-test follows 
equation 3.3, where pD is the mean difference between measured /  labelled values 
(pg/g), n is the number o f samples and op is the standard deviation o f the 
differences [Miller and M iller, 1983].
t =  pD V(n /  cjd) eq (3.3)
The t value was calculated for infant formula from all regions, U K  and other regions 
from around the World: 86.19, 57.19 and 70.46, respectively. The calculated t value 
for each group was greater than 3.18, therefore the null hypothesis was rejected and 
the difference between measured and labelled iodine concentrations in infant 
formula are deemed significant. The percentage difference between the measured 
and labelled iodine concentrations was also used to illustrate the conclusion o f the 
paired t-test (Figure 3.17). Infant formulas were presented as types o f infant
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formula from the U K  and all types o f infant formula from all regions around the 
World. Measured iodine concentrations for infant formula from the U K were on 
average 18% lower than the labelled iodine concentration and 7 %  lower for all 
infant formulas studied. These results are comparable to the findings o f Bratter, 
who determined that measured iodine concentrations for infant formula were 13%  
lower than the labelled values [Bratter, 1996].
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Figure 3.17: Percentage difference between measured and labelled Iodine 
concentrations present in infant formulas.
The iodine concentration present in infant formula is generally reported in the 
scientific literature as pg/lOOg, pg/kg, pg/100ml or pg/1. The levels o f iodine 
measured in infant formula are compared with published values in terms o f pg/kg or 
pg/1 in Table 3.15. Measured iodine concentrations (43 -  158 pg/1) for infant 
formula compare favourably with published values, when considering reconstituted 
infant formula. However, when considering the concentration o f iodine in infant 
milk powder (fresh weight), measured values (265 -  953 pg/kg) are generally lower 
than published values (800 -  1490 pg/kg).
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Table 3.15: Comparison o f reported levels o f Iodine in infant formula cited in 
scientific literature and measured values in this study.
Scientific literature Year Region Iodine
(p.g/0
Wenlock et al. 1979 U K 800 -  1300 pg/kg
Moxon and Dixon 1980 U K 1220 -  1490 pg/kg
Dellaville and Barbano 1984 Europe 91-1 00
Flynn 1992 USA 30-150
Gokmen 1995 Europe 7 5 - 8 5
Bratter et al. 1996 Europe 25-1 50
Measured Infant Formula 2001 U K 43-158  
265 -  953 pg/kg
3.3.4.2 Measured and labelled selenium concentrations 
Selenium concentrations measured in infant formula collected from the U K  and 
around the World are summarised in Table 3.16. Selenium concentrations provided 
by the manufacturers o f infant formula are also cited. Infant formula has been 
grouped into three types o f  infant formula: 1 st feed, follow-on and soya-based infant 
formula. Figure 3.18 Illustrates the mean and range o f selenium concentrations for 
both measured and labelled values, within each type o f infant formula from the U K. 
Infant formula from around the World, were illustrated as a group o f regions in 
Figure 3.18, due to the small number o f infant formulas collected from each region.
Table 3.16 shows that infant formula from Oceania contained the highest selenium 
concentrations (143 -  158 pg/kg) compared to mean selenium concentrations for 
other regions ( 1 2 - 1 3 9  pg/kg). Infant formula collected from Africa contained the 
lowest levels o f selenium across the three types o f infant formula (52 -  82 pg/kg).
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Table 3.16 Selenium concentrations (pg/kg) measured in infant formula and labelled 
values provided by the manufacturers.
R e g io n 1st F eed F o llo w -o n S o y a
U K
Measured
Labelled
105 ± 6 2  (n =  5) 
1 1 2  ±  18 (n =  2 )
111 ± 6 5  (n =  7) 
111 ± 2 1  (n =  3)
139 ± 3 8  (n =  3) 
130 ± 3  (n =  2)
South America
Measured
Labelled
102 ± 2 1  (n =  3) 
N G
111 ±  27 (n =  5) 
N G
1 2 (n =  1 ) 
N G
Africa
Measured
Labelled
82 ±  5 (n =  2) 
N G
52 (1 1 =  1) 
NG
54 ( n = l )  
N G
Oceania
Measured
Labelled
1 4 3 ( n = l )  
1 3 0 ( n =  1)
1 5 8 ( n =  1) 
1 2 0  ( n =  1 )
NS
NS
N G  - no labelled value given, NS -  no sample.
ug/kg
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Figure 3.18: Mean and range o f Selenium concentrations measured or labelled for 
each type o f infant formula.
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A  comparison o f the measured selenium concentrations and labelled values provided 
by manufacturers was limited, owing to the lack o f information provided by most o f  
the manufacturers. Only Cow + Gate, SM A  (UK) and infant formulas from New  
Zealand provided information regarding their selenium content. The paired t-test 
was used to evaluate whether measured selenium concentrations were significantly 
different from labelled selenium values, using the criteria discussed in Section 
3.2.2.1. The t value was calculated for infant formula from the U K, Oceania, and 
U K  /  Oceania together: 24.47, 79.06 and 30.36, respectively. The calculated t value 
for each group was greater than 3.18, therefore the null hypothesis was rejected and 
the difference between measured and labelled iodine concentrations in infant 
formula are deemed significant. The percentage difference between the measured 
and labelled iodine concentrations was also used to illustrate the conclusion o f the 
paired t-test (Figure 3.19). Infant formulas were presented as types o f infant 
formula from the U K  and all types o f infant formula from Oceania. Measured 
selenium concentrations for infant formula from the U K were on average 30%  
higher than the labelled selenium concentration and 34%  higher for all infant 
formulas studied. Unlike iodine there is a lack o f published material, which 
compared the measured and labelled selenium concentrations present in infant 
formula. This would be due to the lack o f information about the selenium content o f  
infant formulas provided by the majority o f manufacturers.
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Figure 3.19: Percentage difference between measured and labelled Selenium 
concentrations present in infant formulas.
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The selenium concentration present in infant formula is generally reported in the 
scientific literature as pg/100g5 pg/kg, pg/lOOml or pg/1. The levels o f selenium 
measured in infant formula are compared with published values in terms o f pg/kg or 
pg/1 in Table 3.17. Measured selenium concentrations (3 -  32 pg/i) for infant 
formula compare favourably with published values ( 2 - 3 4  pg/1), when considering 
reconstituted infant formula. However, when considering the concentration o f  
selenium in infant milk powder (fresh weight), measured values (32 -  191 pg/kg) 
are generally higher than published values (29 -  53 pg/kg), which is the opposite 
trend to that for iodine.
Table 3.17: Comparison o f reported levels o f Selenium in infant formula cited in 
scientific literature and measured values in this study.
Scientific literature Year Region Selenium
(fig/1)
Kumpulainen 1987 Europe 2 - 6
Litov 1989 Europe 2 - 6
Lonnerdal 1991 Europe 1 5 - 2 0
Lombeck 1992 U SA 9
Aleajos et al. 1995 Europe 1 3 - 1 5
Barclay et al. 1995 U K 2 9 - 5 3  pg/kg
Jochum 1995 Europe 4 - 8
Bratter et a l 1996 Europe 15
Measured Infant Formula 2 0 0 1 U K 3 - 3 2  
3 2 - 1 9 1  pg/kg
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3.4 Summary: Total Elemental Content of Human Breast Milk 
and Infant Formula
The development o f an analytical procedure for the analysis o f iodine and selenium 
in human breast milk and infant formula by ICP-MS resulted in a number o f  
modifications to traditional methods o f sample preparation and analysis. For 
example, a wash solution was developed to reduce the memory effects o f iodine 
observed for ICP-MS measurements. The use o f tetramethyl ammonium hydroxide 
(TM AH ) for sample dissolution provided vast improvements in the accuracy and 
precision o f iodine measurements for NIST CRM  1549 non-fat milk powder, 
compared to the use o f H N O 3 . The development o f an enzymolysis procedure for 
pre-digestion prior to dissolution with T M A H  did not provide improvements for
NIST CRM  1549 measurements. However, the coupled procedure did produce
improved accuracy and precision for actual samples that contained lipid material, 
compared to the single step T M A H  method. In addition, the sample clean-up was 
improved through greater removal o f the fat and protein content o f  human breast 
milk and infant formula. This aspect resulted in greater signal stability for ICP-MS  
measurements and less shutdown time for the cleaning o f instrument components, 
such as sample tubing, nebuliser, injector, cones and skimmers.
The gradual reduction o f iodine and selenium measured in human breast milk during 
lactation, generally agreed with the trend cited in the scientific literature. Although, 
one subject from the U SA  exhibited almost five times the level o f selenium
compared to breast milk collected from the UK. This is probably due to the higher
dietary intake o f selenium in North America. Diplock stated that the selenium 
dietary intake o f the U K  was 60 pg/day, compared to 168 pg/day for the U SA  
[Diplock, 1987], Higher levels o f iodine and selenium were measured in human 
breast milk than infant formula, as observed in the scientific literature. This may in 
part be due to the loss o f selenium during the pasteurisation o f infant formula 
[Alaejos and Romero, 1995]. In addition, only 9 o f the 37 infant formula studied 
provided selenium concentration data on their labels, suggesting that there could be 
a lack o f selenium supplementation to infant formula. Infant formulas collected 
from South America exhibited the highest levels o f iodine, whereas infant formula
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from New Zealand contained the highest levels o f selenium. The iodine 
concentration measured in infant formula from the UK, was 18%  lower than labelled 
values provided by the manufacturers o f infant formula. Bratter also observed a 
similar trend where measured iodine concentrations were 13%  below labelled values 
[Bratter, 1996]. However, selenium concentrations measured in infant formula 
from the U K  were 3 0%  higher than labelled values. Owing to the lack o f  
information provided by manufacturers a comparison o f measured and labelled 
selenium concentrations was only possible with a limited number o f infant formula.
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Chapter 4
Speciation Analysis of Iodine
CH APTER 4 - SPECIATION ANALYSIS OF  
IODINE
4.0 General Review of Speciation Analysis
Speciation has been defined by IUPAC as “The distribution o f an element among 
defined chemical species” [IUPAC, 2000], The term speciation analysis should be 
referred to for analytical activities. Some elements can be highly toxic to various 
life forms, others are considered essential, but can become toxic at higher doses. 
These effects depend upon the form in which the element is present in the system. 
For example, Cr(VI) ions are more toxic than Cr(III) and exhibits cytotoxic effects 
within cells, due to the reduction o f Cr(VI) to Cr(III) after entry into the cell. This 
results in the release o f electrons, hence free radical generation [Fairweather-Tait, 
1999]. The chemical forms o f a particular element or its compounds are referred to 
as “ species” . The fact that these species can have a major influence on the 
behaviour o f an element, with regal'd to their bioavailability and toxicity has been 
accepted in fields governing toxicology, clinical chemistry, geochemistry and 
environmental chemistry [Templeton, 1999].
The progress o f analytical identification and measurement o f elemental species is 
gradually replacing the total elemental determinations o f trace elements. This is 
becoming the case for iodine, where the measurement o f the total elemental content 
for clinical purposes is being replaced by measuring the concentrations o f the 
thyroid hormones T 3 , T 4  and other related hormonal compounds [Cornells, 1996]. 
Since many trace elements involve a number o f species with different properties, the 
information on total element concentration in a biotissue or biofluid could be 
misleading when considering the metabolism, bioavailability and toxicity o f a metal 
or metalloid. Information on the trace metal and metalloid species has been limited 
by the analytical methodology available. Total trace element analysis at naturally 
occurring levels is difficult, but speciation analysis is further complicated by the fact 
that the amount o f trace element is divided among several species. Often the
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molecular identity o f the ligand is unknown and the low thermodynamic stability o f  
the complex, make the analytical task even more difficult.
At the end o f the 1970s the acquisition o f species-selective information at trace and 
ultra-trace levels became possible with the coupling o f a chromatographic (later 
electrophoretic) separation technique with a sensitive and element specific detector. 
These were usually an atomic absorption, emission or mass spectrometer and 
became known as the hyphenated (coupled, hybrid) techniques. This approach 
gained particular attention in the speciation analysis o f environmental organic 
pollutants. Later developments involved the coupling o f gas chromatography, 
capillary zone electrophoresis, or liquid chromatography to ICP-AES or ICP-MS 
[Szpunar, 2000, Szpunar, 2000b]. A s a result, the increasing sensitivity offered by 
these coupled techniques spurred the development for the detection, identification 
and determination o f endogenous elemental species in biological systems. In recent 
years, bioinorganic trace analytical chemistry has developed rapidly through the 
introduction o f the coupled techniques and has become a fundamental tool for the 
characterisation o f trace elements in biological systems. The main objectives have 
been the detection, identification and characterisation o f substrates and products 
from reactions by trace metals and metalloids with living cells and tissues. The 
main obstacles to achieving these objectives have been the insufficient detection 
limits, problems associated with sample preparation and separation aspects, often 
preventing the analysis o f real samples with adequate accuracy and reproducibility.
Quality control is an extremely important tool for ensuring the quality and reliability 
o f analytical data, particularly in the field o f speciation analysis. Successful 
speciation requires the preservation o f the species integrity during the whole 
analytical procedure, from sampling to analysis. This is extremely difficult in 
speciation analysis, the possible occurrence o f errors is high and the expense in 
overcoming these problems may be prohibitive. Therefore, quality control must be 
used in all stages o f analysis beginning with the planning stage o f experimentation, 
through to the research o f literature, which can be adapted to the actual element or 
matrix o f interest, in order to avoid errors [Gardiner, 1988]. The following points 
should be considered prior to undertaking speciation analysis:
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(1) Sample collection - stability problems o f species during storage, extraction, 
clean-up or preconcentration are likely. Extraction from solid materials 
without any loss or contamination or alteration o f species is very difficult. 
This problem can be monitored throughout the analysis by measuring the 
recovery rates o f spiked samples. Alternatively, derivatisation can be used to 
increase analyte sensitivity, but is usually undesirable for speciation analysis, 
since the species can be altered,
(2) Separation -  the destruction o f species at stationary phases, losses caused 
through adsorption and contamination from mobile and stationary phases are 
possible [Michalke, 1994],
(3) Certified reference materials (CRM s) -  confirmation o f the target value can 
prove the reliability o f the results from unknown samples /  standards and 
offer a measure o f traceability [Michalke, 1999]. There are few  
commercially available CRM s available for speciation analysis, owing to the 
complex nature o f the technique, lack o f consensus about the detection and 
identification o f certain species. However, some progress towards the 
development o f multi-element /  multi-species CRMs for bio-tissues and 
environmental samples has been achieved by the European Commission 
[Muntau, 2001]. Routine speciation analysis is still far from gaining a 
general concept, which follows the criteria for analytical quality assurance 
[Mohl, 2001, Neidhardt, 2001].
This chapter reviews the publications related to the speciation analysis o f iodine and 
selenium in human breast milk and infant formula and the procedures developed to 
overcome the problems discussed. In addition, the speciation analysis o f iodide was 
investigated using ion chromatography with amperometric detection and the 
coupling o f ion chromatography to ICP-MS. Problems associated with the 
speciation analysis o f real samples will be discussed.
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4.1 Literature Review of Speciation Analysis of Human Breast 
Milk and Infant Formula
Human breast milk and infant formula are the prinicipal source o f nutrients for 
infants. Since the speciation o f trace elements influences their bioavailability (or 
toxicity) they should be present in milk not only in the appropriate amounts but also 
specific forms. Despite the considerable amount o f research performed on ‘ total’ 
trace element analysis o f such milk samples, there is a lack o f reliable and updated 
species information on reference concentration values in milk provided by 
organisations, such as the World Health Organisation (W H O ) and European 
Commision (EC). There is a fundamental requirement for the development o f  
speciation analysis in these samples concerning the bioavailability /  toxicity o f trace 
elements. This will help to improve the efficacy o f the essential trace element 
supply in early infancy. Speciation analysis can be applied to characterise the 
binding pattern after the processing o f the raw material and supplementation o f  
infant formulas. Speciation analysis o f human breast milk may also improve the 
understanding o f the mechanism o f uptake, utilisation and interaction o f trace 
elements.
Speciation analysis o f human breast milk and infant formula often involves the 
analysis o f  the whey component. The lipid fraction has been removed by 
centrifugation, followed by direct dilution in the mobile phase. Bratter studied the 
binding pattern o f trace elements, including iodine and selenium, by using the whey 
fraction o f the milk sample. Inorganic iodide, selenate and selenite were measured 
by anion exchange chromatography (ion chromatography) coupled to ICP-MS. 
Organically bound compounds o f iodine and selenium were identified by passing the 
whey fraction through a size exclusion column (SEC), as an alternative to ion 
chromatography. Organic iodine was estimated to account for approximately 2 0%  
of the supply o f iodine. Although these organic compounds were identified, Bratter 
was unable to characterise or even quantify these components, owing to the 
extremely low levels present in milk samples. A  similar case was found for 
selenium, up to 80%  o f the total supply o f selenium is organically bound [Bratter et 
al., 1998]. Although many o f the organic components for iodine and selenium have
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been identified, there is a lack o f information with regards to their characterisation 
and quantification [Michalke et al., 2000, Bratter et al., 2001].
Alternative methods for sample preparation have been investigated to provide a 
sufficient analyte signal for the organic components o f iodine and selenium. For 
example, Bermejo preconcentrated the whey protein fractions by ultrafiltration. The 
protein profile was identified by SEC-H PLC-UV, subsequent protein fractions were 
collected, digested and reduced to obtain selenium hydride. This hydride was pre­
concentrated in an iridium coated graphite tube and selenium determination 
conducted by ETA AS. However, this procedure required the complete conversion 
o f all selenium components to selenium (IV) to enable the quantification o f each 
protein fraction [Bermejo et a l., 2001]. Extraction methods have been applied to 
the identification o f selenium components. Casiot developed a sequential extraction 
procedure, including the use o f sodium dodecyl sulphonate (SDS) and proteolytic 
enzymes. This method resulted in the production o f eight compounds, among which 
Se(IV) and selenomethionine could be identified, using a combination o f (1) SEC,
(2) Ion chromatography and (3) reversed-phase chromatography. Although limited 
identification o f chromatographic signals was achieved, the determination o f total 
selenium in each o f the sequential leachates, provided as much information as 
FIPLC-ICP-MS. Whilst SEC-ICP-MS provided valuable screening o f selenium 
species, this approach enabled the basic information on the speciation o f selenium to 
be obtained without a coupled technique, by sequential leaching with specific 
reagents [Casiot et al., 1999].
The use o f extraction reagents such as sodium dodecyl sulphonate (SDS) and 
enzymes was also investigated for the speciation analysis o f iodine in milk by 
Sanchez. Although iodine is generally present in cows milk as iodide (ca 80% ), 
other possible species include iodate and the thyroid hormones (T3 and T 4 ). 
Speciation analysis by SEC-ICP-MS o f the whey fraction revealed that iodide 
accounts for only 50%  o f the total iodine present in human breast milk and only 4 -  
2 7%  in infant formula. The infant formula produced a major signal corresponding 
to an iodine-containing compound excluded from the column. This signal represents 
60 -  93%  o f the total iodine present. Three other minor signals were detected, one
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o f them iodide, but no hypothesis regarding their identity was put forward. The use 
o f SDS led to a small increase in the peak excluded from the column for human 
breast milk, but a marked increase for infant formula. Enzymolysis resulted in a 
complete change in the elution profile o f all milk samples. The SEC-ICP-MS  
chromatograms showed a continuum signal o f iodine starting at the exclusion 
volume and lasting for several minutes, followed by a broad iodide signal. Sanchez 
suggested that iodine present in the species excluded from the column was not 
covalently bound and is attached to a mixture o f macromolecular compounds by 
coordination bonds or even less specific interactions [Sanchez et al., 1999].
Iodide is the major species o f  iodine in cows milk, but a more complex speciation o f  
this element occurs in human breast milk and infant formula (e.g. iodide, iodate, T 3 , 
T 4 ). Therefore, species-selective analysis is necessary to gain an insight into the 
bioavailability o f iodine in infant nutrition. This is also the case for species- 
selective analysis o f selenium, where a number o f compounds have been recognised 
(e.g. selenomethionine, selenocysteine, selenite and selenate), but further 
characterisation and quantification is required [Michalke et al., 2000, Bratter et al., 
2001, Ward and Adair, 2001, Watts and Ward, 2001].
4.2 Ion Chromatography
Ion chromatography (IC) is useful for the determination o f highly ionic species in 
solution. This technique can provide rapid analysis and quantification o f anions and 
cations in a range o f solutions, with reasonable sensitivity. A  conductimetric 
detector can provide sub-mg /1  determination o f anions and cations, whilst 
amperometric detection provides low-pg / 1  determination o f iodide, without the need 
for pre-concentration. For the separation o f analyte ions the technique utilises the 
ion exchange between the mobile phase and ion exchange groups bonded to the 
stationary phase support material. This is followed by amperometric detection, 
which involves the application o f a voltage to the working electrode in the 
amperometry cell. An electron transfer between the electrode and analyte molecules 
results in a current that is the detector signal. The detector signal is transferred via 
an interface to a computer, which uses the Dionex AI-450 software to produce a 
chromatogram that can be determined qualitatively using known standard solutions.
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Quantitative analysis was achieved by analysing a series o f standard solutions o f a 
known concentration and plotting a calibration curve using the “ C ALPLOT” facility 
in the Dionex AI-450 software [Watts, 1998].
4.2.1 Instrumentation
The ion chromatography instrument used in this work consisted o f the Dionex 20201 
system, and an ED40 Electrochemical Detector and A I-450 data manipulation 
software (Figure 4.1). Columns used for the determination o f iodide and iodate, 
were the Dionex IonPac AG11 50 x 4.6mm guard column and AS11 250 x 4.6m m  
analytical column. A  mobile phase o f 5 m M  H N 0 3 was utilised, with a flow rate o f  
1.5 ml/min and sample injection volume o f 75 pi.
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Figure 4.1: Summary o f Dionex 20201 Ion Chromatography system [Watts, 1998].
4.2.2 Chemicals and reagents
Standard solutions for iodide and iodate were prepared by the dissolution o f  
potassium iodide (BDH, Poole) or potassium iodate (BDH, Poole) in deionised 
water. An Elgastat UHQ water dispenser (Elga Ltd, High Wycombe) was used to 
produce double distilled deionised water (D D W ), with a resistivity o f lS Q M cm '1.
4.2.3 Methods
Electrochemical detection utilised a silver electrode, since the reaction producing the 
potential depended upon the formation o f A g l at the electrode. The main problem 
associated with silver electrodes is their high oxidation sensitivity, leading to rapid 
electrode surface coating, a loss o f sensitivity and destruction o f the electrode. The 
electrode surface was susceptible to the deposition o f contaminants, despite attempts
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to inhibit this process by using positive and negative cleaning potentials prior to 
sample injection.
4.2.4 Calibration and validation
A  detection limit o f 3 pg/1 for iodide standard solutions (n =  5) was obtained with a 
working range o f 5 -  200 pg/1 (Figure 4,2). Good resolution was obtained for each 
iodide standard; 5, 10, 25, 50, 100, 150, 200 pg/1 (Figures 4.3: 5 pg/1 and Figure 4.4: 
200 pg/1). The detection limit, calibration range and chromatograms for standards 
matched the performance stated in Application Note 37, achieved by Dionex Co 
[Dionex Co., 2000]. The determination o f iodate was not possible due to the rapid 
elution o f iodate in the void volume.
Figure 4.2: Calibration curve for iodide, by Ion Chromatography.
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Figures 4.3 & 4.4: Chromatograms for 5 and 200 pg/1 iodide standard solutions.
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4.2.5 Measurement o f iodide in ‘real’ samples (electrochemical 
detection)
The milk whey fraction o f reconstituted infant formula was treated by centrifugation 
at 13,000 rpm for 15 minutes, followed by either filtration (0 . 2 0  pm) or solid phase 
extraction (C8, Cis, C 8EC, CigEC, Varian, Harbor City, C A , U SA ). The sample was 
then injected directly on to the column, via a 3-way valve system. Following the 
injection o f 5 -  10 ‘ real’ samples (infant formula) onto the column a continuous 
signal was produced, with no iodide peak determination (Figure 4.5). Despite 
attempts to clean the A g/A gC l reference electrode and regenerate the electrode 
surface, iodide peaks could not be obtained for ‘real’ samples. This was also the 
case for standard solutions, where previously standard solutions for iodide could be 
detected at 3 pg/1. This method o f detection was considered unsuitable for the 
routine analysis o f iodide in milk samples, owing to the rapid degradation o f the 
electrode and lack o f robustness for application to ‘real’ samples. Therefore, 
inductively coupled plasma mass spectrometry was considered as a more robust and 
sensitive method for iodide species determination in milk. This was achieved 
through the coupling o f ion chromatography to ICP-MS.
1800 '
mV
200 '  
0.00 5.00 10.00 rnins
Figure 4.5: Chromatogram for the iodide speciation analysis o f Cow +  Gate Plus 
infant formula, prepared by centrifugation (13,000 rpm) and solid phase 
extraction (Cig).
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4.3 Ion Chromatography -  Inductively Coupled Plasma Mass 
Spectrometry (IC-ICP-MS)
Three main types o f high pressure liquid chromatography (HPLC) are used for 
elemental speciation: size exclusion (SEC), reverse phase (RP) and ion exchange 
chromatography (IC). These techniques can be used for the separation, 
identification and quantification o f the different oxidation states or chemical species 
o f a particular trace element. Inductively coupled plasma mass spectrometry (ICP- 
M S) alone is not suitable for speciation studies, since all molecules introduced into 
the plasma are broken down into atoms, which are subsequently ionised. However, 
the employment o f an HPLC for the separation o f species prior to introduction into 
the plasma, allows the ICP-MS to be used as a highly sensitive, element-specific on­
line multi-element detector [Vanhaecke and Moens, 1999]. The coupling o f HPLC 
to ICP-MS has received considerable attention. The flow rate o f an HPLC column 
matches the typical flow rate required for most nebulisers allowing the coupling o f  
both systems to be straightforward. The possibility o f using reverse phase ion 
pairing, size exclusion or ion exchange chromatography means that there is a wide 
range o f applications for HPLC-ICP-MS [Bratter et al., 1998, Lobinski et al., 
1998, Michalke et al,, 2000, Szpunar, 2000, Szpunar, 2000b].
The coupling o f ion exchange chromatography (Ion chromatography -  IC) to ICP- 
M S has been utilised in a variety o f biomedical and environmental roles. For 
example, anion exchangers (IC) have been widely used for the separation o f metal 
species, especially or gano arsenic and organoselenium compounds. In 
metalloprotein biochemistry the technique has been widely used for the fractionation 
o f metallothionein and serum proteins [Szpunar, 2000]. IC-ICP-MS has been used 
in the speciation analysis o f arsenic [Lythgoe, 2001, Centeno et al., 2001, 
Feldmann et al., 2001], selenium [Casiot et al., 1999, Ward and Adair 2001], 
chromium [Inoue, 1995] and many other trace elements. The determination o f  
iodide [Bratter et a l ,  1998, Sanchez et a l ,  1999, Watts and Ward, 2001] has also 
been studied by using IC-ICP-MS.
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The ion chromatography system outlined in section 4.2.1 , was directly coupled to 
the Finnigan M A T  Sola ICP-M S instrument, using the same chromatographic 
conditions (5 m M  H N O 3) as for electrochemical detection. In this work it was 
necessary for the ICP-M S instrument to scan for 1 2 7I+ over a continuous period, 
since the elution time for iodide by IC-ICP-M S was longer than by electrochemical 
detection (longer tubing). This allowed the determination o f the elution profile for 
iodide following separation by the IC instrument, with subsequent ionisation in the 
plasma and detection by the ICP-M S instrument. This was achieved by increasing 
the dwell time ( 1 0 0  ms), number o f  passes ( 1 0 0 ), number o f  channels (16) and 
decreasing the number o f  scans. This enabled a scan time o f  approximately 5 
minutes, which was sufficient to measure the iodide peak eluted from the 
chromatography system. Longer scan times were achieved by further increasing the 
dwell time and number o f  passes (approximately 17 minutes), but no other peaks 
(including iodate) were observed beyond 6  minutes. The elution profile o f  iodide 
was illustrated by plotting in Microsoft Excel™ , the scan intensity files against the 
time taken for the complete scan, producing an iodide chromatogram (Figure 4.6).
4.3.1 Instrumentation and methods
Figure 4.6: Chromatogram for an iodide standard (200 pg/1) eluted within 5 minutes 
(300 seconds).
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4.3.2 Calibration and validation
In general, the resolution o f the iodide peak was satisfactory despite band 
broadening, due to the increased length o f tubing used to couple the IC to the ICP- 
M S and the lack o f temperature control for the IC columns. Background levels o f  
iodide were not reduced below 25 pg/1, even after prolonged flushing o f the IC 
column, resulting in poor detection limits (50pg/l). The working calibration range 
for iodide was 50 to 150 pg/1 (50, 100, 150 pg/1). Stark experienced similar 
problems with memory effects when attempting to measure iodide and iodate. Stark 
suggested that ‘ total’ iodine could be formed in the mobile phase, particularly when 
using acidic solutions (equation 4.1). This could lead to analyte losses, carry-over, 
memory effects and significant alterations in the sensitivity o f pneumatic 
nebulisation ICP-MS [Stark et a l ,  1997].
I 0 3' +  51" +  6 H+ <+ 3I2  +  3H20  (eq 4.1)
4.3.3 Measurement o f iodide in ‘real’ samples (ICP-MS)
Human breast milk and infant formula were either; centrifuged (13,000 rpm) and 
filtered (0.2 pm) or digested by enzymolysis (section 3.2) and then filtered, prior to 
sample introduction. Table 4.1 shows that iodide levels were significantly higher in 
all samples that underwent enzymolysis, compared to the samples prepared by 
centrifugation and filtration alone (whey fraction). In this instance it does appear 
that enzymolysis improved the extraction o f iodide from the solid material (i.e. fat 
and protein) into solution, as shown in Table 4.1. NIST CRM  1549 non-fat milk 
powder, when digested by enzymolysis iodide accounted for 71%  o f the total iodine 
content (certified value -  3380 pg/kg). In contrast, iodide accounted for 36%  o f the 
total iodine content when just the whey fraction o f NIST CR M  1549 was used 
(centrifugation /  filtration). Enhanced extraction o f iodide into solution by 
enzymolysis, is illustrated for human breast milk and infant formula in Figures 4.7  
and 4.8. The extraction o f iodide from Cow +  Gate Plus infant formula produced 
reasonable levels o f reproducibility for 5 repeat enzyme digests (611 ±  52 pg/kg), 
with precision levels o f < 1 0%  (%  rsd =  8.50).
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Table 4.1: Iodide concentration values in samples that have undergone enzymolysis 
or just centrifugation /  filtration.
Samples Whey 
(no enzymolysis) 
(M-g/kg)
Enzymolysis
(pg/kg)
Cow +  Gate Plus 415 611
Cow +  Gate Soya 434 532
N A N I 224 735
NIST CRM  1549 
(3380 pg/kg)
1216 2404
H B M  S 103 pg/1 126 pg/1
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Figures 4 .7 and 4.8: Chromatograms for human breast mi 11c (HBM ) and infant
formula (Cow +  Gate Plus), comparing the influence o f  
enzymolysis on the extraction o f  iodide into solution.
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4.3.4 Comparison of iodide and total iodine
Enzymolysis o f human breast milk and infant formula increased the extraction o f 
iodide into the soluble whey fraction. Table 4.2 compares the total iodine and 
inorganic iodide concentration measured in human breast milk and infant formula. 
The total iodine data compares the use o f enzymolysis /  T M A H  for sample 
dissolution, with the single step T M A H  method. The measurement o f inorganic 
iodide was used to evaluate the efficiency o f enzymolysis (with centrifugation and 
filtration) for the extraction o f iodide into the soluble whey fraction, compared to 
just centrifugation and filtration (without enzymolysis). In addition, inorganic 
iodide data is presented as a percentage (% ) value, with respect to the total iodine 
measured.
Table 4.2: Comparison o f iodide and total iodine data for human breast milk (pg/1) 
and infant formula (pg/kg).
Samples Total Iodine (pg/kg) Iodide (pg/kg)
TM A H Enzymolysis 
/  TM A H  -
Whev -  no 
enzymolysis (% )
Enzymolysis 
-  whey (% )
C +  G Plus 798 675 415 62 611 91
C +  G Soya 860 750 434 58 532 71
N A N I 814 90 223 *27 735
oON
N IST CRM  1549 
(3380 pg/kg)
3250 2990 1216 41 2404 80
H B M S 140 pg/1 141 pg/1 103 pg/1 73 126 pg /1 89
(% ) -  percentage inorganic iodide compared to total iodide by enzymolysis /
TM AH .
* - percentage inorganic iodide compared to total iodide by TM A H .
Inorganic iodide accounted for 7 1%  o f the total iodine content o f the soluble whey 
fraction o f human breast milk (with no enzymolysis). In contrast, enzymolysis o f  
human breast milk increased the extraction o f iodide into the soluble whey fraction
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to 89% . This data compares favourably to the study o f Bratter, who reported iodide 
concentrations equivalent to 78%  (76 -  87% ) o f total iodine in human breast milk 
from Europe [Bratter et al., 2000], A  similar trend was observed for the iodide 
content o f infant formula where the extraction o f iodide into the solution (no 
enzymolysis versus enzymolysis) increased from 49%  (27 -  62% ) to 84%  (71 -  
91% ) o f the total iodine. Sertl and Malone conducted a collaborative study across 
Europe and North America, involving nine laboratories. It was determined that 
infant formula contained iodide as 87%  (76 -  94% ) o f the total iodine content [Sertl 
and Malone, 1993].
4.4 Summary: Speciation Analysis of Iodine
Despite the limitations o f available equipment, speciation analysis o f iodine in 
human breast milk and infant formula was investigated. An on-line coupled 
technique, consisting o f ion chromatography and ICP-MS was successfully 
developed for the analysis o f iodide. Problems were encountered through the lack o f  
data manipulation software for a coupled technique, although this was solved by the 
use o f manual methods discussed in section 4.3.1. Enzymolysis clearly improved 
the extraction o f iodide into the soluble whey fraction o f human breast milk and 
infant formula (Table 4.2). The determined levels o f inorganic iodide in both human 
breast milk and infant formula, prepared by enzymolysis, were equivalent to 89 and 
84% , o f the total iodine content, respectively. This data compared favourably to the 
study o f human breast milk by Bratter (78%  iodide) [Bratter et a l., 2000] and infant 
formula by Sertl and Malone (87%  iodide) [Sertl and Malone, 1993],
Chromatography (e.g. resolution o f iodide peak) could have been improved with the 
temperature regulation o f the columns and by reducing band broadening, but was 
adequate for the semi-quantitative analysis o f iodide. Stark suggested that 
improvements to the sensitivity o f  iodine speciation analysis and the reduction o f  
memory effects could be achieved by the addition o f a matrix modifier (although no 
chemical was stated), thus preventing the conversion o f iodide and iodate to total 
iodine [Starke/a i, 1997].
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Further development o f iodine speciation analysis is necessary in order to identify 
and characterise the other species present in human breast milk and infant formula. 
This would require the purchase o f reverse phase and /  or size exclusion columns for 
the identification o f the organic components. Owing to the prohibitive cost o f these 
columns further investigation was not possible at this stage.
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Chapter 5
Conclusions
CH APTER 5 -  CO NCLUSIONS
5.0 Review of Analytical Procedures
A  greater understanding o f the amount and form that trace elements occur in human 
breast milk will ultimately lead to the development o f infant formula that closely 
matches the characteristics o f breast milk and thus the dietary requirements o f  
infants. Ultra-trace element analysis has generally focussed upon ‘total’ element 
analysis, often by inductively coupled plasma mass spectrometry (ICP-MS). 
Problems associated with the analysis o f iodine and selenium in human breast milk 
and infant formula by ICP-M S, include; memory effects, poor precision and 
accuracy. The reduction o f memory effects for iodine was achieved through the 
development o f wash solutions in section 2.4.3 (nitric acid sample digests: 5%  
H 2 SO 4 /  0 .5%  triton X -1 0 0  and tetramethyl ammonium hydroxide (TM A H ) sample 
digests: 1%  TMAPI). Poor accuracy and precision for ICP-MS measurements was 
attributed to the deposition o f fat in the ICP-MS sample tubing, nebuliser, injector, 
sampling cone and skimmers. This was attributed to the incomplete digestion o f  
human breast milk and infant formula by traditional methods for sample preparation 
that utilised H N O 3 (section 3.1). Therefore, a pre-digestion method was developed 
which incorporated enzyme systems (Candida rugosa , M ucor m iehei and Pronase) 
for the reduction o f relatively high lipid and protein levels present in human breast 
milk and infant formula (section 3.2), The complete dissolution o f enzyme digests 
was achieved by follow-up dissolution with tetramethyl ammonium hydroxide 
(TM AH ), using an open vessel (kjeldahl tubes).
In recent years there has been great interest in determining the ‘ species’ o f trace 
elements to provide additional information about the bioavailability or toxicity o f  
trace elements in human breast milk and infant formula [Bratter et al., 1998, 
Szpunar, 2000]. This has largely been achieved by the coupling o f a separation 
technique (e.g. gas - /  size exclusion - /  reverse phase - /  ion exchange - 
chromatography) to a sensitive detector (e.g. ICP-MS, ICP-AES, ESI-M S/M S) 
[Szpunar, 2000, Lobinski, 2001, Pannier et al., 2001], Speciation analysis has
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presented a number o f challenges, in particular the preservation o f species during 
sample collection and preparation. This may include considerations for the physical 
status o f the material, extraction behaviour, identification o f naturally occurring 
species and unwanted species transformations during the analytical process 
[Michalke, 1994, Michalke, 1999, Donard, 2001, Mohl et a l ,  2001]. Although 
methods for the identification o f many iodine and selenium species have been 
published in the scientific literature, there is still a lack o f information regarding the 
characterisation o f all o f their organically bound species [Bratter et a l., 2001, 
Caruso et al., 2001, Gawloska, 2001, Gardiner, 2001, Michalke et at., 2001, 
Ward and Adair, 2001]. In addition, not all o f the iodine and selenium species can 
be quantified with a reasonable degree o f confidence owing to the lack o f certified 
reference materials (CRM ) for speciation analysis. However, the future 
development o f CRMs by statutory bodies (e.g. EC), will enable the implication o f  
quality control and quality assurance procedures for speciation analysis [Muntau, 
2001, Neidhardt, 2001].
Further knowledge about the correct levels o f iodine and selenium supplementation 
to infant formula, through the progress o f ‘ total’ and speciation analysis will be 
useful where the manufacturers often provide little or no information, particularly in 
the case o f selenium. Accurate determination o f trace elements will ensure that 
labelling for trace element concentrations on infant formula is correct and enable an 
accurate comparison between types o f infant nutrition and between sources from 
different regions around the World.
5.1 What Was Accomplished?
In section 1.8, the aim and objectives o f this study were outlined, namely;
The aim of this thesis was: to provide accurate and precise total /  speciation 
analysis o f iodine and selenium in human breast milk and infant formula, using ion 
chromatography and inductively coupled plasma mass spectrometry (IC- /  ICP-MS). 
Therefore, the following objectives were required in order to meet this aim:
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(1) optimisation, calibration and validation o f ICP-MS total analysis for iodine 
and selenium, including the reduction o f memory effects for iodine,
(2 ) development and evaluation o f enzymolysis for the reduction o f the high 
levels o f lipid present in human breast milk and infant formula, involving a 
series o f enzymes or follow-up digestion with acid or alkali solutions. The 
development o f protocol for enzymatic digestion (enzymolysis) will 
encompass the evaluation o f ‘ ideal’ conditions for this procedure namely, 
pH, temperature, time, amount o f substrate, additives and enzyme. The 
efficiency o f enzymolysis will be monitored by measuring the free fatty acid 
(FFA) content o f the sample using, capillary gas chromatography (GC). The 
FFAs present in human breast milk and infant formula are usually 18 to 24 
carbons in length (C j8 to C 2 4 ). After decomposition o f the sample lipid 
content this carbon chain length should be reduced, resulting in an increase 
in the FFAs with a lower chain length. On this basis, the influence o f the 
lipids on the signal stability o f the ICP-MS should be minimised, through 
improvements in the precision and accuracy o f ‘ total’ iodine and selenium 
measurements,
(3) development o f iodine speciation analysis, by the coupling o f ion exchange 
chromatography to ICP-MS should indicate the form in which these trace 
elements occur in human breast milk and infant formula,
(4) this research will be investigated by determining the ‘ total’ and ‘ species’ 
content o f human breast milk and infant formula samples, which have been 
collected from various regions around the World (U K, North /  South 
America, Africa, Oceania). Problems associated with the dietary intake /  
requirements o f certain trace elements, notably iodine and selenium vary 
greatly between these regions. Data from the analysis o f  both forms o f infant 
nutrition should reveal differences in trace element composition between 
regions and the type o f nutrition.
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5.1.1 Problems encountered
The total analysis o f iodine can be difficult due to its memory effects within the 
ICP-MS instrument. This led to significant carry-over between standards, samples 
and blanks and also limited the maximum concentration o f iodine that could be 
passed through the ICP-MS. In addition, selenium has a number o f isotopes, thus 
splitting the signal between each one. The most abundant isotopes (77, 78, 80) 
could not be analysed due to polyatomic interferences. Therefore, 8 2 Se+ was the 
only appropriate isotope even though its isotopic abundance was only 9% . 
Enhanced sensitivity was achieved by optimising instrumental parameters (e.g. 
nebuliser flow rate, forward power) in section 2.4.2. The choice o f internal standard 
depended upon the matrix used for the dissolution of human breast milk and infant 
formulas. For example, 1 1 5In+ was suitable for HN O 3 digests, but not appropriate for 
TMAE1 digests, due to the probable formation o f InOH3  and subsequent disruption 
in signal sensitivity for 1 1 5In+ [Vanhoe, 1993]. Therefore, 1 2 ISb+ was selected for 
internal standardisation, since it was not adversely affected by alkali solutions, as 
observed for il5 In+. In addition, l2 1 Sb+ had a similar mass number to 1 2 7I+ and 
similarly high 1st ionisation energy (8 . 6  eV) [Langford and Crews, 2000].
An evaluation o f traditional sample preparation techniques was made for dry ashing, 
open vessel and microwave dissolution with HNO 3 . Dry ashing did not provide 
adequate signal stability, resulting in the blockage o f the ICP-MS injector within 2 
to 3 digested milk samples. Open vessel and microwave dissolution with HNO 3 - 
H 2 O 2  did not completely dissolve all o f the fat and protein in the human breast milk 
and infant formula. Large deposits o f fat were evident 011 the surface o f the sample 
digest, as illustrated in the photographs in section 3.1. Fat deposition also occurred 
within the sample tubing, nebuliser, injector and sampling cones, reducing the signal 
stability, accuracy and precision o f ICP-MS measurements for iodine and selenium 
(Table 3.1). For example, NIST CR M  1549 non-fat milk powder measurements for 
iodine and selenium using HNO 3 -H 2 O 2  (microwave) were 1233 ±  121 pg/kg for 
iodine and 391 ±  228 pg/kg for selenium. These measurements did not compare 
favourably to the certified values o f 3380 pg/kg (iodine) and 110 pg/kg (selenium). 
In addition, these components needed to be cleaned on a regular basis during and 
after analyses, resulting in instrument downtime. The use o f  T M A H  for the
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dissolution o f human breast milk and infant formula also led to the deposition o f  
carbon on the ICP-MS injector, thus influencing plasma efficiency and leading to 
instrument downtime for the cleaning o f the injector.
Speciation analysis through the coupling o f HPLC to ICP-MS was limited to the 
identification o f inorganic species (iodide) via ion chromatography, owing to the 
availability and prohibitive cost o f alternative HPLC columns. Difficulties in 
maintaining the columns at a constant temperature led to some problems in the 
quality o f the chromatography, with some loss o f resolution due to the band 
broadening o f the iodide peak. The sensitivity o f iodide analysis by IC-ICP-M S was 
limited due to significant memory effects, despite prolonged flushing o f the sample 
loop and columns. Software limitations o f the Finnigan M A T  Sola ICP-MS  
instrument prevented the direct viewing o f chromatograms for iodide, since a time 
resolution capability was not available.
The overall cost o f performing total /  speciation analysis by IC-/ICP-M S was a 
consideration for all aspects o f research undertaken. The high cost o f purchasing the 
various columns (e.g. size exclusion, reverse phase) for characterising the organic 
species o f iodine and selenium, limited the speciation analysis o f iodine to the 
inorganic species. In addition, the high cost o f enzymes and reagents for the 
development o f enzymolysis limited the number o f investigative experiments and 
repetitions required for the optimisation and validation o f the procedure.
The comparison o f commercial and experimental values was difficult, due to the 
lack o f traceability, with regards to the iodine and selenium concentrations on the 
labels o f infant formula. Manufacturers values are presented on the product labels 
as; pg/100g, j_ig/30ml, pg/100ml. It is not clear as to which preparation instruction 
(reconstitution o f milk powder into liquid) was used to establish these values.
5.1.2 Problems resolved
Memory effects associated with the analysis o f iodine by ICP-MS were reduced 
through the development o f a pneumatic nebulisation wash solution, namely, 5%  
H2 SO 4  /  0 .5%  triton X -1 0 0  for H N O 3 sample digests and 1%  T M A H  for T M A H
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sample digests (section 2.4.3). This solution was passed through the ICP-MS after 
each standard or sample to reduce the background signal for iodine ( 1 2 7I+) to 
‘normal’ levels within 3 - 4  minutes. The use o f TM AH  rather than H N O 3 for the 
digestion o f samples and dilution o f standards did not result in significant memory 
effects for iodine. Therefore, a shorter washout period was required, using 1%  
TM A H . Despite the low isotopic abundance for 8 2 Se+ (9% ), sensitivity was more 
than adequate (1 pg/1) for the analysis o f selenium in human breast milk (16 -  175 
pg/1) and infant formula (dry weight: 32 -  191 pg/kg or reconstituted solution: 3 -  
32 pg/1).
Enzymolysis was successfully developed for the reduction o f the fat and protein 
content o f human breast milk and infant formula, using enzymes: Candida rugosa , 
M ucor m iehei and Pronase. Experimental conditions and reagents used for 
enzymolysis are summarised in section 3.2.7. Enzymolysis proved to be a useful 
pre-digestion step when coupled with open vessel TM AH  dissolution, by providing 
a vastly improved sample clean-up procedure (section 3.2.6). This new procedure 
resulted in better analyte signal and instrument stability, hence improved levels o f  
accuracy and precision for ICP-MS measurements o f iodine and selenium (section 
3.2.5). In addition, instrument downtime for cleaning the sample tubing, nebuliser, 
injector and sampling cones during and after analyses was reduced. Alternatively, 
enzyme digests were directly injected onto an ion exchange column for speciation 
analysis , following centrifugation (13,000 rpm) and filtration (0 . 2  pm).
The prohibitive cost o f enzymes and reagents prevented some o f the investigative 
experiments to determine parameters, such as pH (buffers), temperature, time for 
reaction, amount o f enzyme /  substrate /  additives. These parameters were selected 
for the enzymolysis o f milk samples by reviewing a large number o f publications in 
the field o f enzyme and food technology [Sternberg, 1972, Linfield et al., 1984, 
Chen and Pen, 1991, Tanaka et al., 1992, Patel et al, 1996, QunSun and 
O ’ Connor, 1999]. Although a certified reference material was used, namely NIST  
CRM  1549 (a non-fat milk powder), it was deemed that this material was not 
suitable for monitoring the efficiency o f lipases. Therefore, a representative infant 
formula Cow +  Gate Plus, was used to compare the efficiency o f the enzymolysis.
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A  limited number o f repetitions were performed using Cow +  Gate Plus infant 
formula, which allowed some measure o f precision.
Despite the problems in achieving good chromatography (i. e. resolution), the iodide 
peak was successfully identified. Although the sensitivity for measuring iodide was 
poor (>50 pg/1) it was adequate for the evaluation o f human breast milk and infant 
formula samples (>100 pg/1). The lack o f time resolved software on the Finnigan 
M A T  Sola ICP-MS did not allow for the immediate viewing o f the iodide peak. 
This was solved by plotting the length o f time taken for the scan o f 1 2 7I+ against the 
scan intensity files obtained every 10 seconds, in Microsoft Excel™ , Owing to the 
poor resolution and band broadening o f the iodide peak, peak height was used 
instead o f peak area for the quantification o f iodide measurements.
Despite the limitations o f  available equipment, speciation analysis o f iodine in 
human breast milk and infant formula was investigated. Enzymolysis clearly 
improved the extraction o f iodide into the soluble whey fraction (Table 4.2). The 
determined levels o f inorganic iodide in human breast milk and infant formula, 
prepared by enzymolysis, were equivalent to 89 and 84%  o f the total iodine content, 
respectively. This data was in close agreement to the study o f human breast milk by 
Bratter (78%  iodide) [Bratter et al., 2000] and infant formula by Sertl and Malone 
(87%  iodide) [Sertl and Malone, 1993].
In general, there was a lack o f traceability between the iodine and selenium 
concentrations provided on the labels o f infant formula and the method for 
reconstituting the milk powder (i.e. quantity o f milk powder and water). 
Furthermore, the stated concentrations for iodine and selenium were not 
standardised (i.e. pg/lOOg, pg/100ml). These factors were not conducive to the 
direct comparison o f measured and labelled concentrations o f iodine and selenium in 
infant formula. Therefore, it was assumed that the first feeding preparation on the 
product label equated to the stated iodine and selenium concentrations. This 
assumption enabled the conversion o f all labelled values to pg/kg (dry weight: D W ) 
for a direct comparison with measured values (pg/kg). The same assumption was
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used when converting measured values (pg/kg) for the comparison o f infant formula 
to human breast milk (pg/1).
The levels o f iodine (95 -  140 pg/1) and selenium ( 1 6 - 5 0  pg/1) measured in human 
breast milk collected from the U K  were in agreement with previously reported 
values for iodine (29 -  168 pg/1) and selenium (7 -  62 pg/1), as shown in section
3.3.2 (Table 3.12). However, one subject from the U SA  expressed breast milk that 
contained selenium levels (175 pg/1) approximately five times higher than the U K  
subjects and three times higher than the highest value stated in the scientific 
literature (Table 3.12). This is probably due to the higher dietary intake o f selenium 
in North America. Diplock determined that the selenium dietary intake for the U K  
was 60 pg/day, compared to 168 pg/day for the U SA  [Diplock, 1987]. The decrease 
in the levels o f iodine and selenium measured in human breast milk during lactation 
was in agreement with observations in the scientific literature (section 3.3.1). The 
concentration o f iodine (expressed as 265 -  953 pg/kg D W  or 43 -  158 pg/1 
reconstituted solution) measured in infant formula from the U K  was in close 
agreement to reported values (25 -  150 pg/1) in Table 3.15. However, when 
considering the milk powder (D W ), measured iodine levels were at the lower range 
o f reported values (800 -  1490 pg/kg). The concentrations o f selenium (32 -  191 
pg/kg or 3 - 3 2  pg/1) measured in infant formula from the U K  were slightly higher 
than previously reported values in Table 3.16 (29 -  53 pg/kg or 2 - 2 0  pg/1).
5.2 Conferences / Publications
Findings from the evaluation o f traditional sample preparation methods, problems 
associated with the total and speciation analysis o f iodine by IC- /  ICP-MS and 
developments in the use o f enzymolysis as a pre-digestion step for human breast 
milk and infant formula have been presented at a range o f international conferences. 
These include; Surrey /  Kingston /  Portsmouth University 2000 colloquia, Whistler
2000 Speciation Conference, Durham 2000 ICP-MS Conference and the Munich
2001 Conference for Trace Metal Speciation in Biomedical, Nutritional and
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Environmental Sciences. Presentations were made both orally and with poster /  
discussion sessions. Details o f  the conferences and work presented during this 
thesis are as follows:
W ATTS, M.J., HARES, R.J., ZETTEL, V.H., STEAD, IC, WARD, N.I., 2000, 
“Drainage and Discharge o f Salt in Urban Storm waters: A  potential hazard for 
increased heavy metal pollution o f the environment” , Heavy Metals in the 
Environment, University o f  Michigan, Ami Arbor, Michigan, U SA.
W ARD, N.I., STEAD, K., HARES, R.J., KERWICK, M., OUGHTON, D., 
ROSTEN, L-S., TEINEN, H-C., WATTS, M.J., 2000, “Mobilisation o f Chemical 
Pollutants from Contaminated Sediments” , 5th International Conference on 
Environmental Pollution, Thessaloniki, Greece.
W ATTS, M.J., 1999, Breast is Best -  Human Breast Milk versus Infant Formula, 
Oxfordshire Sixth Form Conference -  POW ER, St Catherine’ s College, Oxford.
W A T T S , M .J ., 2000, Breast is Best -  Human Breast Milk versus Infant Formula, 
Surrey /  Kingston /  Portsmouth Universities, University o f Surrey, UK.
W ATTS, M.J., WARD, N.I., 2000, “The Analysis o f Human Breast Milk and 
Infant Formula for Total Iodine and Speciation Analysis, by Ion Chromatography 
and Inductively Coupled Plasma Mass Spectrometry (IC-ICP-M S)” , 4th International 
Symposium on Speciation o f Elements in Biological, Environmental and 
Toxicological Sciences, Whistler, BC, Canada.
WATTS, M.J., WARD, N.I., 2000, “Analysis o f Total Iodine in Human Breast 
Milk and Infant Formula by Inductively Coupled Plasma Mass Spectrometry (ICP- 
M S)” , 2000, 7th International Conference on Plasma Source Mass Spectrometry, 
Durham, UK.
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W A T T S , M .J ., W A R D , N .I., 2001, “Development o f a Pre-digestion procedure for 
measuring Iodine in Human Breast Milk and Infant Formula, by IC-ICP-M S” , 2nd 
International Conference on Trace Element Speciation in Biomedical, Nutritional 
and Environmental Sciences, May 07 -  10/05/2001, Munich, Germany.
5.3 Aspects for Future Work
The use o f enzymolysis as a pre-digestion step for sample clean-up requires further 
investigation. Initial results showed that enzymolysis is a useful technique to be 
employed in the analytical process, but further experiments should be undertaken to 
optimise the complex parameters involved (e.g. amount o f substrate /  enzyme /  
additive). An acceptable level o f precision must be attained to provide a reliable and 
robust method for sample preparation o f human breast milk and infant formula. The 
coupling o f enzymolysis to a closed vessel system or microwave, should result in 
improved sample dissolution and higher analyte recoveries. Furthermore, the use o f  
smaller sample volumes would result in reduced use o f expensive enzymes.
Speciation analysis o f iodine and selenium must be developed to provide 
information about the bioavailability and toxicity o f these elements. This could be 
achieved by the use o f reverse phase and size exclusion HPLC columns for the 
identification, characterisation and quantification o f organically bound components. 
Furthermore, the application o f enzymolysis and total /  speciation analysis could be 
used to study the iodine and selenium content o f human breast milk at different 
times o f the day and during varying periods o f lactation.
5.4 Conclusions
The Finnigan M A T  Sola inductively coupled plasma mass spectrometer (ICP-MS) 
used for this work was capable o f providing acceptable data for the determination of  
iodine and selenium in human breast milk and infant formula. Recent advances by 
ICP-MS manufacturers has led to instruments with superior mass discrimination 
features, enabling a reduction in polyatomic interferences. For example, the 
Micromass Hexapole ICP-MS instrument enables the measurement o f 8 0 Se+ and
150
other isotopes with higher relative abundance by reducing the relevant polyatomic 
interferences, resulting in lower levels o f sensitivity [Micromass Ltd, 1999]. In 
addition, advances in ICP-MS software allow for the direct identification o f species 
separated on an HPLC column.
Advances in chromatographic instrumentation has led to improved separation and 
resolution o f organic metal-bound species. This will enable the identification o f  
more trace metal species, providing greater information about the bioavailability and 
potential toxicity o f selected trace elements. In addition, the development o f  
certified reference materials for speciation analysis will provide confidence in the 
measurements and enhance the significance o f such data.
151
Bibliography
Bibliography
Abou-Shakra, F.R., M.P. Rayman, N.I. Ward, (1997), Enzymatic digestion for the 
determination o f trace elements in blood serum by Inductively Coupled Plasma Mass 
Spectrometry, J. Anal. At. Spectrom., 12, 429 -  433.
Alaejos, M.S., C.D. Romero, (1995), Selenium in human lactation, Nutrition Reviews, 
53, (6), 1 5 9 - 166.
Amarasiriwardena, D., M. Kotrebai, A. Krushevska and R.M. Barnes, (1997), 
Multielement analysis o f human milk by inductively coupled plasma mass spectrometry 
after high pressure, high temperature digestion, Canadian J. o f Anal. Sci. and Spect., 42
(3), 6 9 - 7 8 .
Analytical Methods Committee, (1987), Recommendations for the definition, 
estimation and use o f the detection limit, Analyst, 112. 199 -  204.
Analytical Methods Committee, (1995), Internal Quality Control o f Analytical Data, 
Analyst, 120, 2 9 - 3 4 .
Anke, M., B. Groppel, M. Muller, E. Scholz, K. Kramer, (1995), The iodine supply o f  
humans depending on site, food offer and water supply, F. J. Anal. Chem., 352, 9 7 -  101.
Arthur, J.R., G.J. Beckett, (1989), Selenium deficiency and thyroid hormone 
metabolism. In: Wendel, A . (ed), Selenium in Biology and Medicine, Springer-Verlag, 
Heidelberg, Germany.
Arthur, J.R., (1992), The roles o f selenium in thyroid hormone metabolism, Trace 
Elements in Man and Animals, T E M A  7-3 , (ed. Anke, M ., D. Meisner, C.F. Mills), 
Verlag Media Touristik, Gersdorf.
152
Arthur, J.R., K.M. Brown, S.J. Fairweather-Tait, H.M. Crews, (1997), Dietary 
selenium: why do we need it and how much is enough?, Nutrition and Food Sciences, 
No. 6 , 2 2 5 -2 2 8 .
Barclay, M.N.I., A. Macpherson, J. Dixon, (1995), Selenium Content o f a Range o f  
U K  Foods, J. o f Food Composition and Analysis, 8 , 307 -  318.
Basu, T.K., J.W. Dickerson, (1996), Vitamins in Human Health and Disease, Cab 
International, Guildford, UK.
Baumann, H., (1990), Rapid and sensitive determination o f iodine in fresh milk and 
milk powder by inductively coupled mass spectrometry (ICP-M S), F. J. Anal. Chem., 
338. 8 0 9 -8 1 2 .
Beckett, G.J., (1989), Inhibition o f type I and type II iodothyronine deiodinase activity 
in rat liver, kidney and brain produced by selenium deficiency, Biochemical Journal, 259. 
8 8 7 -8 9 2 .
Behne, D., (1990), Identification o f type I iodothyronine 5 ’ -deiodinase as a seleno- 
enzyme, Biochemical and Biophysical Research Communications, 173. 1143 -  1149.
Bermejo, P., J. Barciela, E.M. Pena, A. Bermejo, J.M. Frega, J.A. Cocho, (2001), 
Determination o f selenium in infant formula whey fractions by SEC -H PLC-H G -ETAAS, 
J. Anal. At. Spectrom., 16, 1 8 8 -  193.
Berry, M., (1991a), Type I iodothyronine deiodinase is a selenocysteine-containing 
enzyme, Nature, 349, 438 -  440.
BFHI, (2000), BFHI N E W S: The Baby Friendly Hospital Initiative newsletter -  Jan /  
Feb 2000, 3 UN  Plaza, New York, N Y 10017, U SA.
Bird, S.M., (1997), Speciation o f selenoamino acids and organoselenium compounds in 
selenium enriched yeast using HPLC-ICP-M S, J. Anal. At. Spectrom., 12, 7 8 5 -7 8 8 .
153
Bonorden, W.R., M .W . Pariza, (1994), Antioxidant nutrients and protection from free 
radicals. In: Kotsonis, F.N., Mackey, M . and Hjelle, J. (ed), Nutritional Toxicology, 
Raven Press, New York, ppl9 -  48.
Bratter, P., (1996), Essential Trace Elements in the Nutrition o f Infants: In Neve, J. (ed), 
Therapeutic Uses o f Trace Elements, Plenum Press, New York, pp235 - 275.
Bratter, P., I. Blasco, Y.E. Negretti de Bratter, A. Raab, (1998), Speciation as an 
analytical aid in trace element research in infant nutrition, Analyst, 123. 821 -  826.
Bratter, P., I. Blasco, V.E. Negretti de Bratter, I.N. Blasco, A. Raab, (2000), 
Maternal selenium status influences the concentration and binding form o f iodine in 
human breast milk Metai Ions in Biology and Medicine, vol. 6 . In (eds) J.A. Centeno,
P.L. Collery, G. Vernet, R.B. Finlcelman, H. Gibb, J.C. Etienne and J. Libbey,Eurotext, 
Paris, pp244 -  247.
Bratter, P., A. Richarz, C. W olf and U. Rosick, (2001), Speciation o f trace elements in 
human tissues, 2nd International Conference on Trace Element Speciation in Biomedical, 
Nutritional and Environmental Sciences, May 07 -  10/05/2001, Munich, Germany.
Bruhne, J. C., A.A. Franke, (1984), Iodine in human milk, J. Dairy Sci., 6 6 , 1396 -  
1398.
BS 696, (1989), British Standard: Determination o f fat content o f  milk and milk products 
(Gerber Method), Part 1: Specification for apparatus, Part 2: Methods, British Standards 
Institute.
Caroli, S., (1994), The assessment o f reference values for elements in human biological 
tissues and fluids: A  systematic review, Critical Review in Analytical Chemistry, 24  
(5,6), 363 - 3 9 8 .
154
Caruso, J.A., M. Montes Bayon, E.G. Yanes and C. Ponce de Leon, (2001), 2nd 
International Conference on Trace Element Speciation in Biomedical, Nutritional and 
Environmental Sciences, May 07 -  10/05/2001, Munich, Germany.
Casiot, C., J. Szpunar, R. Lobinski, M. Potin-Gautier, (1999), Sample preparation and 
HPLC separation approaches to speciation analysis o f selenium in yeast by ICP-M S, J. 
Anal. At. Spectrom., 14, 645 -  650.
Centeno, J.A., (2001), Chronic arsenic toxicity: environmental, natural history and 
pathology, 2nd International Conference on Trace Element Speciation in Biomedical, 
Nutritional and Environmental Sciences, May 07 -  10/05/2001, Munich, Germany.
Chen, J.P., H. Pai, (1991), Hydrolysis o f milk fat with lipase in reversed micelles, J. 
Food Sciences, 56 (1), 234 -  237.
Chierici, R., C. Gamboni, V. Vigi, (1994), Milk formulae for the normal infant III. 
Lipids and Trace Elements, Acta Pediatr. Suppl., 402, 50 -  56.
Cho, T., I Akabane, Y. Muralami, (1989), A  Basic Study o f the application o f T M A H  
alkaline digestion for the determination o f some volatile elements by ICP-M S, The 
proceedings o f the 3rd Surrey Conference on Plasma Source Mass Spectrometry, 
University o f Surrey, 16 -  19th July 1989, RSC, Cambridge. In: Jarvis, K .E ., Gray, A .L . 
(eds), Plasma Source Mass Spectrometry.
Collares, F.P., C.V. Goncalves, J.S. Ferreira, (1997), Creamatocrit as a rapid method 
to estimate the contents o f total milk lipids, Food Chemistry, 60 (4), 465 -  467.
Commission of the European Communities, (1991), Commission Directive o f  14th 
M ay 1991 on Infant Formulae and Follow-on Formulae, The Commission o f the 
European Communities, Official Journal o f the European Communities, (91/321/EEC).
155
Contempre, B., (1991a), Effect o f selenium supplementation in hypothyroid subjects o f  
an iodine and selenium deficient area: the possible danger o f indiscriminate 
supplementation o f iodine-deficient subjects with selenium, J. Clin. Endocrinol. Metab., 
7 3 ,2 1 3 - 2 1 5 .
Contempre, B., (1991b), Cretinism, thyroid hormones and selenium, Mollecular and 
Cellular Endocrinology, 81, C193 -  C195.
Contempre, B., (1992), Effect o f selenium supplementation on thyroid hormone 
metabolism in an iodine and selenium deficient population, Clinical Endocrinology, 36, 
5 7 9 -5 8 3 .
Cornells, R., (1996), Involvement o f analytical chemistry in chemical speciation o f 
metals in clinical samples, Annals o f Clin. &  Lab. Sci., 26 (3), 252 -  263.
Delange, F., (1982), Nutritional factors involved in the goitrogenic influence o f dietary 
goitrogens during pregnancy, Ottawa International Development Research Centre, pp40 
- 5 0 .
Delange, F., (1989), Cassava and the thyroid In: Gaitan, E., (ed) Environmental 
goitrogens, CRC Press, Boca Raton, pp 173 -  194.
Delange, F., (1993), Requirements o f Iodine in Humans, In: Delange, F., (ed) Iodine 
Deficiency in Europe, Plenum Press, New York.
Delange, F., (1994), The Disorders Induced by Iodine Deficiency, Thyroid, 4, 107 -  128.
Dellaville, M.E., D.M. Barbano, (1994), Iodine Content o f Milk and Other Foods, 
Analyst, 47 (9), 6 7 8 -6 8 4 .
Department of Health, (1992), Report on Health and Social Subjects: 41. Dietary 
reference values for food energy and nutrients for the United Kingdom, H M SO , London.
156
Department of Health, (1995), Breastfeeding: Good practice guidelines for the NH S, 
http :/ /www.unicef. org/Ukbab vfriendlvinitiati ve -  10/03/00.
Dionex Co., (1998), The determination o f iodide in milk products, Application Note 37, 
Dionex Co., Camberley, UK.
Dionex Co., (2000), Ion Chromatography /  Inductively Coupled Argon Plasma (IC /  
ICAP): A  new technique for trace metal determinations, Application Note 28, Dionex 
Co., Camberley, UK.
Diplock, A.T., (1987), Trace elements in human health with special reference to 
selenium, Am . J. Clin. Nutr., 45, 1313 - 1322.
Donard, O., (2001), Sample preparation technologies with special respect to species 
preservation (sampling, storage, extraction), 2nd International Conference on Trace 
Element Speciation in Biomedical, Nutritional and Environmental Sciences, May 07 -  
10/05/2001, Munich, Germany.
Dudding, L., (2000), Determination o f Platinum in Environmental Samples by 
Inductively Coupled Plasma Mass Spectrometry, PhD thesis: Department o f Chemistry, 
University o f Surrey, Guildford, GU2 7XPI, UK.
Dunn, J. T., (1993), Sources o f Dietary Iodine in Industrialised Countries. In: Delange, 
F. (eds), Iodine Deficiency in Europe. A  Continuing Concern, Plenum Press, N ew  York, 
p p l7 -  24.
Durrant, S.F., N. Walker, N.I. Ward, (1988), Multielemental analysis o f Commercial 
baby milk food by ICP-MS and IN A  A , Trace Element Analytical Chemistry in Medicine 
and Biology, 5, 403 - 4 1 1 .
Durrant, S.F., N.I Ward, (1989), Multi-elemental Analysis o f Human Milk by 
Inductively Coupled Plasma-Sonrce Mass Spectrometry: Implications for Infant Health, 
J. o f Micronutrient Analysis, 5, 111 -  126.
157
Ehrenkranz, R.A., (1991), Selenium absorption and retention by very-low-birth-weight 
infants: studies with the extrinsic stable isotope tag 7 4 Se, J. Pediatr. Gastroenterol. Nutr., 
13, 125 -  133.
Elthom, A., M. Elthom, B. Elnager, M. Elbagir, M. Gebre-Medhin, (2000), Changes 
in iodine metabolism during late pregnancy and lactation: a longitudinal study among 
Sudanese women, Eur. J. Clin. Nutr., 54, 429 -  433.
Ermans, A. M., (1980), Role o f Cassava in the Etiology o f Endemic Goiter and 
Cretinism, International Development Research Centre, Ottawa, ppl -  182.
Espargne Committee on Nutrition: Aggett, P.J., F. Haschke, W . Leine, O. Lernell, B. 
Koletzko, IC. Louniala, J. Rey, A . Rubino, G. Schroch, J. Senterre, R. Tarmo (eds), 
(1991), Committee Report: Comment on the content and composition o f lipids in infant 
formulas, Acta Pediatr. Scand., 80, 887 -  896.
Evans, E.H., J.J. Giglio, M. Castillano, J.A. Caruso, (1995), Inductively Coupled and 
Microwave Induced Plasma Source for Mass Spectrometry, 1st edition, Royal Society o f 
Chemistry, Cambridge, UK.
Fairweather-Tait, S.J., (1997), Bioavailability o f  selenium, Eur. J. o f Clin. Nutr., 51, 
suppl. 1 , s2 0  -  s23.
Fairweather-Tait, S.J., (1999), The importance o f trace element speciation in nutritional 
sciences, F. J. Anal. Chem., 363, 536 -  540.
Fecher, P.A., A. Nagengast, (1994), Trace analysis in high matrix aqueous solutions 
using helium microwave induced plasma mass spectrometry, J. Anal. At. Spectrom., 9, 
1021 -1 0 2 7 .
Fecher, P.A., I. Goldman, A. Nagengast, (1998), Determination o f iodine in food 
samples by Inductively Coupled Plasma Mass Spectrometry after alkaline extraction, J. 
Anal. At. Spectrom., 13, 977 -  982.
158
Feldmann, J., H. Hansen, D. Sandhya, (2001), An appetite for arsenic: the seaweed- 
eating sheep from Orkney, 2nd International Conference on Trace Element Speciation in 
Biomedical, Nutritional and Environmental Sciences, May 07 -  10/05/2001, Munich, 
Germany.
Finnigan M AT Ltd, (1993a), Finnigan M A T  Sola ICP/GD-M S Multi-element analyser, 
Finnigan M A T  Institute, Hertfordshire, U K.
Flynn, A., (1992), Minerals and trace elements in milk, Advances in Food and Nutrition 
Research, 36? 209 -  236.
Food and Nutrition Board, (1980), Recommended Daily Allowances, 9th Edition, 
Iodine, US National Research Council, National Academy Press, Washington DC, pp213 
-2 1 7 .
Food and Nutrition Board, (1989), Recommended Daily Allowances, 10th Edition, 
Iodine, US National Research Council, National Academy Press, Washington DC, pp213 
- 2 1 7 .
Foster, IC, D. Lader, S. Cheeseborough, (1997), Infant Feeding 1995, H M SO , London.
Foster, L.H., S. Sumar, (1995), Methods o f analysis for the determination o f selenium 
in milk and infant formulae: a review, Food Chemistry, 53, 453 -  466.
Gaitan, E., (1989), Environmental Goitrogenesis, CRC Press Inc., Boca Raton, Florida, 
pp 1 4 3 -  144.
Gardiner, P.E., (1988), Chemical speciation in biology and medicine: the role o f atomic 
spectroscopic techniques, J. Anal. At. Spectrom., 3, 163 -  168.
Gardiner, P.E., (2001), Recent developments in selenium speciation, 2nd International 
Conference on Trace Element Speciation in Biomedical, Nutritional and Environmental 
Sciences, May 07 -  10/05/2001, Munich, Germany.
159
Gawloska, A., (2001), Speciation o f selenium in natural samples, 2nd International 
Conference on Trace Element Speciation in Biomedical, Nutritional and Environmental 
Sciences, May 07 -  10/05/2001, Munich, Germany.
Gelinas, Y., G.Y. Iyengar and R.M. Barnes, (1998), Total iodine in nutritional and 
biological reference materials using N A A  and ICP-MS, F.J. Anal, Chem., 362, 483 -  
488.
Gelinas, Y ., A . Krushevska and R.M. Barnes, (1998b), Determination o f total iodine in 
nutritional and biological samples by ICP-MS following their combustion within an 
oxygen stream, Anal. Chem., 70, 1021 -  1025.
Gilon, N., (1995), Selenoamino acid speciation using H PLC-ETAAS following an 
enzymic hydrolysis o f selenoprotein, Applied Organometallic Chemistry, 9, 623 -  628.
Golstein, J., (1988), Effect o f selenium deficient diet on thyroid function o f normal and 
perchlorate treated rats, Acta Endocrinologica (Copenh.), 118, 495 -  502.
Goncalves, C.Y., F.P. Collares, (1999), Industrial application o f the creamatocrit 
method to estimate total contents o f lipids in value cows milk, Food Chemistry, 64, 567 -  
570.
Gramlich, J.W. and T.J. Murphy, (1989), Determination o f trace level iodine in 
biological and botanical reference materials by isotope dilution mass spectrometry, J. o f  
Res. Nat. Inst, o f Stds. and Technol, 94 (4), 215 -  220.
Gray, A.L., A.R. Date, (1989), Applications o f Inductively Coupled Plasma Mass 
Spectrometry, 1st edn, Blackie &  Son Ltd, London, UK.
Gu, F., A. Marchetti and T. Straume, (1997), Determination o f iodine in milk and 
oyster tissue samples using combustion and peroxydisulphate oxidation, Analyst, 122, 
5 3 5 -5 3 7 .
160
Gushurst, C.A, (1984), Breast Milk Iodide: Reassessment in the 1980s, Pediatrics, 73
(3), 3 5 4 -3 5 7 .
Haldimann, M., A. Eastgate and B. Zimmerli, (2000), Improved measurement o f  
iodine in food samples using inductively coupled plasma isotope dilution mass 
spectrometry, Analyst, 125, 1977 -  1982.
Hetzel, B. S., (1989), The Story o f Iodine Deficiency: An International Challenge in 
Nutrition, Oxford University Press, New York.
Hojo, (1982), Selenium concentration and glutathione peroxidase activity in cows milk, 
Biological Trace Element Research, 4, 233 -  239.
Horlick, G., S.H. Tan, M.A. Vaughan, C.A. Rose, (1985), The effect o f plasma 
operating parameters on analyte signals in inductively coupled plasma mass 
spectrometry, Spectrochimica Acta, 40B , (10-12), 1555 -  1572.
Houk, R.S., V.A. Fassel, G.D. Flesch, H.J. Svec, A.L. Gray, C.E. Taylor, (1980), 
Inductively coupled argon plasma as an ion source for mass spectrometric determination 
o f trace elements, Anal. Chem., 52, 2283 -  2289.
Houk, R.S., (1986), Mass spectrometry o f inductively coupled plasmas, Anal. Chem., 
58 (1), 9 7 A -1 0 5 A .
Hua, K.M., M. Kay, H.E. Indyk, (2000), Nutritional element analysis in infant formulas 
by direct dispersion and inductively coupled plasma -  optical emission spectrometry, 
Food Chemistry, 68,463 -  470.
Hurrel, R.F., N. Berocal, J.R. Neeser, (1989), Micronutrients in Infant Formula. In: 
Renner, E., (ed). Micronutrients in milk and milk-based food products, Elsevier Applied 
Science, London, 1989.
161
IDF, (1991), Determination o f Free Fatty Acids in milk and milk products, Bulletin o f 
the International Dairy Federation, No. 265, Brussels, Belgium.
Innis, S.M., (1992), Human milk and formula fatty acids, J. Pediatr. Suppl., 120, S56 -  
S61.
Inoue, Y., T. Sakai, H. Kumasi, (1995), Simultaneous determination o f Cr (III) and Cr 
(VI) by Ion Chromatography and Inductively Coupled Plasma Mass Spectrometry (IC- 
ICP-M S), J. Chrom. A , 706, 127 -  136.
Ito, IC, (1997), Determination o f iodide in seawater by ion chromatography, Anal. 
Chem., 69, 3628 -  3632.
IU P A C , (2000), Guidelines for terms related to chemical speciation and fractionation o f 
elements, definitions, structural aspects and methodological approaches, Templeton, 
D .M . (ed), Pure Applied Chemistry, 72 (8 ), 1453 -  1470.
Jarvis, ICE., A.L. Gray, R.S. Houk, (1992), Handbook o f Inductively Coupled Plasma 
Mass Spectrometry, Blackie &  Sons Ltd, London, UK.
Jensen, R.G., R.M. Clark, A.M. Ferris, (1979), Composition o f the lipids in human 
milk: A  Review, Lipids, 15 (5), 345 -  355.
Jensen, R.G., A.M. Ferris, C.J. Lammi-Keefe, (1992), Lipids in human milk and infant 
formulas, Annu. Rev. Nutr., 12, 417 -  441.
Jensen, R.G., (1995), Handbook o f Milk Composition, Academic Press, London, UK.
Johnson, L.A., H.C. Ford, J. Doran and V.F. Richardson, (1990), A  survey o f the 
iodide concentration o f human milk, N .Z . Med. J., 103, 393 -  394.
Johnson, C.E., A.M. Smith, Chan, (1993), Selenium status o f term infants fed human 
milk or selenite-supplemented soy formula, J. Pediatr., 122. 7 3 9 -7 4 1 .
162
Kebata-Pendias, A. and H. Pendias, (1984), Trace elements in soils and plants, CRC  
Press, Boca Raton, Florida, U SA.
Kivisaari, S., S. Vermuelen, (1995), Assessment o f selenium in the agronomy sector. 
In: Proceedings o f the Selenium-Tellurium Development Association, Grimbergen, pp95 
- 102.
Knapp, G., B. Maichin, P. Fecher, S. Hasse, P. Schramel, (1998), Iodine 
determination in biological materials: Options for sample preparation and final 
determination, F. J. Anal. Chem., 362, 5 0 8 -5 1 3 .
Koletzko, B. I. Thiel, P. Abiodun, (1992), The fatty acid composition o f human milk in 
Europe and Africa, J. Pediatr. Suppl., 120 (4), S62 -  S71.
Koletzko, B., I. Thiel, P.O. Abiodun, (1992), The fatty acid composition o f human milk 
in Europe and Africa, J. Pediatr. Suppl, 120, s62 -  70.
Kumpulainen, J.L., A.M. Salmenpera, (1985), Selenium status o f exclusively breast­
fed infants as influenced by maternal organic or inorganic selenium supplementation, 
Am . J. Clin. Nutr., 42, 829 - 835.
Kumpulainen, J.L., (1987), Formula feeding results in lower selenium status than 
breast-feeding or selenium supplemented formula feeding: a longitudinal study, Am. J. 
Clin. Nutr., 45, 49 -  53.
Langford, N., D.J. Lewis, H.M. Cruz, (2000), Iodine speciation in pasteurised milk and 
infant formula, Whistler 2000 Speciation conference, Whistler, 25th June -  1st July 
2000, British Columbia, Canada.
Larsen, E.H., M.B. Ludwegsen, (1997), Determination o f Iodine in Food-related 
Certified Reference Materials using W et Ashing and Detection by Inductively Coupled 
Plasma Mass Spectrometry, J. Anal. Atom. Spectrom., 12, 435 -  439.
163
Larsen, E.H., P. Knuthsen, M. Hansen, (1999), Seasonal and regional variations o f  
iodine in Danish dairy products determined by ICP-MS, J. Anal. At. Spectrom., 14, 41 -  
44.
Lee, C.K., R.J. Finlayson, (1986), Analysis o f Milk Powder by Direct Nebulisation into 
the ICP, Pertanika, 9 (3), 35 3 -3 5 8 .
Levander, O.A., P.B. Moser, V.C. Morris, (1989), Dietary selenium intake and 
selenium concentrations in plasma, erythrocytes, human milk in pregnant post-partum 
lactating and non-lactating women, Am . J. Clin. Nutr., 46, 694 -  698.
LGC, (1999), Current Procedures to ensure that conclusions in research papers from 
postgraduate research are based on valid measurements, Laboratory o f the Government 
Chemist, Teddington, U K, 1 -  26.
Linfield, W .M ., D.J. O ’Brien, S. Serata, R.A. Barauskas, (1984), Lipid-lipase 
interactions 1. Fat splitting with lipase from Candida rugosa, J. A O C S, 61 (6 ), 1067 -  
1071.
Litov, R .E ., (1989), Selenium status in term infants fed human milk or infant formula 
with or without added selenium, Nutr. Res., 9, 585 -  596.
Litov, R.E., G.F. Combs, (1991), Selenium in pediatric nutrition, Pediatrics, 87, 339 - 
351.
Lonnerdal, B., (1991), Concentration, compartmentation and bioavailability o f  trace 
elements in the nutrition o f children II., Raven Press, New York.
Lonnerdal, B., (1997), Effects o f Milk Components on Calcium, Magnesium, and Trace 
Element Absorption During Infancy, Physiological Reviews, 77, (3), 643 -  669.
164
Lucas, A., J.A.H. Gibbs, R.L.J. Lyster, J.D. Baum, (1978), Creamatocrit: simple 
clinical technique for estimating fat concentration and energy value o f human milk, 
British Medical Journal, I ,  1018 -  1020.
Lythgoe, P.R., D.A. Polya, C. Parker, (2001), Improved determination o f arsenic and 
selenium species in water by coupled Ion Chromatography and Inductively Coupled 
Plasma Mass Spectrometry with post column reaction and ultrasonic nebulisation, to 
press.
Matusciewicz, H., R.E. Sturgeon, S.S. Bennan, (1989), Trace element analysis o f  
biological materials with H N 0 3 -H 2 0 2  and microwave heating, J. Anal. At. Spectrom., 4, 
3 2 3 -3 2 7 .
Meinhold, H., (1991), Effects o f selenium deficiency on thyroid hormone synthesis and 
metabolism. Abstract no. 309, 10th International Development Research Centre, IDRC  
136, Ottawa, Canada.
Mesley, R.J., W.D. Pocklington, R.F. Walker, (1991), Analytical quality assurance: A  
review, Analyst, 116 (10), 975 -  989.
Michalke, B., (1994), Quality control in speciation investigations, F.J. Anal. Chem., 350 . 
2- 6.
Michalke, B., (1999), Quality control and reference materials in speciation analysis, F. J. 
Anal. Chem., 363, 439 -  445.
Michalke, B., P. Schramel and A. Kettrup, (1999a), Capillary electrophoresis coupled 
to inductively coupled plasma mass spectrometry (CE /  ICP-M S) and to electrospray 
ionisation mass spectrometry (CE /  ESI-M S): An approach for maximum species 
information in speciation o f selenium, F. J. Anal. Chem., 363. 456 -  459.
165
Michalke, B., P. Schramel and H. Witte, (2000), Method Developments for Iodine 
Speciation by Reversed-Phase Liquid Chromatography -  ICP -  Mass Spectrometry, Biol. 
Trace Elem. Res., 78, 6 7 - 7 9 .
Michalke, B., H. Witte and P. Schramel, (2001), Developments for a robust method for 
selenium speciation, 2nd International Conference on Trace Element Speciation in 
Biomedical, Nutritional and Environmental Sciences, May 07 -  10/05/2001, Munich, 
Germany.
Micromass Ltd, (1999), 2nd International Symposium on the enabling role o f Mass 
Spectrometry: ICP and stable isotopes, November 1999, Manchester, UK.
Miller, J.C., J.N. Miller, (1988), Statistics for Analytical Chemistry, 2nd edition, Ellis 
Horwood Ltd., Chichester, UK.
Milner, J.A., L. Sherman, and M.F. Picciano, (1987), Distribution o f selenium in 
human milk, Am . J. Clin. Nutr., 45, 617 -  624.
Mishra, S., V. Singh, A. Jain and K.K. Verma, (2000), Determination o f iodide by 
derivatisation to 4-iodo-N, N-dimethylaniline and gas chromatography -  mass 
spectrometry, Analyst, 125, 459 -  464.
Mohl, C., H. Emons, M. Burow, K. Hoppstock and K. May, (2001), Reference 
materials and quality assurance for speciation analysis in biomonitoring programs, 2 nd 
International Conference on Trace Element Speciation in Biomedical, Nutritional and 
Environmental Sciences, May 07 -  10/05/2001, Munich, Germany.
Moser-Yeillon, P.B., A.R. Mangels, ICY. Patterson, C. Veillon, (1992), Utilisation o f  
two different chemical forms o f selenium during lactation using stable isotope tracers: an 
example o f speciation in nutrition, Analyst, 117. 559 -  562.
166
Muntau, H., P.H. Quevaiviller, (2001), Reference materials for metal species analysis, 
2nd International Conference on Trace Element Speciation in Biomedical, Nutritional 
and Environmental Sciences, May 07 — 10/05/2001, Munich, Germany.
Negretti de Bratter, V .E ., S. Recknagel, D. Gawlik, (1995), Speciation o f Se, Fe and
Zn in Human Milk Whey: The use o f Instrumental Neutron Activation Analysis (IN A A ) 
to corroborate element profiles measured with Inductively Coupled Plasma Atomic 
Emission Spectrometry (ICP-AES), F.J. Anal. Chem., 353. 137 -  142.
Neidhardt, B., (2001), Quality assurance and reference materials in speciation analysis, 
2nd International Conference on Trace Element Speciation in Biomedical, Nutritional 
and Environmental Sciences, May 07 -  10/05/2001, Munich, Germany.
Nobrega, J.A., Y. Gelinas, A. Knishevska, R.M. Barnes, (1997), Direct determination 
o f major plus trace elements in milk by ICP-AES /  -M S, J. Anal. At. Spectrom., 12, 1243 
-  1246,
Oster, O., (1988), The organ distribution o f selenium in German adults, Biol. Trace 
Elem. Res., 15, 23 - 4 5 .
Pannier, F., J. Szpunar, R. Lobinski and M. Potin-Gautier, (2001), Speciation and 
characterisation o f selenocompounds in bio-materials by combination o f HPLC-ICP-MS  
and ESI-M S /  E SI-M S-M S, 2nd International Conference on Trace Element Speciation in 
Biomedical, Nutritional and Environmental Sciences, May 07 -  10/05/2001, Munich, 
Germany.
Parr, R. F., (1991), Minor and trace elements in human milk from Guatemala, Hungary, 
Nigeria, Philippines, Sweden and Zaire, Biol. Trace Elem. Res., 29, 51 -  60.
Passwater, R.M., E.M. Cranton, (1983), Trace elements, hair analysis and nutrition, 
Keats Publishing Inc., CT, U SA , pp!71 -  207.
167
Patel, M.T., R. Nagarajan, A. Kilara, (1996), Hydrolysis o f milk fat by lipase in 
solvent-free phospholipid reverse micellar media, J. Food Science, 61, (1), 3 3 - 3 8 .
Pennington, J. A. T., (1989), Nutritional elements in US diets: results from the Total 
Diet Study, 1982 to 1986, J. Am . Diet. Assoc., 89, 659 -  664.
Picciano, M.F., (1998), Human Milk: Nutritional Aspects o f Dynamic Food, Biol. 
Neonate, 74, 8 4 -9 3 .
Potts, P.J., (1987), A  Handbook o f Silicate Rock Analysis, Blackie &  Sons Ltd, London, 
UK.
QunSun, C., C. O ’Connor, (1999), Communication: Application o f enzymolysis to 
milk samples and measurement o f Free Fatty Acids (FFA) by GC-FID.
Radlinger, G., K.G. Heuinann, (1998), Iodine determination in food samples using 
Inductively Coupled Plasma Isotope Dilution Mass Spectrometry, Anal. Chem., 70, 2221 
-  2224.
Raghunadha, R., A . Chatt, (1993), Determination of nanogram amounts o f  Iodine in 
foods by R N A A , Analyst, IT, 1247 -  1251.
Rao, R.R., A . Chatt, (1991), Microwave acid digestion and preconcentration Neutron 
Activation Analysis o f biological and diet samples for iodine, Anal. Chem., 63, 1298 -  
1303.
Rao, R .R ., A . Chatt, (1993), Determination o f ng amounts o f iodine in foods by 
radiochemical neutron activation analysis (N A A ), Analyst, IT, 1247 -  1251.
Rayman, M.P., F.R. Abou-Shakra, N.I. Ward, (1996), Determination o f Selenium in 
Blood serum by Hydride Generation Inductively Coupled Plasma Mass Spectrometry, J. 
Anal. At. Spectrom., IT, 61 -  6 8 .
168
R aym an, M .P ., (2000), The importance o f selenium to human health, The Lancet, 356 . 
2 3 3 -2 4 1 .
Renner, E., (1989), Micronutrients in milk and milk-based food products, Elsevier 
Applied Science, London.
Sakurai, H. and K. Tsuchiya, (1975), A  tentative recommendation for the maximum 
daily intake o f selenium, Environ. Physiol, and Biochem., 5, 107 -  118.
Sanchez, L.H. and J. Szpunar, (1999), Speciation analysis for iodine in milk by size- 
exclusion chromatography with inductively coupled plasma mass spectrometric detection 
(SEC-ICP-M S), J. Anal. At. Spectrom., 14, 1697 -  1702.
Satatchandra, IC, W . Heller, (1981), Oxidation o f elemental selenium to selenite by 
Bacillus megaterium, Science, 211. 600 - 601.
Schroeder, H .A ., (1970), Essential trace elements in man; Selenium, J. Chronic 
Diseases, 23, 227 -  243.
Sertl, D., W . Mallone, (1993), Liquid Chromatography method for determination o f  
iodine in milk: collaborative study, J. A O  A C  Int., 76, (4), 711 -  720.
Sherlock, J.C., W.H. Evans, J. Hislop, J.J. Kay, R. Law, D.J. McWeeny, G.A.,
(1985), Analysis -  accuracy and precision?, Chemistry in Britain, November, 1019 -  
1021.
Smart, G. Topping and R. Wood, (1985), Analysis -  accuracy and precision?, 
Chemistry in Britain, November, 1019-1021.
Smith, A.M., M.F. Picciano, J.A. Miller, (1982), Selenium intakes and status o f human 
milk and formula-fed infants, Am . J. Clin. Nutr., 35, 521 - 526.
169
Sokoloff, L., (1985), Endemic forms o f osteoarthritis, Clinics in Rheumatic Diseases, 11. 
1 8 7 -2 0 2 .
Stark, H.J., J. Mattusch, R. Wennrich, A. Mroczek, (1997), Investigation o f the IC- 
ICP-MS determination o f iodine species with reference to sample digestion procedures, 
F.J. Anal. Chem., 359, 371 -  374.
Sternberg, M., (1972), Bond specificity, active site and milk clotting mechanism o f the 
mucor miehei protease, Biochim. Biophys. Acta, 285 . 383 - 3 9 2 .
Sturup, S., A. Buchert, (1996), Direct determination o f copper and iodine in milk and 
milk powder in alkaline solution by flow injection ICP-MS, F.J. Anal. Chem., 354, 323 -  
326.
Szpunar, J., (2000), Bio-inorganic speciation analysis by hyphenated techniques, 
Analyst, 125. 963 -  988.
Szpunar, J., (2000b), Trace element speciation analysis o f biomaterials by high- 
performance liquid chromatography with inductively coupled plasma mass spectrometric 
detection, Trends in Anal. Chem., 19, (2/3), 127 -  137.
Tanaka, Y., J. Hirano, T. Funada, (1992), Concentration o f docosahexaenoic acid in 
glyceride by hydrolysis o f fish oil with Candida cylindracae lipase, J. A O C S, 69, (12), 
1 2 0 1 -1 2 1 4 .
Taylor, J.K., (1983), Validation o f Analytical Methods, Anal. Chem., 55 (6 ), 600A  -  
608A.
Templeton, D.M., (1999), Biomedical aspects o f trace element speciation, F. J. Anal. 
Chem., 363, 5 0 5 -5 1 1 .
Thompson, C.D., R.D.H. Stewart, (1973), Metabolic studies o f 75Se-selenite in the rat, 
B.J. Nutr., 30, 1 3 9 -1 4 7 .
170
Thompson, C.D., (1994), Proc. Nutr. Soc, N .Z ., J_9, 115.
Thompson, C.D., (1998), Selenium speciation in human body fluids, Analyst, 123. 827 -  
831.
Thompson, M., (1988), Variation o f precision with concentration in an analytical 
system, Analyst, 113. 1579 -  1587.
Tsang, R., (1988), Nutrition during infancy, Hanley &  Befing Inc., Phil., U SA , p p l34  -  
409.
UNICEF, (2000), The Best Start to Life, http://www.unicef.org/uniceft98-1009/pirozzi 
and http://www.unicef.org/ffl/bf.htm.
VandeCasteele, C., C.B. Block, (1993), Modern methods for trace element 
determination, John Wiley &  Sons, Chichester, UK.
Vandecasteele, C. and C.B. Block, (1994), Modern Methods for Trace Element 
Determination, John W iley &  Sons, Chichester, UK.
Vanhaecke, F., L. Moens, (1999), Recent trends in trace element determination and 
speciation using ICP-MS, F.J. Anal. Chem., 364. 440 -  451.
Vanhoe, H., VandeCasteele, C., Versieck, J. and Dams, R., (1989), Determination o f  
iron, cobalt, copper, zinc, rubidium, molybdenum and cesium in human serum by 
inductively coupled plasma mass spectrometry, Anal. Chem., 61, 1851 -  1857.
Vanhoe, H., VandeCasteele, C., Versieck, J. and Dams, R., (1989a), Determination o f  
trace elements in a human serum reference material by inductively coupled plasma mass 
spectrometry, Mikrochimica Acta, 1 1 1 ,3 7 3 -3 7 9 .
Vanhoe, H., F.V. Allemeersch, (1993), Effect o f solvent type on the determination o f  
total iodine in milk powder and human serum by ICP-MS, Analyst, 118. 1 0 1 5 -1 0 1 9 .
171
Vanhoe, H., J. Goossens, L. Moens, R. Dams, (1994), Spectral interferences 
encountered in the analysis o f biological materials by inductively coupled plasma mass 
spectometry, J. Anal. At. Spectrom., 9, 177 -  185.
Vanhoe, H., L. Moens, R. Dams, (1994), Thermospray nebulisation as sample 
introduction for inductively coupled plasma mass spectrometry, J. Anal. At. Spectrom., 9 
( 8 ), 8 1 5 -8 2 1 .
Ward, N.I., F.R. Abou-Shakra, S.F. Durrant, (1990), Trace Element Content o f 
Biological Materials. A  Comparison o f N A A  and ICP-MS Analysis, Biol. Trace Elem. 
Res.. 26 /2 7 . 1 7 7 - 188.
Ward, N.I, J.A. Adair, M.J. Watts, (2000), Analytical Methods for Trace Elements in 
Biological Tissues and Fluids: Principals and Fundamentals o f ICP-M S, 6 th International 
Symposium on Metal Ions in Biology and Medicine, May 7 -  10, 2000, San Juan, Puerto 
Rico.
Ward, N.I., J.A. Adair, (2001), Selenium speciation o f blood serum and urine in 
relation to selenium supplements by HPLC-ICP-QM S, 2nd International Conference on 
Trace Element Speciation in Biomedical, Nutritional and Environmental Sciences, May 
07 -  10/05/2001, Munich, Germany.
Watts, M.J., (1998), Evaluation o f de-icing salt application to British motorways using 
Ion Exchange Chromatography and Inductively Coupled Plasma Mass Spectrometry, 
M Sc thesis, Department o f Chemistry, University o f Surrey, Guildford, GU2 7XH , UK.
Watts, M.J. and N.I. Ward, (2001), Enzymatic pre-digestion o f human breast milk and 
infant formula for total iodine and speciation analysis by Ion Chromatography and 
Inductively Coupled Plasma Mass Spectrometry (IC-ICP-M S), 2nd International 
Conference on Trace Element Speciation in Biomedical, Nutritional and Environmental 
Sciences, May 07 -  10/05/2001, Munich, Germany.
172
Weast, R.C., (1995), CRC Handbook o f Chemistry and Physics, 64th Edition, CRC  
Press Inc., New  York, U SA.
Webb, G.P., (1995), Nutrition: A  health promotion approach, Edward Arnold, London, 
U K , pp235 -  275.
Wellington, S.N., R.L. Masamba, A. Montaser, (1983), Investigation o f helium 
inductively coupled plasma mass spectrometry for detection o f metals and non-metals in 
aqueous solutions, Anal. Chem., 65, 2784 -  2790.
W HO, (1981), International code o f marketing o f Breast milk substitutes, World Health 
Organisation, Geneva.
W H O, (1987), Selenium: Environmental Health Criteria, 58, World Plealth Organisation, 
Geneva.
W H O / IAEA, (1989), Minor and Trace Elements in Milk, World Health Organisation /  
International Atomic Energy Authority, Geneva.
W HO, (2000), Disease Eradication /  Elimination goals: Iodine Deficiency Disorders 
http://www.who.int/nut/malniitrition worldwide.htm.
http://www.who.int/aboutwho/en/disease er.htm -  01/03/00, World Health Organisation, 
Geneva.
Williams, J.G., A.L Gray, (1988), High dissolved solids and ICP-M S: are they 
compatible?, Analytical Proceedings, 25, 385 -  388.
Wolff, J., (1969), Transport o f Iodide and other Anions in the Thyroid Gland, Physiol. 
Rev., 44, 45 -  90.
Workshop on Current Issues in Feeding the Normal Infant, (1984), The Baby 
Friendly Hospital Initiative, 3 UN  Plaza, New York, N Y  10017, U SA.
173
Yang, G .I., Wang, S., Zhou, R. and Sun, S., (1983), Endemic selenium intoxication o f  
humans in China, Am . J. o f Clin. Nutr., 37, 872 - 881.
Yang, G .I., (1989), Studies o f safe maximal daily dietary selenium intake in a 
seleniferous area in China. 1. Selenium intake and tissue selenium levels o f inhabitants, 
J. Trace Elements and Electrolytes in Health and Disease, 3, 77 -  87.
Ysart, G., P. Miller, H. Crews, P. Robb, M. Baxter, C. DeL'Argy, S. Lofthouse, C. 
Sargent and N. Morrison, (1999), Dietary Exposure estimates o f 30 elements from the 
U K  Total Diet Study, Food Additives and Contaminants, 16, (9), 391 -  403.
Zetterstrom, R., (1999), Breastfeeding and mother-infant interaction, Acta Pediatr. 
Suppl., 430 . 1 —63.
Zheng, J., W . Gossler, W . Kosmus, (1998), The chemical forms o f selenium in 
selenium nutritional supplements: an investigation by using HPLC-ICP-M S and GF- 
A A S , Trace Elements &  Electrolytes, 15 (2), 7 0 - 7 5 .
174
Appendices
Appendix A
Appendix A .l :  Comparison o f H N O 3 used with: microwave, open vessel, 
enzymolysis coupled with open vessel digestion.
Infant Formula Microwave
digestion
Open Vessel Open Vessel 
Enzymolysis /  H N O 3 
(C.rugosa /  M.miehei)
Iodine
(gg/kg)
Selenium
(Pg/kg)
Iodine
(Pg/kg)
Selenium
(Pg/kg)
Iodine
(Pg/kg)
Selenium
(Pg/kg)
NIST CR M  1549
(I2: 3380 /  Se: 110 pg/kg)
987 +  
97
391 +  
228
855 + 10 415 +  
288
na na
Cow +  Gate Plus 1090 2231 829 74 1 1 1 2 na
Cow +  Gate Premium 930 996 841 620 na na
Cow +  Gate Step-up 910 892 831 29 11a na
Cow +  Gate W ysoy 852 155 840 0 11a na
S M A  Gold 961 1 1 2 2 823 29 11a na
SM A  White 887 189 818 392 na na
S M A  Progress 864 4395 821 1302 na na
SM A  W ysoy 877 234 839 119 na na
Farleys 1st milk 928 41 819 29 11a na
Farleys 2nd milk 871 416 814 301 na na
Farleys follow - 0 1 1 858 143 813 0 na na
Farleys Infasoy 851 166 817 301 na 11a
Boots 1 934 2 1 2 825 0 na na
Boots 2 914 1462 824 29 na na
Boots Follow-on 864 0 817 756 na na
Milupa from birth 897 87 832 29 na na
Milupa forward 827 178 824 119 na na
Aptamil 1st 873 132 821 0 na na
Aptamil 2nd 932 416 822 0 na na
HIPP organic follow-on 848 1 2 0 844 0 11a na
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Appendix A .l: continued
Infant Formula Microwave
digestion
Open Vessel Open Vessel 
Enzymolysis /  H N O 3
Iodine
(Pg/kg)
Selenium
(Pg/kg)
Iodine
(Pg/kg)
Selenium
(Pg/kg)
Iodine
(pg/kg)
Selenium
(Pg/kg)
Nanny 865 1393 824 0 na na
Ninho 1 1057 439 833 846 na na
Ninho 2 884 98 843 165 11a na
N A N  1 860 1416 828 711 1464 na
N A N  2 882 1007 831 165 na na
N A N  PRE (mex) na na na na na na
N A N  1 (mex) na na na na na na
N A N  2 (mex) na na na na 11a na
N A N  H A  (mex) na na na na na na
Prosobee na na na na 11a na
S-26 na na na na na na
al- 1 1 0 na na 828 0 na na
Isomil na na . 818 0 954 na
Lactogen 1 na na na na na 11a
Lactogen 2 na na na na na na
Nurture Premium na na na na na na
Nurture Follow-on na na na na na na
na -  not analysed
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Appendix A .2 : Comparison o f HNO3 and T M A H  used for open vessel digestion o f  
the whey fraction (solute -  centrifuged /  filtered).
Infant Formula Open Vessel 
HNO3 -  whey fraction
Open Vessel 
TMAH -  whey fraction
Iodine
(pg/kg)
Selenium
(Pg/kg)
Iodine
(pg/kg)
Selenium
(Pg/kg)
NIST CR M  1549
(I2: 3 3 8 0 /S e : 110 pg/kg)
1827 ± 4 3 7 200 ±  89 1162 ± 2 4 0 72 ± 5 3
Cow +  Gate Plus 1272 2045 995 600
Cow +  Gate Premium 1642 822 846 196
Cow ±  Gate Step-up 1272 2934 883 511
Cow ±  Gate W ysoy 1 2 1 0 156 859 156
SM A  Gold 840 1822 505 320
SM A  White 469 1933 797 320
SM A  Progress 407 na 546 631
SM A  W ysoy 654 156 285 1 2 0
Farleys 1st milk 840 711 411 58
Farleys 2ncl milk 840 1156 430 31
Farleys follow-on 1170 1711 420 84
Farleys Infasoy 2616 1512 244 36
Boots 1 654 600 702 191
Boots 2 531 1045 624 236
Boots Follow-on 407 1822 367 253
Milupa from birth 2198 4156 576 311
Milupa forward 7260 45 366 4
Aptamil 1st 1951 2711 892 364
Aptamil 2 nd 840 711 267 0
HIPP organic follow-on 1 2 1 0 489 417 53
Nanny na 11a na na
Ninho 1 6864 2090 1067 595
Ninho 2 1580 711 724 213
177
Appendix A.2: continued
Infant Formula Open Vessel 
HNO3 -  whey fraction
Open Vessel 
TMAH -  whey fraction
Iodine
(pg/kg)
Selenium
(Pg/kg)
Iodine
(Pg/kg)
Selenium
(Pg/kg)
N A N  1 2074 489 720 93
N A N  2 2692 822 1283 98
N A N  PRE (mex) 5556 248 1227 151
N A N  1 (mex) 722 352 479 182
N A N  2 (mex) 6665 30 2076 373
N A N  H A  (mex) 4890 160 618 0
Prosobee 500 2 1 0 62 71
S-26 1138 130 459 0
al- 1 1 0 889 13 186 0
Isomil 1445 124 251 151
Lactogen 1 3195 148 601 0
Lactogen 2 4445 1204 1 2 1 0 0
Nurture Premium 2056 920 403 298
Nurture Follow-on 1584 1852 204 2 2 2
na -  not analysed
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Appendix B
Appendix B .l: Total fat measurements in human breast milk and infant formula 
digested by enzymolysis. (TL: Top layer, SL: Solute layer)
S am p le T L  (m m ) S L  (m m ) T L /S L  x  1 00  
( %  T ota l Fat)
C +G  Plus Ohrs (Mean: n =  5) 5.05 +  0.41
C +G  Soya Ohrs 3 29 10.34
Isomil Ohrs 2.5 31.5 7.94
Nani Ohrs 2 28 7.14
H BM  S Ohrs 1 28 3.57
H B M  S Ohrs 1 32.5 3.08
H B M  D1 Ohrs 1.5 27 5.56
H BM  D1 Ohrs 1.5 28 5.36
E l /I  C +G  Plus (m. miehei 3mg/ml) 0.5 33 1.52
E l/2  C +G  Plus (m. miehei 5mg/ml) <0.5 29 <1.52
E l/3  C +G  Plus (2 lipases) 1 29.5 3.39
E l/4  C +G  Plus (2 lipases) 1 27 3.70
E l/5  C +G  Plus (C. rugosa) 1 33 3.03
E l / 6  Nani (C.rugosa) 1.5 25.5 5.88
E l/7  Nani (C.rugosa) 1.5 26 5.77
E l / 8  Isomil (C. rugosa) 1.5 25 6 . 0 0
E l/9  Isomil (C. rugosa) 2 24.5 8.16
E2/1 2hrs C +G  Plus (3 enzymes) <0.5 29.5 <1.52
E2/1 24hrs C+G  Plus (3 enzymes) 0.5 30 1.67
E2/2 C +G  Plus (3 enzymes) 0.5 28.5 1.75
E2/3 2hrs C+Gplus (3 enz.) <0.5 26.5 <1.52
E2/3 4hrs C+Gplus (3 enz.) 0.5 25.5 1.96
E2/3 16hrs C +G  Plus (3 enz.) 0.5 2 2 2.27
E2/3 24hrs C +G  Plus (3 enz.) 0.5 27.5 1.82
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Appendix B .l: continued
S am p le T L  (m m ) S L  (m m ) T L /S L  x  1 0 0  
( %  T ota l F at)
E2/4 CRM  1549 (3 enzymes) 0 26.5 0 . 0 0
E2/5 H BM  S (3 enzymes) 0.5 27 1.85
E2/6 Nani (3 enzymes) 1 30 3.33
E2/7 Isomil (3 enzymes) 0.5 29 1.72
E2/8 C +G  Soya (3 enzymes) 0.5 32 1.56
E2/9 C+G  Plus (2 lipases) 0.5 33 1.52
E2/10 C +G  Plus (Pronase) 1.5 33 4.55
E 2 /1 1 C+G  Plus (m. miehei) 0.5 33 1.52
E3/1 C+G  Plus (3 enzymes) <0.5 27 <1.52
E3/2 C +G  Plus (3 enzymes) <0.5 29 <1.52
E3/3 2hrs C +G  Plus (3 enz +  lecithin) <0.5 30 <1.52
E3/3 4hrs C+G  Plus (3 enz +  lecithin) 0.5 24.5 2.04
E3/3 16hrs C+G  Plus (3enz.+ lecithin) 0.5 28 1.79
E3/3 24hrs C +G  Plus (3enz.+ lecithin) 0.5 27 1.85
E3/4 H BM  S (3 enz. +  lecithin) 0.5 27 1.85
E3/5 H BM  D1 (3 enzymes) 0.5 30.5 1.64
E3/6 H B M  D1 (3 enzymes) 0.5 27.5 1.82
< 1 .52% : Lower limit o f detection for percentage (% ) total fat.
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Appendix B.2.1: Gas chromatograph o f C6, Cg, Cio and C 12 free fatty acids (FFA).
Appendix B.2: Determination o f free fatty acids (FFA) in human breast milk and
infant formula.
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Appendix B.2.2: Gas chromatograph o f  C 14, Ci6 and Cis free fatty acids (FFA).
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Appendix B.2.3: Gas chromatograph o f C2o (15.97 mins), C22 (17.58 mins) and 
C 2 4 ( 19.99 mins) free fatty acids (FFA).
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Appendix B.2.4: Peak height observed for free fatty acids before (0 hrs) and after 
enzymolysis.
Sample Free fatty acids (Peak height)
c6 c8 Cio C l2 C , 4 Cifi Cig C 2 0 C 2 2 C 2 4
0 hrs
CRM  1549 Ohrs 4.25 3.23 1.74 6.3 1.37 1.48 1.22 2.24 1.50 1.61
H BM  D1 Ohrs 10.39 2.08 1.02 14.74 0.83 1.16 0.83 2.42 2.74 2.11
H BM  S Ohrs 7.03 1 . 8 1.99 4.12 0.69 1.14 0.55 1 . 0 1 0.55 0 . 6 6
C+G  Soya Ohrs 8.33 1 . 2 0 . 6 6 4.25 0.50 1.08 0.96 0.94 1.26 2.50
C+G  Plus Ohrs 3.29 0.83 0.24 5.31 1.72 4.73 2.15 4.44 1.31 2.06
N A N I Ohrs 4.84 1.54 0.61 6.76 1.78 4.89 2.48 1.25 1.40 2.07
Isomil Ohrs 8.08 1.28 0.34 8.45 1.80 4.26 2.14 1.16 1.15 1.74
Enzyme Digestion 1
C +G  Plus Ohrs 3.29 0.83 0.24 5.31 1.72 4.73 2.15 4.44 1.31 2.06
1 C+G  Plus 
(3 mg/ml M.miehei)
5.13 2.02 1.93 3.56 1.02 3.13 2.27 0.83 0.94 1.19
2 C+G  Plus 
(5 mg/ml M.miehei)
3.71 1.78 1.63 2.78 1 . 0 0 3.16 1.93 0.95 1.15 0.83
3 C +G  Plus (M. 
miehei +  C.rugosa)
3.39 1.63 1.21 2.27 0.75 2.57 1.56 0.97 1.03 0.91
4 C +G  Plus 
(M.miehei +  
C.rugosa)
6.60 1.49 1.13 1.97 0.75 1.75 1.28 0.82 0.63 0.46
5 C+G  Plus 
(C.rugosa)
5.59 1.93 1.27 2.97 1.18 3.61 1.40 1 . 1 1 1.16 1.37
N A N I Ohrs 4.84 1.54 0.61 6.76 1.78 4.89 2.48 1.25 1.40 2.07
6  N A N I (C.rugosa) 3.98 2 . 6 8 1.72 2.76 1.50 5.31 2.89 1.85 1.84 1.56
7 N A N I (C.rugosa) 4.52 2.62 1.89 2.93 1.40 3.29 1.89 1.76 2.69 1 . 2 1
Isomil Ohrs 8.08 1.28 0.34 8.45 1.80 4.26 2.14 1.16 1.15 1.74
8  Isomil (C.rugosa) 2 . 0 2 1.82 1.24 2.07 0 . 8 6 1.97 1 . 6 8 1.17 1.25 1.45
9 Isomil (C.rugosa) 8.97 1.77 1.13 1.89 0.65 1.74 1.29 2.85 1.58 3.17
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Appendix B.2.4: continued
Sample Free fatty acids (Peak height)
c6 c8 Cio C l2 C 14 C i6 Cis C2o C 2 2 C24
Enzyme Digestion 2
C +G  Plus Ohrs 3.29 0.83 0.24 5.31 1.72 4.73 2.15 4.44 1.31 2.06
1 C +G  Plus 4.04 2.34 2.17 7.83 1.71 1.63 2.28 3.70 4.42 4.79
2 C+G  Plus 3.64 1.72 2.15 10.41 2.14 1.41 1.51 2.67 2.85 4.76
3 C +G  Plus 2hrs 7.42 16.5 19.66 21.09 1.50 1.64 1.39 6.30 10.56 9.94
3 C +G  Plus 4hrs 4.12 2.38 5.88 10.29 1.54 1.72 7.22 10.26 8 . 0 0
3 C+G  Plus 16hrs 8 . 2 0 22.3 15.03 2.58 3.91 3.09 9.19 1 1 . 6 9.87
3 C +G  Plus 24hrs 3.95 1.60 1.23 10.67 1.40 2.09 2.07 5.47 7.27 6.34
CRM  1549 Ohrs 4.25 3.23 1.74 6.30 1.37 1.48 1 . 2 2 2.24 1.50 1.61
4 CR M  1549 2.13 0.67 2.47 3.75 2.48 2.4 1.87 1.65 2.15 3.09
H BM  S Ohrs 7.03 1 . 8 1.99 4.12 0.69 1.14 0.55 1 . 0 1 0.55 0 . 6 6
5 H BM  S 3.01 1.07 1.09 3.16 1.74 1.94 1.81 1.71 1.98 2.93
N A N I Ohrs 4.84 1.54 0.61 6.76 1.78 4.89 2.48 1.25 1.4 2.07
6  N A N I 2.63 1.58 2.07 10.79 4.38 4.28 7.00 4.21 6 . 2 0 4.21
Isomil Ohrs 8.08 1.28 0.34 8.45 1.80 4.26 2.14 1.16 1.15 1.74
7 Isomil 2.81 2.80 3.07 15.5 6.77 9.83 8.89 3.84 7.57 7.79
C +G  Soya Ohrs 8.33 1 . 2 0 0 . 6 6 4.25 0.50 1.08 0.96 0.94 1.26 2.50
8  C +G  Soya 2.69 1.48 1 . 8 8 9.80 2.76 3.25 3.70 2.45 4.56 4.58
C +G  Plus Ohrs 3.29 0.83 0.24 5.31 1.72 4.73 2.15 4.44 1.31 2.06
9 C +G  Plus 
(C.rugosa)
4.16 1.76 1.78 8.23 3.02 3.42 4.14 2.42 5.66 4.63
10 C +G  Plus 
(pronase)
4.36 2.23 9.63 12.84 2.48 2 . 1 1 2.25 1.44 2.71 3.50
11 C +G  Plus 
(M. miehei)
4.55 4.06 3.44 8.89 2 . 2 1 2.43 3.14 2.23 3.05 2.97
Enzyme Digestion 3
C +G  Plus Ohrs 3.29 0.83 0.24 5.31 1.72 4.73 2.15 4.44 1.31 2.06
1 C +G  plus 2.53 0.78 0.60 10.73 0.81 1.07 1.33 2.14 2.79 2.06
185
Appendix B.2.4: continued
Sample Free fatty acids (Peak height)
c 6 c 8 Cio C , 2 C)4 C i6 C i8 C2o C 2 2 C 2 4
2 C+G  Plus 2.61 1.37 1 . 0 0 11.06 1 . 0 1 1 . 2 1 1 . 2 2 1.33 1.50 1.48
3 C +G  Plus 2hrs 2.85 1.70 1 . 0 0 8.52 1.64 1.85 2.06 1.94 1 . 8 6 2.77
3 C +G  Plus 4hrs 3.21 1.93 1.38 9.50 1.23 1.44 1.72 2.05 2.30 3.23
3 C +G  Plus 16hrs 3.06 1 . 6 8 1.34 10.91 1.60 1.75 1.90 1.93 3.10 3.14
3 C +G  Plus 24hrs 2.41 1.37 1.03 9.71 0.99 0 . 8 6 1.19 1.54 1.67 1.90
H BM  S Ohrs 7.03 1.80 1.99 4.12 0.69 1.14 0.55 1 . 0 1 0.55 0 . 6 6
4 H BM  S 24hrs 2.94 2.34 0.77 1.54 0.65 0.97 0.87 1.42 1.39 1.37
H BM  D1 Ohrs 10.39 2.08 1 . 0 2 14.74 0.83 1.16 0.83 2.42 2.74 2 . 1 1
5 H B M D 1 4.85 1.64 1.06 6 . 0 2 0.91 1.15 1.13 1.38 1.43 1 . 6 6
6 H B M D 1 4.80 1.51 1.17 7.72 1.08 1.47 1.09 1 . 1 2 1.80 2.76
Appendix B .3: Total protein measurements in human breast milk and infant formula 
digested by enzymolysis.
Sample Absorbance
Reagent Blank 1.05
Protein STD 0.90
Protein STD 0.79
No Enzyme Digestion
C +G  Plus Ohrs 2.69
C +G  Soya Ohrs 4.01
Isomil Ohrs 4.06
Nani Ohrs 3.69
CRM  1549 Ohrs 1 . 1 2
H BM  S Ohrs 3.03
H BM  D1 Ohrs 2.53
Enzyme Digestion 1
E l /I  C +G  Plus (M. miehei 3mg/ml) 1.43
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Appendix: B.3: continued
Sample Absorbance
E l/2  C +G  Plus (M . miehei 5mg/ml) 1.33
E l/3  C +G  Plus (C.rugosa +  M.miehei) 1.72
E l/4  C+G  Plus (C.rugosa +  M.miehei) 1.72
E l/5  C +G  Plus (C. rugosa) 1.49
E l / 6  Nani (C.rugosa) 1.74
E l/7  Nani (C.rugosa) 1.51
E l / 8  Isomil (C. rugosa) 2.62
E l/9  Isomil (C. rugosa) 1.81
Enzvine Digestion 2
E2/1 2hrs C +G  Plus (3 enzymes) 0.96
E2/2 C +G  Plus (3 enzymes) 0.95
E2/3 2hrs C+G  Plus (3 enzymes) 1 . 0 0
E2/3 4hrs C+G  Plus (3 enzymes) 1.03
E2/3 16hrs C+G  Plus (3 enzymes) 1 . 0 0
E2/3 24hrs C+G Plus (3 enzymes) 1.06
E2/4 CR M  1549 (3 enzymes) 0.91
E2/5 H BM  S (3 enzymes) 1.03
E2/6 Nani (3 enzymes) 1.23
E2/7 Isomil (3 enzymes) 1.04
E2/8 C +G  Soya (3 enzymes) 0.96
E2/9 C +G  Plus (C.rugosa +  M.miehei) 1.37
E2/10 C +G  Plus (Pronase) 1.21
E 2 /1 1 C +G  Plus (M. miehei) 1.36
Enzyme Digestion 3
E3/1 C +G  Plus (3 enzymes) 1.01
E3/2 C +G  Plus (3 enzymes) 1.03
E3/3 2hrs C+G  Plus (3 enz +  lecithin) 0.98
E3/3 4hrs C +G  Plus (3 enz +  lecithin) 0.99
E3/3 16hrs C+G  Plus (3enz.+ lecithin) 0.98
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Appendix: B.3: continued
Sample Absorbance
E3/3 24hrs C+G Plus (3enz.+ lecithin) 0.99
E3/4 HBM  S (3 enz. +  lecithin) 1.04
E3/5 HBM  D1 (3 enzymes) 1.05
E3/6 HBM  D1 (3 enzymes) 1 . 0 0
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